Stereochemical Control in Complex Molecule Synthesis by White, Lorenzo
Stereochemical Control in Complex 
Molecule Synthesis 
 
A thesis submitted for the Degree of Doctor of Philosophy 
of the Australian National University 
by 
Lorenzo Valentino White 
 
Research School of Chemistry  
 
 
Canberra, Australia 
 
December, 2015.
 
i 
 
Declaration  
 
I declare that the material presented in this Thesis represents the result of original work 
carried out by me during the period 2012-2015 and has not been submitted for examination 
for any other degree. This thesis by publication is comprised of eight journal articles. 
Wherever possible, established methodologies have been acknowledged by citation of the 
original publications. 
 
 
 
 
 
 
Lorenzo White 
December, 2015.  
 
 
 
 
 
 
 
 
 
 
ii 
 
Dedication 
 
Although these words represent the beginning of the end of this body of work, it is never too 
late to say grace: ‘For the scientific work we are able to carry out, we thank the working 
class.’ We should begin by thanking our own stores, workshop and administrative staff, who 
themselves know that the creative labour they perform is made possible by things that come 
from far further afield than the store room. Hence, we thank the packers, postal workers and 
delivery drivers; the factory hands and plant workers who built the trailers and trucks; the 
navvies who laid the highways and rail tracks; the building workers who built the processing 
plants and warehouses; the clerks, secretaries and public servants in offices and 
administration buildings; and the cleaners and cafe staff who every day carry out the 
necessary labour that constitutes the true material structure of our society. It is to them, and 
many more, who we owe the research we undertake every day. Hence we owe all of our 
science to the entirety of the working people, to a social continuum of human creativity 
spanning the globe. We should have the grace to thank them. 
 
 
 
 
 
 
 
 
 
 
 
iii 
 
Acknowledgements 
 
I owe a significant debt to Brett Schwartz, Laurent Petit and Pat Sharp, all of whom were 
senior researchers during the course of my studies and who contributed more than anybody 
else to my theoretical knowledge and practical skills in this field. Above all, these men taught 
me the most important thing: to love our science.  
To Nadia Gao, Ping Lan, Sylvia Yang, Xiang Ma, Qiang Liu, Geoffroy Lonca, Song Bae and 
Giuseppe Barca, who were at different times colleagues and lab mates during my PhD studies 
and who all, in their own ways, lightened the burden of my work with encouragement, with 
sympathy, and with brave words in which high courage glowed. I hope that our friendships 
endure for much longer than our scientific careers.  
To Professor Sam Zard, who generously accommodated me in his group at the École 
Polytechnique in Paris for the last 6 months of my PhD studies. I have never met a man of 
such towering intellect who at the same time remains so gentle and compassionate in his 
dealings with those around him.  
To Tony Willis, for his highly thorough and professional X-ray crystallographic work and to 
the Research School of Chemistry safety committee for the important and challenging work 
they do ensuring that we are able to come home to our loved ones every night.  
To my colleague and now my love Shen Tan. I could not have done this without her.  
And finally to my supervisor Professor Martin Banwell. The standard platitudes will simply 
not suffice to describe the debt that I and the entire scientific community owe to this unique 
man. Over our nearly 8 year relationship he has become like a father figure to me, and the 
course of my entire life has been changed for the better as a result of the faith that he has 
always placed in me.  
Thank you. 
 
 
iv 
 
Publications and Presentations 
 
The following list details the publications and presentations that have resulted from the 
author’s research work performed during his candidature for the Degree of Doctor of 
Philosophy. 
Publications: 
1. Raney® Cobalt – An Underutilised Reagent for the Selective Cleavage of C–X 
and N–O Bonds 
Martin G. Banwell, Mathew T. Jones, Tristain A. Reekie, Brett D. Schwartz, Shen H. 
Tan and Lorenzo V White.  
Organic and Biomolecular Chemistry, 2014, 7433. 
(Article featured on journal cover). 
2. A Chemoenzymatic Route to Enantiomerically Pure and Highly Functionalized 
Analogues of Vindoline 
Lorenzo V. White and Martin G. Banwell. 
Manuscript submitted to Journal of Organic Chemistry.  
3. ABC → ABCE/D Based Approaches to the Pentacyclic Ring System of the Vinca 
Alkaloids Using Intramolecular Hetero-[2+2]Cycloaddition and Gold(I)-
Catalysed 6-endo-dig Cyclisation Protocols 
Lorenzo V. White, Martin G. Banwell and Anthony C. Willis.  
Heterocycles, 2015, 90, 298. 
(Invited submission on the occasion of Professor Isao Kuwajima’s 77th birthday). 
4. Chemoenzymatic Pathways for the Synthesis of Biologically Active Natural 
Products 
Martin G. Banwell, Benoit Bolte, Joshua N. Buckler, Ee Ling Chang, Ehab S. Taher, 
Lorenzo V. White and Anthony C. Willis.  
(Invited submission) 
Manuscript submitted to The Journal and Proceedings of the Royal Society of NSW. 
 
 
v 
 
5. New, Homochiral Synthons Obtained through Simple Manipulations of 
Enzymatically Derived 3-Halo-cis-1,2-dihydrocatechols 
Lorenzo V. White, Martin G. Banwell, Ping Lan, Brett D. Schwartz and Anthony C. 
Willis. 
Australian Journal of Chemistry, 2015, 68, 1467. 
(Royal Australian Chemical Institute feature article for October 2015). 
6. The Conversion of Levoglucosenone into Isolevoglucosenone  
Xingua Ma, Natasha Anderson, Lorenzo. V. White, Song Bae, Warwick Raverty, 
Anthony C. Willis and Martin G. Banwell.  
Australian Journal of Chemistry, 2015, 68, 593. 
(Published in the Sir John Cornforth Memorial Issue). 
7. A Radical Solution to the Alkylation of the Highly Base-Sensitive 1,1-
dichloroacetone. Application to the Synthesis of Z-alkenoates and E,E-dienoates 
Lorenzo V. White, Lucile Anthore, Shiguang Li, and Samir Z. Zard. 
Organic Letters, 2015, 17, 5320. 
8. Carbonodithioic Acid S-[3-(Diethoxyphosphinyl)-2-oxopropyl] O-Ethyl Ester 
Lorenzo V, White.   
Encyclopedia of Reagents for Organic Synthesis [Online  (eEROS)],  
eds. D. Crich, A. B. Charette, P. L. Fuchs and T. Rovis, John Wiley and Sons Ltd.  
To be published online March 2016.  
 
 
 
 
 
 
 
 
 
 
vi 
 
Presentations: 
1. The Claisen Rearrangement in Alkaloid Synthesis: Aspidosperma and Beyond.  
Lorenzo V. White 
Invited lecture for the École Polytechnique Monday Seminar Series 2015.  
Paris, France, September 14th, 2015.  
2. Chemoenzymatic Approaches to the Vinca Alkaloids. 
Lorenzo V. White  
Invited lecture for the RACI NSW Organic Chemistry Group 35th Annual  
One-Day Symposium.  
Canberra, Australia, December 3rd, 2014. 
 
 
 
 
 
 
 
 
 
 
 
 
 vii 
Commentary on the Contributions of Mr Lorenzo White to 
the Eight Papers Included in this PhD Thesis by Publication 
 
Publication 1. This is a review article that was written by Professor Martin Banwell. It 
incorporates descriptions of research conducted by the co-authors including Mr White. Mr 
White carried out relevant literature surveys as part of his additional contributions to the 
preparation of the article. 
 
Publication 2. This is a full paper detailing extensive experimental work directed towards the 
synthesis of the complex alkaloid vindoline. Mr White carried out the entirety of the 
laboratory work reported in this article. In addition he collated/formatted all of the reported 
spectral data presented in the Supporting Information document. Mr White also wrote the 
whole of the Experimental Section and conducted relevant literature surveys. Professor 
Martin Banwell wrote the body of the paper (viz. the Introduction, Results and Discussion 
Section as well as the Conclusion). 
 
Publication 3. As with publication No. 2 listed immediately above, this is a full paper 
detailing extensive experimental work also directed towards the synthesis of the complex 
alkaloid vindoline. Mr White carried out the entirety of the laboratory work reported in this 
article save for the X-ray crystallographic studies that were conducted by the RSC’s resident 
crystallographer Dr Anthony Wills. In addition, Mr White collated/formatted all of the 
reported spectral data presented in the Supporting Information document. Mr White also 
wrote the whole of the Experimental Section and conducted relevant literature surveys. 
Professor Banwell wrote the body of the paper (viz. the Introduction, Results and Discussion 
and Conclusion). Mr White conceived of the precise details of this model study. 
  
Publication 4. This is a review article that was written by Professor Martin Banwell. It 
incorporates descriptions of research conducted by all of the co-authors including Mr White. 
Mr White carried out relevant literature surveys as part of his additional contributions to the 
preparation of the article. 
 viii 
Publication 5. Mr White conceived of and then conducted the bulk (ca. 80%) of the research 
work reported in this article. He assigned the structures of the novel products described and 
directed the work of his co-authors who assisted with the completion of the latter stages of 
the experimental work. In addition, Mr White collated/formatted the bulk (ca. 80%) of the 
spectral data presented in the Supporting Information document. Mr White also wrote ca. 
90% of the Experimental Section and conducted relevant literature surveys. Professor 
Banwell wrote the body of the paper (viz. the Introduction, Results and Discussion and 
Conclusion). 
 
Publication 6. Professor Banwell proposed the research work reported in this article while 
Mr White initiated the experimental aspects as well as providing detailed supervision of his 
co-author Mr Song Bae (a Summer Research Scholar in the Banwell Group at the time). Mr 
White assigned various of the structures of the products described while completion of key 
aspects of the experimental work were carried out by Dr Xinghua Ma with some assistance 
from Ms Natasha Anderson (a third-year undergraduate). Professor Banwell wrote the body 
of the paper (viz. the Introduction, Results and Discussion and Conclusion). The X-ray 
crystallographic studies that were conducted by the RSC’s resident crystallographer Dr 
Anthony Wills while Dr Warwick Raverty provided key technical advice. In overall terms, 
Mr White’s contributions to this paper were of the order of 30%. 
 
Publication 7. The initial idea behind this work came from Professor Zard. While resident in 
the Zard Group in Paris, Mr White carried out just over 50% of the experimental work 
reported in the paper and wrote the paper entirely on his own – the associated SI was 
composed with the assistance of his co-authors.  
 
Publication 8. This is a by-invitation, single-author article. Mr White conducted all of the 
relevant literature searches and wrote the article entirely on his own. 
 
ix 
Table of Contents 
Declaration……………………………………………………………………………..............i 
Dedication……………………………………………………………………………..............ii 
Acknowledgements…………………………………………………………………...............iii 
Publications and Presentations………………………………………………………..............iv 
Relative Contributions to Publications……………………………………………………....vii 
Table of Contents……………………………………………………………………………..ix 
Abstract……………………………………………………………………………………….1 
Thesis Overview………………………………………………………………………………5 
Publication 1………………………………………………………………………………...18 
Publication 2………………………………………………………………………………...32 
Publication 3………………………………………………………………………………...82 
Publication 4……………………………………………………………………………….133 
Publication 5……………………………………………………………………………….151 
Publication 6……………………………………………………………………………….172 
Publication 7……………………………………………………………………………….199 
Publication 8……………………………………………………………………………….305 
Appendices…………………………………………………………………………………308 
1 
 
Abstract 
 
The body of this thesis is comprised of eight scientific articles and is preceded by an 
overview that contextualises all of this submitted/published work. 
The work described in this thesis contributes to the chemical methodologies that can be 
deployed when attempting to exert stereochemical control in complex molecule synthesis. 
Such contributions are desirable given the often profoundly different chemical, physical 
and/or biological properties that the varying stereoisomeric forms of a given molecular 
framework can possess.  
The methodologies detailed herein can be divided into three parts: 
The first part is comprised of Publications 1-4 and is concerned with the development of a 
chemoenzymatic total synthesis of the natural enantiomeric form of vindoline (A) from the 
enantiomerically pure cis-1,2-dihydrocatechol B, itself a metabolite generated 
stereospecifically via the whole-cell biotransformation of bromobenzene. 
 
 
Specifically, Publication 1 represents the first (and extensive) literature review of the 
chemistry of RANEY®-cobalt, a readily generated catalyst that when used in the presence of 
dihydrogen facilitates the chemoselective reduction of C-N and N-O multiple bonds. This 
catalyst can be exploited to great effect in the stereoselective assembly, through tandem 
reductive cyclisation processes, of polycyclic, nitrogen-containing molecular frameworks. 
Publication 2 describes the results of synthetic studies that exploit RANEY®-cobalt for the 
purposes of converting compound B into a pentacyclic system, C, embodying most of the key 
structural features of vindoline (A). Publication 3 describes novel gold-catalysed cyclisation 
and [2+2]cycloaddition reactions developed as part of related efforts to assemble the 
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vindoline framework. Two key products resulting from these studies are the pentacyclic 
compounds D and E.  
 
 
Publication 4 represents another invited review article and contextualises the work reported 
in the first part of the thesis by describing various of the contemporary ways in which cis-1,2-
dihydrocatechols such as B have been exploited as starting materials for the stereochemically 
controlled synthesis of a range of natural products.    
The second part of this thesis is comprised of Publications 5 and 6. These detail the synthesis 
and/or manipulations of the chirons F, G and H. The first two of these were obtained through 
chemical modifications, developed by the author, of congener B while compound E is the 
product of the large-scale pyrolytic degradation of acidified biomass, most notably waste 
paper and sawdust. 
 
 
So, Publication 5 describes the preparation of synthon F via an initial reaction between the 
conjugate base of p-methoxybenzyl alcohol and an epoxide derived from cis-1,2-
dihydrocatechol B with trapping of the oxy-anion so formed using MOM-chloride. The 
reaction was extended to the generation of enone G and thereby establishing a significantly 
improved protocol for the production of chirons of demonstrated utility in the total synthesis 
biologically active natural products. Publication 6 describes various novel manipulations of 
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levoglucosenone (H), including those involving Wharton rearrangement chemistry, to 
produce isolevoglucosenone and related compounds of likely synthetic utility.  
The third and final part of this thesis is comprised of Publications 7 and 8. It details work 
focused on exploiting, via radical transfer processes, xanthates in the stereoselective synthesis 
of either E- or Z-configured olefins. Two types of xanthate, I and J, were employed for such 
purposes, with manipulations of the former allowing for the introduction of Z-configured 
olefins into complex molecular frameworks while the latter served as a precursor to a range 
of E-configured olefins.  
 
 
Specifically, then, Publication 7 describes the synthesis of compound I and its addition, via a 
radical-based xanthate transfer reaction, to various olefins. The adducts of this process were 
engaged in Favorskii chemistry that allowed for the stereoselective synthesis of Z-alkenoates. 
Publication 8 reviews the literature concerned with xanthate J and details the capacity of 
radical adducts of this species to add to double bonds and so providing a means for effecting 
Horner-Wadsworth-Emmons reactions with aldehydes and thereby generating E-alkenoates.  
The Appendices to the thesis are a series of reports arising from single-crystal X-ray analyses 
of certain key compounds synthesized by the author. These analyses and the derived reports 
are the result of studies carried out by Dr Anthony Willis, a member of the Research School 
of Chemistry’s Crystallographic Analysis Unit. 
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Stereochemical Control in Complex Molecule Synthesis 
(A PhD Thesis presented to the ANU by Lorenzo White) 
Thesis Overview 
 
Publication 1: Raney® Cobalt – An Underutilised Reagent for the Selective Cleavage of 
C–X and N–O Bonds. 
RANEY® cobalt1 is known to function as an effective catalyst for certain chemoselective 
reductions, especially of C-N and N-O multiple bonds. However, its utility in chemical 
synthesis does not seem to have been fully appreciated. This publication is a review that 
provides the first comprehensive survey of the literature on chemical transformations 
involving RANEY® cobalt and attempts, among other things, to highlight the differences 
between the performance of this system and its much more well-known but usually less 
selective congener RANEY® nickel. A reliable method for preparing a consistently effective 
RANEY® cobalt catalyst is also presented together with a protocol that avoids the need to use 
it with high pressures of dihydrogen. As such, this review describes the means by which 
RANEY® cobalt can be deployed as a powerful tool for chemical synthesis, particularly in 
the assembly of polycyclic frameworks through tandem reductive cyclisation processes. 
In more specific terms, Publication 1 describes, inter alia, studies directed towards the 
synthesis of the alkaloid limaspermidine7 and during the course of which it was observed 
(Scheme 1) that brief treatment of a methanolic solution of compound 1 with dihydrogen in 
the presence of RANEY® cobalt and p-toluenesulfonic acid (p-TsOH) monohydrate afforded 
a mixture of the N-hydroxylated tetracyclic indole 2 (29%) and its deoxygenated counterpart 
3 (29%). On the other hand, sustained reaction of substrate 1 under the same conditions 
provided compound 3 (85%) exclusively, as did analogous treatment of congener 2. 
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Scheme 1. 
 
The tandem reductive process outlined in Scheme 1 represents an important example of a 
methodology by which the carbon framework of the Aspidosperma alkaloid family could be 
assembled in an efficient manner.  
 
Publication 2: A Chemoenzymatic Route to Enantiomerically Pure and Highly 
Functionalized Analogues of Vindoline  
Vindoline (4, Figure 1) is a key member of the Aspidosperma family of alkaloids. It is a 
biogenetic and synthetic precursor to vinblastine (5) and vincristine (6), compounds produced 
by the Madagascan rosa periwinkle (Catharanthus roseus)2 and shown to perturb microtubule 
dynamics in ways that lead to inhibition of mitosis.3,4 As testimony to their importance, 
compounds 5 and 6 have been used in the clinical treatment of various human cancers for 
over 50 years.3 Owing to their low natural abundance and the prospect of identifying more 
potent analogues, there is an increasing interest in the development of practical total 
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syntheses of compounds 5 and 6. Compound 4 is an important synthetic precursor to these 
binary indole-indoline alkaloids.5  
 
Figure 1. The structures of vindoline (4), vinblastine (5) and vincristine (6). 
 
Accordingly, Publication 2 details the elaboration of the enzymatically-derived and 
enantiomerically pure cis-1,2-dihydrocatechol6 7 (Figure 2), over seventeen steps, into 
compounds 8 and 9, each of which embodies the ABCDE-ring system and much of the 
functionality associated with vindoline7 (4). The exploitation of an enzymatic process to 
establish the absolute stereochemistry of the starting metabolite 7, which in turn provides a 
basis for establishing the absolute stereochemistry required in the target molecule 4, is 
advantageous as these types of biotransformations proceed in essentially quantitative yield 
and delivering the cis-1,2-dihydrocatechols in >99.8% ee. Furthermore, these conversions can 
be carried out on the kilogram if not the tonne scale.3 One of the key synthetic 
transformations associated with synthesis of compounds 5 and 6 is a RANEY® cobalt-
mediated tandem reductive cyclisation processes.  
 
Figure 2. The Starting Material, 7, and Key Targets Associated with the Work Presented in 
Publication 2.  
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Other key steps involved in the elaboration of enantiomerically pure metabolite 7 into 
compound 8 are shown in Scheme 2. They involve the Eschemoser-Claisen rearrangement8 
of allylic alcohol 10 to give N,N-dimethylamide 11, the palladium-catalysed Ullmann cross-
coupling9 of iodide 12 to furnish the arylated enone 13 and the RANEY® cobalt-mediated 
tandem reductive cyclisation10 of this last compound to give the indole 14.  
 
Scheme 2. Key steps involved in the conversion of enantiomerically pure metabolite 7 into 
vindoline analogue 8.  
 
Publication 3: ABC → ABCE/D Based Approaches to the Pentacyclic Ring System of 
the Vinca Alkaloids Using Intramolecular Hetero-[2+2]Cycloaddition and Gold(I)-
Catalysed 6-endo-dig Cyclisation Protocols 
The work reported in this publication sought to address the shortcomings of the approach to 
the synthesis of vindoline (4) described in Publication 2, most particularly the lack of a 
capacity to install a 6,7-double bond within the D-ring of advanced intermediate 8. The 
identification of protocols that could address this challenge was pursued via the model system 
15 and efforts to convert this into compounds such as 16 (Figure 3).  
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Figure 3. 
 
To such ends, and as outlined in Scheme 3, the known indole11 17, itself the product of a 
Fischer-indole synthesis involving commercially available starting materials, was converted, 
over 9 steps, into the isothiocyanate12 18. Photolysis of this last compound afforded, via an 
unprecedented intramolecular hetero-[2+2]cycloaddition reaction,13 the pentacyclic β-
thiolactam 19 that incorporates four out of the five rings of the target model compound 16. 
Attempts to effect a two-carbon homologation of the four-membered ring within compound 
19, and thereby establish the final ring of the target 16, failed. The azide 20, also obtained 
from compound 17 over 9 steps, formed the cyclic imine 21 on thermolysis14 in refluxing 
toluene, and the readily derived enamide 22 engaged in a Au(I)-catalysed 6-endo-dig 
cyclisation15 reaction to furnish the piperidinone 23, a compound that embodies the complete 
ring system of the target alkaloid 4.  
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Scheme 3. Synthesis of model compounds 18 and 20 and their subsequent reactions. 
 
The chemistries described in this paper should assist in addressing the difficulties 
encountered during the approach outlined in Publication 2 and thus set the stage for effecting 
the conversion of the readily available, enantiomerically pure cis-1,2-dihydrocatechol 7 into 
target compound 4. 
 
Publication 4: Chemoenzymatic Pathways for the Synthesis of Biologically Active 
Natural Products 
This publication surveys some of the ways in which the chemistry of enantiomerically pure 
cis-1,2-dihydrocatechols, analogous to those that served as the basis of the synthetic work 
carried out in Publication 2, can be extended to the stereochemically controlled synthesis of 
various other biologically active natural products embodying a range of complex structural 
features. These include (Figure 4) members of the ribisin family of natural products such as 
ribisin C (25) as well as galanthamine (26) and platencin (27). 
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Figure 4. Compounds synthesised using enantiomerically pure metabolites such as 7 and 24 
as starting materials. 
 
The necessary manipulations included, as shown in Figure 5, C-C bond-forming steps 
employing palladium-catalysed cross-coupling of the halogen residue, regio- and stereo-
selective functionalization of the more nucleophilic (non-halogenated) double-bond,16 
Claisen-type rearrangements17 of the allylic alcohol residues, and regio- and stereo-selective 
manipulations of the diol unit.18  
 
Figure 5. Reactivities of cis-1,2-dihydrocatechols such as 7 and 24 surveyed in    
Publication 4. 
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Publication 5: New, Homochiral Synthons Obtained through Simple Manipulations of 
Enzymatically Derived 3-Halo-cis-1,2-dihydrocatechols 
The cis-1,2-dihydrocatechol 7, generated in enantiopure form via the whole-cell 
biotransformation of bromobenzene3 and which “inspired” the synthetic studies described in 
Publications 2, 3 and 4, is only one of many such metabolites that can be generated via this 
type of enzymatic process. Thus, a wide range of substituted arenes can be converted into the 
corresponding cis-1,2-dihydrocatechols using certain mutant forms of bacteria that express 
dioxygenase enzymes.3 As detailed in Publication 4, compounds such as 7 have proven to be 
extraordinarily versatile starting materials in chemical synthesis, as evidenced by their 
exploitation in the synthesis of a wide range of natural products including carbohydrates, 
terpenoids, and alkaloids.3 Publication 5 reports simple methods by which metabolite 7 can 
be converted into the related diene 28 or the enone 29 (Figure 6), compounds that are also 
likely to serve as useful new chirons in a range of settings. The synthesis of the chlorinated 
analogue, 30, of the latter product is also described.  
 
Figure 6. New homochiral synthons described in Publication 5. 
 
Thus, as noted in Publication 2, cis-1,2-dihydrocatechol 7 can be converted, over two steps 
(Scheme 4), into the previously reported and well-known19 epoxide 31. This epoxide was 
treated with the anion derived from p-methoxybenzyl alcohol in the expectation that the 
nucleophilic ring-opening product 32 would form and then, from it, the corresponding ether 
upon quenching with methoxymethyl chloride (MOM-Cl). However, when seemingly 
relevant conditions were employed for this purpose, the novel diene 28 was obtained instead 
(and in 74% yield). Alternately, when the reaction mixture, presumed to contain anion 32, 
was quenched with water (rather than MOMCl) and then worked up in the usual manner, a 
light-yellow oil was obtained. On standing, this material delivered the crystalline enone 29 in 
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60% yield. Access to chirons of the form 29 by this means greatly extends the synthetic 
potential of cis-1,2-dihydrocatechols such as 7.  
 
Scheme 4. Stereo-controlled preparation of chirons 28 and 29 from enantiomerically pure 
metabolite 7. 
 
Publication 6: The Conversion of Levoglucosenone into Isolevoglucosenone. 
This publication describes various chemical manipulations of levoglucosenone (33, Scheme 
5), a 1,6-anhydro-bridged and monosaccharide-derived chiron that can be obtained, via 
pyrolysis of mineral acid-impregnated waste paper,20 in enantiomerically pure form at the 
tonne scale.21 Specifically, Publication 6 details the conversion of levoglucosenone into 
isolevoglucosenone (34) using Wharton rearrangement22 protocols as the key step of the 
sequence. 
 
Scheme 5. The conversion of levoglucosenone into isolevoglucosenone. 
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Publication 7: A Radical Solution to the Alkylation of the Highly Base-Sensitive  
1,1-Dichloroacetone. Application to the Synthesis of Z-alkenoates and E,E-dienoates 
Olefins are a ubiquitous structural feature of biologically significant molecules.23 They also 
serve as substrates for many valuable synthetic transformations.24 The stereochemical 
configuration of the olefin influences its biological properties and chemical reactivity.25 
While numerous methods are available for the preparation of E-olefins,26 the stereocontrolled 
synthesis of the corresponding Z-olefins can be problematic. The work defined in 
Publication 7 provides a new method for addressing such matters.  
Specifically, this paper details radical transfer chemistry27 that allows for the effective 
alkylation, via xanthate-based reagents of the form 35, of 1,1-dichloroacetone, a previously 
unattainable and distinctly challenging transformation (Scheme 6). The ,-dihaloketone-
containing adducts of the general form 36 obtained as products of this alkylation process can 
then be subjected to Favorskii rearrangement28 chemistry and so selectively furnishing Z-
configured olefins of the form 37.  
 
Scheme 6. 
 
Publication 8: Carbonodithioic Acid S-[3-(Diethoxyphosphinyl)-2-oxopropyl] O-Ethyl 
Ester 
This work reviews the literature surrounding the use of xanthate 39 (Scheme 7) in synthesis. 
So, while Publication 7 was focused on the development of xanthate-based technologies that 
allow for the stereochemically-controlled preparation of Z-olefins, the subject matter of 
Publication 8 details a similar xanthate-based approach that, in this instance, allows for the 
selective incorporation of E-olefins into a range of molecular systems. A summary of the 
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chemistry involved in this process and its application to the synthesis of certain xestamine 
natural products is shown in Scheme 7.29 The reaction sequence starts with a radical-based 
xanthate-transfer reaction between compound 39 and an appropriate olefin, such as 
compound 40. The xanthate residue contained within adduct so formed is reductively 
removed to furnish the phosphonate ester-containing system 41. This latter compound 
contains, as a result of the xanthate transfer reaction, functionality that can be engaged in 
Horner-Wadsworth-Emmons chemistry with various aldehydes so as to stereoselectively 
establish the E-alkenoate residue contained within compound 42, which can itself be 
converted into various xestamine-type natural products.30  
 
Scheme 7. Application of xanthate 39 to the synthesis of an E-olefin-containing precursor to 
xestamine-type natural products. 
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RANEY® cobalt – an underutilised reagent for the
selective cleavage of C–X and N–O bonds
Martin G. Banwell,* Matthew T. Jones, Tristan A. Reekie, Brett D. Schwartz,
Shen H. Tan and Lorenzo V. White
RANEY® cobalt, which was ﬁrst prepared in the 1930s, is known to function eﬀectively as a catalyst for
certain chemoselective reductions. However, its utility in chemical synthesis does not seem to have been
fully appreciated. This ﬁrst comprehensive survey of the literature on chemical transformations involving
RANEY® cobalt attempts to redress matters by, among other things, highlighting the diﬀerences between
the performance of this system and its much more well-known but usually less selective congener
RANEY® nickel. A reliable method for preparing consistently eﬀective RANEY® cobalt is presented
together with a protocol that avoids the need to use it with high pressures of dihydrogen. As such, it is
hoped more attention will now be accorded to the title reagent that oﬀers considerable promise as a
powerful tool for chemical synthesis, particularly in the assembly of polycyclic frameworks through
tandem reductive cyclisation processes.
A. Introduction
The metal-catalysed addition of dihydrogen to both multiple
and single bonds represents one of the most powerful and
economically significant chemical processes known. A
plethora of catalytic systems is available for this purpose and
refinements of these continue to be reported in the unceasing
quest to maximise chemo-, diastereo- and/or enantio-selectiv-
ity.1,2 Given the vast body of research that has been reported
in the area sometimes eﬀective techniques can “fade from
view” as the fascination with new systems and protocols cap-
tures the researcher’s attention. Herein we argue this may be
the case with RANEY® cobalt and suggest that it is a catalytic
system that warrants re-examination by virtue of the capacity it
oﬀers for achieving, among other things, selective reductions
within polyfunctionalised systems. Specifically, then, this
review provides (to the best of our knowledge) the first sub-
stantial survey of the primary literature (including some patent
filings) on RANEY® cobalt and its applications in chemical
synthesis. The work cited herein emerged from a series of
searches, conducted during 2013 and early 2014, of the chemi-
cal literature using both the SciFinder Scholar™ database and
the Google Scholar™ search engine.
B. Historical development, forms of
reagent, modes of preparation and
sources of dihydrogen
The development of nickel-based catalysts preceded that of the
cobalt-based ones.3 In 1897 the Frenchmen P. Sabatier and
J. B. Senderens discovered that unsaturated organic com-
pounds could be hydrogenated in the presence of finely
divided nickel and nickel oxides and the process was greatly
extended by the Russian chemist V. N. Ipatieﬀ in the very early
years of the 20th century. The broad utility of such methods
was recognised by the award of the Nobel Prize to Sabatier
(shared with V. Grignard) in 1912. Prompted by suggestions
that occasionally “ultra catalysts” were encountered on using
the Sabatier/Ipatieﬀ protocols, from 1915 Murray Raney of
Chattanooga, Tennessee conducted systematic studies on the
performance of the nickel/nickel oxides catalyst systems in
hydrogenation reactions as a function of the ratio of the metal
to its oxides. While such experiments were to no avail (in
terms of identifying “ultra catalysts”), his cognate studies on
the industrial production of dihydrogen through the reaction
of ferro-silicon with sodium hydroxide eventually led him to
investigate the properties of the material derived from alkali-
based digestion of finely ground nickel–aluminium alloys. In
1927 Raney was granted a patent for his discovery of the
nickel-based catalyst that bears his name.4 In 1933 another
patent that “contemplates” nickel being replaced by “iron,
copper, cobalt and other catalytic materials”5 was granted.
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Raney’s description of the “more or less spongy and porous
state”4 of the materials he produced led to the trademarking
of these systems as “Sponge Metals Catalysts™”.6 For similar
reasons they are also sometimes referred to as “skeletal”
catalysts.7
While RANEY® nickel was used from the mid-1920s for
eﬀecting the hydrogenation of vegetable oils under relatively
mild conditions, it was Homer Adkins at the University of
Wisconsin who revealed, through a comprehensive series of
studies started around 1930, that this catalyst had many other
useful applications.8 Adkins also made major contributions to
the preparation and categorisation of the various types of
RANEY® nickel9 that now include W1 to W7 forms, details of
which have been tabulated.10
Probably because of the higher cost and lower activity of
RANEY® cobalt, there are far fewer studies on this catalyst
compared with its nickel counterpart. Seemingly, most of the
various procedures available for its preparation have been
summarised.11 In addition, Reeve and Eareckson have
described12 the preparation of “W7” RANEY® cobalt from a ca.
100-mesh alloy derived from 40% cobalt and 60% aluminium
while Chadwell and Smith13 report a very similar protocol and
note that it is somewhat easier to prepare than RANEY® nickel
because removal of alkali by washing can be accomplished
rather quickly (a lengthy washing procedure is required for
nickel).14 A subsequent and detailed study on the preparation
of RANEY® cobalt by Aller15 highlighted the need to treat fine-
mesh cobalt/aluminium alloy powders with alkali at 15–20 °C
in order to obtain highly active forms of the catalyst. Interest-
ingly, it was noted that the use of coarser powders tended to
give massive, agglomerated catalysts that did not disperse
eﬀectively, resulting in lower activity. Aller also reported that
the activity of the cobalt catalyst prepared at 100 °C, even from
fine-mesh powders, is exceedingly low. In contrast, the activity
of the corresponding nickel catalysts increased with increasing
temperatures of preparation. The so-called Aller RANEY®
cobalt has been described as being more active than its W7
counterpart, at least in certain contexts.16
While at various times RANEY® cobalt has been available
from commercial sources, during the course of our recent
studies, some of which are detailed below, we were unable to
secure this catalyst by such means. Accordingly, and after con-
siderable investigation, we have established a protocol17 that
provides material suitable for consistently achieving chemo-
selective reductions (at least of the types required for our pur-
poses). A pivotal aspect to this work was the identification of a
source18 of nickel-free cobalt–aluminium alloy.19
The Urushibara cobalt catalysts,1c,20 which display some
reducing properties similar to RANEY® cobalt, are obtained by
the reduction of cobalt salts (e.g. cobalt hexachloride) with
zinc dust and leaching of the resulting precipitated and finely
divided cobalt metal with aqueous sodium hydroxide, hydro-
chloric acid or acetic acid. Cobalt boride, which is prepared by
treatment of cobalt nitrate (for example) with sodium boro-
hydride in the presence of charcoal (as a supporting agent),21
has proved to be an excellent reagent for the reduction of
nitriles to amines while a mono-dispersed form prepared
using a reversed micellar system is reported to have activity
better than that of RANEY® cobalt in terms of its capacity to
eﬀect the hydrogenation of certain olefins.22 However, given
the scope of this review and the rather limited literature avail-
able on these (Urushibara) catalysts, they will not be the sub-
jects of any further discussion here.
The alkali leaching process associated with the preparation
of RANEY® cobalt from the aluminium alloy normally leaves
at least some dihydrogen adsorbed on its surface with the
result that freshly prepared material can sometimes be used
without needing to run the desired reduction process under
an atmosphere of dihydrogen. Nevertheless, the norm is to run
such reactions under dihydrogen, a procedure that may
become essential as the catalyst “ages” through desorption of
the gas. Isopropanol can serve as a source of dihydrogen as
demonstrated23 by its use in the RANEY® cobalt-catalysed
transfer hydrogenolysis of certain aromatic alcohols (see
section E for details).
C. Hydrogenolytic reactions
(i) Selective cleavage of carbon–halogen bonds
The capacity of the title reagent to eﬀect the cleavage of
carbon–halogen bonds, either directly or in the presence of
dihydrogen, appears to have been the subject of very few
studies and certainly no systematic ones. Kawashima et al.
have reported24 that dihydrogen in the presence of RANEY®
cobalt is able to eﬀect the reductive dechlorination of the ring-
fused gem-dichlorocyclopropane 1 (Scheme 1) and does so
with some levels of stereoselectivity by aﬀording a ca.
2 : 1 mixture of the epimeric endo- and exo-forms, 2 and 3
respectively, of the corresponding mono-chloro derivative.
However, RANEY® cobalt is not distinctive in this regard
because similar outcomes are obtained by using W7 RANEY®
nickel and Urushibara nickel B as catalysts. When PtO2 is used
as catalyst then a 1 : 1 mixture of compounds 2 and 3 is
obtained.
(ii) Selective cleavage of carbon–sulfur bonds
While RANEY® nickel has been used extensively for the desul-
furisation of a wide range of sulfur-containing compounds,10
its cobalt counterpart has been less widely exploited for this
Scheme 1
Review Organic & Biomolecular Chemistry
7434 | Org. Biomol. Chem., 2014, 12, 7433–7444 This journal is © The Royal Society of Chemistry 2014
Pu
bl
ish
ed
 o
n 
17
 Ju
ne
 2
01
4.
 D
ow
nl
oa
de
d 
by
 A
us
tra
lia
n 
N
at
io
na
l U
ni
ve
rs
ity
 o
n 
04
/1
1/
20
15
 0
1:
14
:1
1.
 
View Article Online
21
purpose. A 1959 report by Badger and co-workers established16
that the title reagent could desulfurise dibenzothiophene (4)
[and thus providing biphenyl (5)] (Scheme 2) as well as a range
of other compounds, but in broad terms it was deemed “less
eﬀective” than RANEY® nickel.
One instance in which RANEY® cobalt has proven superior
involves the conversion of phenanthridinethione (6) into phe-
nanthridine (7) (Scheme 3) which proceeds in 72% yield under
the indicated conditions.16 In contrast, when RANEY® nickel
is used to eﬀect the same conversion some over reduction to
dihydrophenanthridine is observed and thus necessitating a
subsequent dehydrogenation step.
The aﬃnity of RANEY® cobalt for organosulfur compounds
has been exploited in chromatographic separations. Thus, for
example, the components of a 1 : 1 w/w mixture of isoeugenol
and 2,5-dimethylthiophene could be readily separated from
one another by methanol elution through a mixture of freshly
prepared RANEY® cobalt and clean sand. The retained thio-
phene was then recovered by Soxhlet extraction of the adsor-
bent with methanol.25
(iii) Selective cleavage of carbon–oxygen bonds
There have been few studies on the capacity of RANEY® cobalt
to eﬀect C–O bond cleavage and this is almost certainly
because it is not very useful for this purpose (however, see
section E). Still, the contemporary focus on the deoxygenation
of biomass as a means of providing sustainable sources of
fuels and other chemically valuable materials has led to exten-
sive screening of a wide range of catalysts, including the title
one, for their capacities to eﬀect the hydrogenolysis of C–O
bonds.26,27 In one instance where RANEY® cobalt has been
investigated for such purposes it proved to be less useful than
other catalysts.26 Nevertheless, in related studies, RANEY®
cobalt was shown to be eﬀective for converting glycerol
(a material readily derived from biomass) into lactic acid28 and
for the isomerisation of erythritol (accessible by the yeast-
mediated fermentation of sugar or sugar alcohols such as
glucose and glycerol) into threitol.29 The glycerol to lactic acid
conversion is presumed to involve initial dehydrogenation of
the substrate to give glyceraldehyde, dehydration of the latter
to pyruvaldehyde and hydroxide-mediated conversion of this
last compound to lactate.28
(iv) Selective cleavage of nitrogen–oxygen bonds
In 1956 Reeve and Christian demonstrated30 that while
RANEY® nickel eﬀected the exhaustive addition of dihydrogen
to oxime 8 (Scheme 4) and so generating amine 9 (20%) when
the same substrate was hydrogenated in the presence of
RANEY® cobalt then only C–O bond cleavage took place and
so aﬀording imine 10 (46%) as the sole reaction product. Ried
and Schiller have made related observations.31
During the course of work directed towards the refinement
of the synthesis of an intermediate associated with the manu-
facture of Gemifloxacin (Factive®), a novel quinolone-based
antibacterial agent, Lee and co-workers established32 that
treatment of the α-cyanooxime O-methyl ether 11 (Scheme 5)
with RANEY® cobalt in the presence of dihydrogen aﬀorded
Scheme 3
Scheme 4
Scheme 2
Scheme 5
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the diamine 12 (unspecified yield and stereochemical
outcome). This product clearly results from N–O bond cleavage
as well as hydrogenation of the imine and nitrile residues (no
order of events implied) within the substrate. In contrast,
when the reaction was carried out with in situ Boc-protection
using (t-Boc)2O then the 1°-amine derivative 13 was obtained
with 83% selectivity over congener 12. The selectivity for the
target compound 13 rose to 91% when a nickel/chromium-
doped form of the catalyst was used while the fully reduced
product predominated when RANEY® nickel alone was
employed as catalyst.
As part of a program of studies directed towards the syn-
thesis of the alkaloid limaspermidine, we observed33
(Scheme 6) that treatment of a methanolic solution of com-
pound 14 with dihydrogen in the presence of RANEY® cobalt
and p-toluenesulfonic acid (p-TsOH) mono-hydrate for short
periods of time aﬀorded both the N-hydroxylated tetracyclic
indole 15 (29%) and its deoxygenated counterpart 16 (29%). In
contrast, sustained reaction of substrate 14 provided compound
16 (85%) exclusively as did analogous treatment of congener 15.
While a full understanding of the precise ordering of events
associated with these conversions requires further investigation, it
seems clear that the nitroarene residue is being converted,
through N–O bond cleavage, into the corresponding N-hydroxy-
aniline and that this then engages in an intramolecular Schiﬀ
base condensation reaction. The conversion 15 → 16 clearly
demonstrates that N-hydroxyindoles can be reduced to the equi-
valent indoles but whether such reductions can be extended to
hydroxyamines more generally remains to be determined.
Obviously the nitrile group within substrate 14 is also being
reduced to the corresponding primary amine during the course
of these conversions and the latter moiety then engages in an
intramolecular hetero-Michael addition reaction. Related chem-
istry leading to the 1,5-methanoazocino[4,3-b]indole framework
of the Uleine and Strychnos alkaloids has been reported.34
Aspects of such work are presented in section H. Further dis-
cussion of the general capacity of RANEY® cobalt to eﬀect the
reduction of nitriles to 1°-amines is presented in section D(ii).
It is interesting to note that when compound 14 was treated
under essentially the same conditions as described above but
using W7 RANEY® nickel in place of its cobalt counterpart
then a mixture of compound 16 (48%) and the partially
cyclised compound 17 (Fig. 1, 24%) was obtained.35,36 The
latter product necessarily arises from reduction of the C–C
double bond of the enone moiety associated with substrate 14
at a relatively early stage in the process and thus preventing
the intramolecular hetero-Michael addition reaction required
for the formation of the desired compound 16. Clearly then,
RANEY® cobalt is a more chemoselective catalyst in this
setting than is its nickel counterpart.
(v) Selective cleavage of oxygen–oxygen bonds
A RANEY® cobalt-type catalyst obtained by digesting an alloy
containing 42% cobalt and 58% aluminium with 20%
aqueous sodium hydroxide at 50 °C has been reported37 to
facilitate the hydrogenolytic conversion of hydroperoxide 18
into the corresponding alcohol 19 in 76% yield (Scheme 7).
D. Hydrogenation reactions
(i) Selective reduction of carbonyl groups
RANEY® cobalt can be employed for the selective reduction of
the carbonyl groups within various unsaturated aldehydes and
ketones. Thus, for example,38 using a reaction temperature of
100 °C and a dihydrogen pressure of ca. 9 atm this catalyst has
been used to eﬀect the reduction of citral (20, Fig. 2) to a
mixture of nerol (21), geraniol (22) and citronellol (23). Under
such conditions a 60% conversion of the substrate was
observed after 3 h and the major products of reaction were the
allylic alcohols 21 and 22. Even greater eﬃciencies were
observed when a Urushibara-type cobalt species was used forScheme 6
Fig. 1 Product arising from the partial reductive cyclisation of com-
pound 14.
Scheme 7
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this purpose. In contrast, when RANEY® nickel was used as
catalyst then citronellal (24) was the major product of reaction.
Various additives have been employed in conjunction with
RANEY® cobalt in an eﬀort to achieve greater selectivities in
the reduction of a range of unsaturated aldehydes. In some
relatively early work in this area, Hott and Kubomatsu39 esta-
blished that 2-methyl-2-pentenal was eﬃciently converted into
the corresponding allylic alcohol (2-methyl-2-penten-1-ol) on
exposure to an atmosphere of dihydrogen in the presence of a
mixture of RANEY® cobalt and ferrous chloride at 55 °C and
using isopropanol as solvent. The yield of product increased
with increasing amounts of ferrous chloride and the rapid
appearance of the blue colour characteristic of Co(II) ions
suggests that the cobalt of the catalyst was being substituted
by iron. The impacts of adding CoCl2, MnCl2, NiCl2, PdCl2
acetic acid and triphenylphosphine to the reaction mixture
have also been investigated.40,41 As a result it has been con-
cluded that both protic and Lewis acidic modifiers promote
the formation of 2-methyl-2-penten-1-ol from the precursor
aldehyde. Similarly, the hydrogenation of cinnamaldehyde to
cinnamyl alcohol over RANEY® cobalt was greatly improved by
modification of the catalyst with certain heteropolyacids such
as Cu3/2PMo12O40.
42 Related outcomes were observed in the
conversion of crotonaldehyde to crotyl alcohol.43
The ketonic residue within a range of non-conjugated
enones is selectively reduced by dihydrogen in the presence of
W4 RANEY® cobalt and sodium hydroxide while carbon mon-
oxide prevents such processes.44 The potentially enantio-
selective reduction of acetylacetone and ethyl acetoacetate by
dihydrogen in the presence of RANEY® cobalt and either S,S
or R,R-tartaric acid or one of eight optically active amino acids
has been investigated.45 However, only modest conversions
and optical yields were observed. While such observations
could be considered promising, the high yielding, enantio-
selective and ruthenium-based CvO reduction protocols deve-
loped by the likes of Noyori have overtaken such procedures.46
The reductive mono-deoxygenation of succinimide (25) to
2-pyrrolidone (26) has been eﬀected (Scheme 8) by dihydrogen
and RANEY® cobalt in the presence of ammonia at 240 °C and
272 atm of dihydrogen.47
(ii) Selective reduction of nitriles
Undoubtedly, the reduction of nitrile groups represents the
most widely exploited application of RANEY® cobalt in chemi-
cal synthesis. While there are suggestions that, in certain set-
tings at least, RANEY® nickel represents a superior catalyst for
such purposes,48 the literature is replete with examples indicat-
ing that RANEY® cobalt is highly eﬀective. So, for instance,
Reeve and Eareckson have shown12 that the reduction of 3,4-
methylenedioxyphenylacetonitrile to homopiperonylamine is
best accomplished (88% yield) in the presence of W7 RANEY®
cobalt and ammonia at 125–150 °C and using 200 atm of di-
hydrogen. When the same transformation is carried out using
RANEY® nickel then the product amine is obtained in 82%
yield. The reduction of p-cyanobenzoic acid (27) to the corres-
ponding benzylamine 28 (Scheme 9) is readily eﬀected at 25 °C
using 3 atm of dihydrogen in aqueous ammonia and W6 or W7
RANEY® cobalt.49 Once again, ammonia is used in the reduction
to suppress the formation of 2°- and 3°-amines that would other-
wise be formed through reductive alkylation processes.50,51
As is the case with other types of reduction reactions, the
use of various additives and/or refined modes of preparation
of RANEY® cobalt have been reported to enhance the eﬃcien-
cies of nitrile reduction processes.52,53
Nitrile reductions can be accomplished without attendant
reductive dechlorination as demonstrated by the conversion of
compound 29 into the corresponding 1°-amine 30 (Scheme 10),
a step that has been employed in the industrial production of
certain propylamine-based fungicides.54
As part of a study directed towards establishing a practical
and scalable synthesis of the drug Eflornithine (used for the
treatment of, among other things, African sleeping sickness),55
an ethanolic solution of nitrile 31 (Scheme 11) was treated
with dihydrogen in the presence of RANEY® cobalt andScheme 8
Scheme 9
Scheme 10
Fig. 2 Citral (20) and the products arising from its reduction under
various conditions – see text.
Organic & Biomolecular Chemistry Review
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thereby producing the piperidone 32 “exclusively” and in 36%
yield. In contrast, when the Schiﬀ base, 33, obtained by con-
densing substrate 31 with benzophenone, was treated under
analogous conditions and the crude reaction mixture then sub-
jected to an aqueous work-up and treatment with HCl then com-
pound 34 was obtained with “>99% selectivity” and in 79% yield.
In neither instance was there any suggestion that competing
hydrogenolysis of the C–F groups had occurred and nor was there
any evidence of reduction of imine residue within compound 33.
During the course of the development of the synthesis of
the 5-lipoxygenase inhibitor MK-0633,56 the coumarin-based
nitrile 35 (Scheme 12) was successfully reduced with RANEY®
cobalt in the presence of methanolic ammonia to give the
7-aminomethyl-substituted congener 36 (62%). Subsequently,
the reduction was carried out using aqueous acetic acid as
solvent because of the instability of the product in original
reaction medium. It is notable that, (i) no hydrogenolysis of
the benzylic C–N bond within the product 36 was observed
and (ii) no reduction of the CvC bond within the heterocyclic
ring of either the substrate or the product took place. Acetal
residues also survive during the course of the RANEY® cobalt
catalysed reductions of nitriles.57
The capacity of RANEY® cobalt to selectively eﬀect the
hydrogenation of unsaturated nitriles and thereby generating
unsaturated 1°-amines is an important feature of this catalyst.
Thus, for example, E-cinnamonitrile is chemoselectively
reduced to 3-phenylallylamine with up to 80% selectivity and
conversions of >90% when methanol in ammonia is used as
the reaction medium.58 Lower selectivities are observed with
RANEY® nickel. When geranylnitrile (37, Fig. 3) was subjected
to hydrogenation over RANEY® nickel doped with chromium
then 3,7-dimethyl-6-octene-nitrile (38) was the favoured product
of reaction while analogous treatment of the same substrate
with the equivalently doped RANEY® cobalt catalyst gave the
allylic amine 39 as the first-formed product of reaction. Sus-
tained exposure of compound 39 to the reaction conditions led
to the formation of mono-unsaturated congener 40.59
More “elaborate” examples of the chemoselective reduction
of nitriles embedded within polyfunctionalised substrates are
presented in section H.
Using chromium-doped RANEY® cobalt, polynitriles
derived from the “capping”, via hetero-Michael addition reac-
tions, of polyols or polyamines with acrylonitrile, can be
reduced to the corresponding poly 1°-amines, including ones
embodied in dendritic like structures.60–62 In those instances
where exhaustive reduction of the nitrile groups cannot be
accomplished using this catalyst system then a Urushibara-type
reagent or a dissolving metal protocol appear to be eﬀective.61
(iii) Reduction of alkynes, alkenes and arenes
In many respects RANEY® cobalt is “prized” as a catalyst because
of the capacity it oﬀers to eﬀect the reduction or reductive clea-
vage of various nitrogen- and sulfur-based functional groups in
substrates also containing C–C multiple bonds. Accordingly,
there is only a very modest literature dealing with the application
of the title system to the reduction of alkynes, alkenes or arenes.
Indeed, and perhaps a little surprisingly, we have been unable to
locate a single report of the subjection of an alkyne to reaction
with dihydrogen in the presence of RANEY® cobalt.
The exhaustive hydrogenation of the arene thymol (41)
(Scheme 13) using RANEY® cobalt and dihydrogen has been
reported to deliver (±)-isomenthol (42) in 80% yield together
Scheme 12
Scheme 13
Fig. 3 Geranylnitrile (37) and the products arising from its reduction
under various conditions – see text.
Scheme 11
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with minor amounts of the racemic modifications of neo-
menthol, neoisomenthol and menthol.63
Various forms of RANEY® cobalt generated under diﬀering
leaching conditions and/or containing additives have been
studied as catalysts for the exhaustive hydrogenation of squa-
lene (representing a model compound for the purposes of
developing protocols that could eventually allow for the
“upgrading” of bio-oil produced by the highly productive algae
Botryococcus braunii).64
Aller65 has investigated the eﬀects of the promoters triethyl-
amine and chloroplatinic acid (or combinations thereof) on
the capacity of RANEY® cobalt to reduce a range of simple
substrates containing both a carbonyl group and CvC units.
When substrates such as crotonaldehyde, mesityl oxide and
ethyl crotonate were involved then the CvC unit was reduced
chemoselectively. Such outcomes stand in stark contrast to the
those detailed at section D(i) above and serve to emphasise the
extraordinarily significant roles that additives/promoters can
play in influencing the outcomes of reactions involving
RANEY® cobalt (and, indeed, RANEY® metals more generally).
Interestingly, the activity of Aller’s triethylamine–chloropla-
tinic acid-doped RANEY® cobalt is such that, at a temperature
of 100 °C, acetophenone could be reduced to ethylbenzene,
presumably via hydrogenolysis of the initially produced α-phen-
ethyl alcohol.65 In contrast, we have observed that when a
methanolic solution of allylbenzene 43 (Fig. 4) was subjected
to reaction, at ca. 25 °C, with 1 atm of dihydrogen in the pres-
ence RANEY® cobalt (prepared using our protocol17) then the
corresponding ethylbenzene 44 was produced in high yield and
without any accompanying hydrogenolysis of the benzyl group.66
E. Transfer hydrogenation reactions
RANEY® cobalt (in this case the 2700 material obtained from
W. R. Grace) has been shown67 to catalyse the transfer of
hydrogen from isopropanol and by such means α-substituted
aromatic alcohols containing two or more aromatic rings can
be deoxygenated selectively. So, for example, each of 1,2-diphe-
nylethanol, benzhydrol, triphenylmethanol, 9-hydroxyfluorene,
1-(2-fluorenyl)ethanol, 1-(1-naphthyl)-ethanol and 1-(2-naphthyl)-
ethanol can be cleaved to give the corresponding aromatic hydro-
carbon in quantitative yield. RANEY® nickel is less eﬃcient
in this regard but can be used to eﬀect the hydrogenolysis
of non-benzylic alcohols while its cobalt counterpart cannot.
So, for example, 5-phenyl-1-pentanol is converted into pentyl-
benzene in 81% yield upon exposure of the former com-
pound to RANEY® nickel and isopropanol but no reaction is
observed when RANEY® cobalt was employed under the same
conditions.
The protocols detailed immediately above, which seem to
be underutilised, avoid the need to handle gaseous dihydrogen
while work up simply involves filtration and concentration of
the filtrate.
F. Reactions involving (deliberate)
racemisation
RANEY® cobalt is known to facilitate the dehydrogenation of a
range of 2°-alcohols and -amines and thereby aﬀording the
corresponding ketone or imine that can themselves accept
dihydrogen under appropriate conditions and so regenerating
the original alcohol or amine. When optically active substrates
are subjected to such conditions then the corresponding race-
mates are obtained. So for example,68 when an ethereal solu-
tion of 63% ee R-(+)-2-amino-1-butanol (45, Fig. 5) was heated
with RANEY® cobalt at 140 °C and 17 atm of dihydrogen for
6.75 h then the corresponding racemate was obtained in 96%
yield. Resolution of this mixture of enantiomers through the
formation and fractional recrystallisation of the derived tar-
trate salts then provided the essentially pure S-enantiomer
required for the manufacture of ethambutol, a bacteriostatic
antimycobacterial drug used to treat tuberculosis.
R-Quinuclidin-3-ol (46, Fig. 6) represents a common phar-
macophore associated with neuromodulators acting at cholin-
ergic muscarinic receptors. Resolution of the corresponding
racemate by various means provides the best way of generating
this material and so methods for recycling the otherwise un-
usable S-enantiomer via its racemisation have been sought.
One of the most eﬀective methods for doing so involves treat-
ing the S-enantiomer with RANEY® cobalt in o-xylene under
ca. 5 atm of dihydrogen and thereby generating the corres-
ponding racemate in 97% yield.69 When the same reaction was
carried out in the absence of dihydrogen then the ketone was
obtained.
A one-pot, dynamic kinetic resolution of certain 2°-amines
has been reported wherein the unwanted enantiomer is race-
mised using RANEY® cobalt in the presence of dihydrogen
Fig. 5 Structure of R-(+)-2-amino-1-butanol.
Fig. 4 Allylbenzene 43 and the product, 44, of its hydrogenation in the
presence of Raney® cobalt.
Fig. 6 Structure of R-Quinuclidin-3-ol.
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and the desired component (enantiomer) of the resulting
mixture is then acetylated enzymatically with Candida Antarc-
tica lipase B.70 RANEY® nickel was generally inferior in this
context.
G. Miscellaneous transformations
It has been noted71 that RANEY® cobalt allows for the (some-
times high yielding) reaction of unsaturated amides with
carbon monoxide to give cyclic imides. So, for example, the
cyclohexenecarbonamide 47 is converted into hexahydrophtha-
limide (48) by such means (Scheme 14).
In a related vein, it has recently been shown72 that RANEY®
cobalt serves as an eﬀective and recyclable catalyst in the intra-
molecular Pauson–Khand reaction. Treatment (Scheme 15) of
the enyne 49, for example, with carbon monoxide (at pressures
of ca. 23 atm) and RANEY® cobalt in THF at 130 °C for 16 h
aﬀorded the anticipated diquinane 50 in ca. 91% yield.
Somewhat more esoteric uses of RANEY® cobalt include, (i)
its catalysis of the Fischer–Tropsch-like reductive oligomerisa-
tion of isonitriles in the presence of dihydrogen and liquid
ammonia73 and, (ii) its conversion into dicobalt octacarbonyl
under high pressures of carbon monoxide at elevated
temperatures.74
H. Domino and related reactions
The chemoselectivities displayed in RANEY® cobalt catalysed
reduction processes mean that these types of transformations
can deliver new functionalities in the presence of others (not
be aﬀected by the reduction) and so establishing possibilities
for cyclisation reactions to take place (see Scheme 6 for
example). The RANEY® cobalt-catalysed reductive cyclisation
of di(cyanomethyl)amine (51) to give piperazine (52)
(Scheme 16) provided an early illustration of the possibilities
in this area.75
The capacity of RANEY® cobalt to eﬀect the reductive cycli-
sation of the α,β-unsaturated and enantiomerically pure nitrile
53 to the caprolactam 54 (Scheme 17) without significant race-
misation or accompanying reduction of the CvC moiety has
been reported by a Merck-based process research group.76 Best
results were obtained using W. R. Grace’s Fe, Cr and Ni-doped
RANEY® cobalt 2724. They noted that when RANEY® nickel
was used for the same purpose then the CvC double bond was
also reduced. With Rh and Pd-based systems only the CvC unit
was removed (and so no cyclisation reaction occurred).
In a true Domino process,77 and as part of a synthetic
program directed toward the synthesis of the Amaryllidaceae
alkaloid lycorine, we observed78 (Scheme 18) that when com-
pound 55, embodying nitrile, alkenic and allylic C–O moieties,
was subjected to reaction with ca. 30 atm of dihydrogen in
Scheme 15
Scheme 14
Scheme 16
Scheme 17
Scheme 18
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methanol–ammonia in the presence of RANEY® cobalt then
the initially formed 1°-amine 56 (not isolated) engaged in an
intramolecular SN′ reaction with the product amino-acid 57
(not isolated either) then undergoing lactamisation to give the
observed product 58 (65%) that embodies the polycyclic frame-
work of the target natural product. We have since found79 that
by using larger quantities of RANEY® cobalt (normally ca.
200% w/w catalyst relative to substrate) then closely related
nitriles can be reduced to the corresponding 1°-amine using
just 1 atm of dihydrogen. Clearly, this makes for an operation-
ally much simpler and thus far more attractive procedure.
Interestingly, when compound 55 was subjected to attempted
reduction using RANEY® nickel then only a complex mixture
of products was obtained.
Upon subjecting the readily accessible and polyfunctiona-
lised cyclohexenone 59 (Scheme 19) to a range of reductive
cyclisation conditions then either partially reduced and par-
tially cyclised, fully reduced and partially cyclised or fully
reduced and completely cyclised products could be obtained.34
So, treatment of the compound with dihydrogen in the pres-
ence of 10% Pd on C in methanol at 18 °C aﬀorded indole 60
(98%) as a result of reduction of the CvC bond and reductive
cyclisation of the nitro-group onto the pendant CvO (no par-
ticular order of events implied). The associated nitrile residue
was clearly not aﬀected under these conditions. On exposure
to dihydrogen in the presence of RANEY® nickel and
p-toluenesulfonic acid monohydrate (p-TsOH·H2O – this acid
is added to prevent reductive alkylation reactions involving the
intermediates arising from nitrile group reduction) substrate
59 engaged in the same set of reactions as encountered in the
first process but, in addition, the nitrile group was also
reduced to the corresponding 1°-amine (and so aﬀording com-
pound 61 which was obtained in 87% yield). Amine 61 was
also formed (in 98% yield) when compound 60 was treated
with dihydrogen in the presence of RANEY® nickel. Finally,
and most importantly, when cyclohexenone 59 was treated
with dihydrogen, RANEY® cobalt and p-TsOH·H2O then two
reductive cyclisation events took place, one involving an intra-
molecular hetero-Michael addition reaction (leading to the for-
mation of a piperidine ring) and the other in which an
intramolecular Schiﬀ base type condensation reaction took
place (leading to the formation of an indole moiety). As a
result the tetracyclic compound 62 was obtained in 72% yield.
The conversion 59 → 62 is of particular interest because the
product embodies the 1,5-methanoazocino[4,3-b]indole frame-
work associated with the Uleine and Strychnos alkaloids.
I. Eﬀect of additives on the reactivity
of RANEY® cobalt
As noted on a number of occasions in the foregoing sections,
the presence of additives can have a dramatic eﬀect on the cata-
lytic properties of Raney® cobalt.19,39–43,64,65 The manner in
which the material is prepared (particularly in terms of the
initial digestion process and the subsequent washing protocols
that are followed) also has an impact on activity14 and is likely
the result, in part at least, of the presence of residual alu-
minium-based species at the surface of the reagent.
Beyond the eﬀects noted above, additional studies80 of this
topic have revealed that, for example, the eﬃciency of
reduction of various nitriles by RANEY® cobalt containing
iron is strongly influenced by the presence of a third com-
ponent selected from the group consisting of Ni, Rh, Ru, Pd,
Pt, Os and Ir or mixtures thereof. Chromium species can also
have significant eﬀects81 as can molybdenum and tungsten.82
Similarly, when RANEY® cobalt is dispersed in an aliphatic
1°-, 2°- or 3°-amine, a diamine or a cyclic one83 then altera-
tions in reactivity are observed. The preservation of the activity
of RANEY® cobalt (and nickel) between runs through its
storage in glycols has been advocated.84
J. Comparisons with RANEY® nickel
In the foregoing sections, frequent comparisons have been
made between the catalytic eﬀects of RANEY® cobalt and its
nickel counterpart. It is quite clear from these that the former
species is the less reactive one. Indeed, the substantial change
in the reactivity of RANEY® cobalt as a function of the pres-
ence of even small quantities (1–2%) of nickel19 in the starting
alloy stands as testimony to the significant diﬀerence in beha-
viours of the two systems. The consequence of this is that
RANEY® cobalt frequently allows for more chemoselective
reactions to be carried out, most particularly when the syn-
thesis chemist is seeking to reduce nitro- and nitrile-based
moieties in the presence of otherwise potentially reactive
species.Scheme 19
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K. Mechanistic studies
The literature focused on elucidating the mechanisms of reac-
tions that employ RANEY® cobalt is rather sparse. Inelastic
neutron scattering studies85 of dihydrogen and butyronitrile
adsorbed on various RANEY® cobalt catalyst systems have led
to the detection of partially hydrogenated and surface-associ-
ated species including (probably) those that arise from reduc-
tive alkylation events. Intriguingly, nitrene-like intermediates
appear to have been detected during the hydrogenation of
CD3CN on RANEY® cobalt.
86
L. Conclusions
While this survey of a rather scattered body of literature on
RANEY® cobalt reveals that it is a reagent capable of facilitat-
ing a number of distinctly fascinating chemical transform-
ations, most notably various chemoselective reduction
reactions, it is by no means one that routinely comes to mind
when synthesis chemists contemplate the vast “tool set” at
their disposal. There are several factors that have contributed
to this situation, the first being the seeming lack of any com-
pilation of the suite of chemical transformations that RANEY®
cobalt can facilitate. Hopefully this review will help redress
matters in this regard. A second factor contributing to the lack
of an extended “uptake” of the title reagent in chemical syn-
thesis is the seemingly disparate array of techniques detailed
in the literature for preparing RANEY® cobalt and its “doped”/
“spiked” variants, all of which appear to display quite distinct
reactivity profiles. The discontinuation of the supply of certain
previously commercially available sources of RANEY® cobalt87
has certainly exacerbated matters. Furthermore, the seemingly
frequent need to use very high pressures of dihydrogen (and,
often simultaneously, high temperatures) is also oﬀ-putting
with the end result that even for all the potential chemoselec-
tivities “on oﬀer” the operational requirements associated with
using the reagent just seem too daunting.
We believe the drawbacks mentioned above are all readily
addressed by using the simple protocols defined below17 that
allow for the ready preparation of RANEY® cobalt possessing
consistent and eﬀective properties. Furthermore, by using
larger quantities of RANEY® cobalt (e.g. ca. 200% w/w wrt sub-
strate)34,79b in the reduction reactions many of these can be
carried out using dihydrogen at atmospheric pressure and
usually at room temperature. Our recent88 application of such
protocols to the tandem reductive cyclisation of the enone 63
(Scheme 20) to compound 6489 (and embodying the ABCD
framework of the important alkaloid vindoline90) has served to
reinforce our enthusiasm for RANEY® cobalt as a catalyst for
the chemoselective reduction of polyfunctionalised substrates.
We contend that RANEY® cobalt is an under utilised but
particularly eﬀective catalyst for the chemoselective reduction
of polyfunctionalised organic substrates, notably those incor-
porating nitro and nitrile moieties. As such, continued and sys-
tematic investigations into its catalytic properties are to be
encouraged as these are very likely to reveal new and valuable
patterns of reactivity.
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ABSTRACT: The enzymatically derived and enantiomerically
pure (1S,2S)-3-bromocyclohexa-3,5-diene-1,2-diol (7) has
been elaborated over 17 steps into compounds 8 and 32,
each of which embodies the pentacyclic framework and much
of the functionality associated with the alkaloid vindoline (3).
This work sets the stage for eﬀecting the conversion of the
related metabolite (1S,6R)-5-ethyl-1,6-dihydroxycyclohexa-2,4-
diene-1-carboxylic acid (4) into compound 3, the latter being a biogenetic precursor to the clinically signiﬁcant anticancer agents
vinblastine and vincristine.
■ INTRODUCTION
The alkaloids vinblastine (1) and vincristine (2) (Figure 1)
have been isolated from various sources, most notably the
ﬂowering plant Vinca rosea (Catharanthus roseus G. Don), a
Madagascan rosy periwinkle, and each is used clinically in the
treatment of a range of pathologies including Hodgkin’s
lymphoma and certain brain and bladder cancers.1 They exert
their beneﬁcial therapeutic eﬀects by binding to tubulin and
thereby inhibiting mitosis.2 Biogenetically speaking, compounds
1 and 2 are produced through the coupling of vindoline (3)
and catharanthine,3 and the eﬀective in vitro mimicking of this
process as well as the development of alternatives have been
described and exploited in various contexts.4
The elaborate molecular architectures of vinblastine (1) and
vincristine (2), their profoundly important medical value, issues
of supply, the development of resistance to these drugs, and the
need to establish structure−activity relationship (SAR) proﬁles
have prompted considerable eﬀorts to develop de novo
syntheses of them. Necessarily, this has involved the establish-
ment of routes to vindoline.5,6 In 2002, Fukuyama and co-
workers claimed the ﬁrst eﬃcient total synthesis of (−)-vindo-
line,7 thus providing access to vinblastine (1) and vincristine
(2) through the above-mentioned coupling process.8 Spectac-
ular additional contributions from the group of Boger4a,9,10
have provided extraordinarily eﬀective means for assembling
the pentacyclic framework of the Eastern hemispheres of
compounds 1 and 2 (as embodied in vindoline) and related
systems. This type of work has also established an important
understanding of the SAR proﬁle within the class and allowed
for the synthesis, through enhanced functionalization, of
compounds that are signiﬁcantly more potent than vinblastine
and/or display reduced resistance by ameliorating Pgp-based
drug eﬄux processes.10,11 Such eﬀorts stand as testimony to
powerful methodological developments that can be made by
targeting complex natural products such as 1 and 2 for
synthesis.10
In 2005 we reported12 a whole-cell biotransformation of m-
ethyltoluene that allowed for its enantioselective conversion
into the cis-1,2-dihydrocatechol 4 (Figure 2). Since this
metabolite embodies key structural components associated
with the highly functionalized C-ring of vindoline, we sought to
establish means by which to eﬀect the conversion 4 → 3. As
part of such a program, we recently reported13 the outcomes of
a model study wherein we were able to convert cyclohexane-
1,4-dione monoethylene ketal (representing the developing C-
ring of the eventual target 3) into the tetracyclic but racemic
amide 5. This last compound could itself be engaged in a
gold(I)-catalyzed cyclization reaction that aﬀorded (after
hydrolysis) the unsaturated lactam 6 (33%), thus establishing
the pentacyclic framework of natural product 3. While
encouraging in various respects, the reaction sequence used
did not seem readily amenable to modiﬁcation so that a C-ring
precursor such as metabolite 4 could be incorporated within it.
Accordingly, we now detail the outcomes of a study that have
Received: December 9, 2015
Published: January 20, 2016
Figure 1. Structures of vinblastine, vincristine, and vindoline.
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allowed for the conversion of the enantiomerically pure cis-1,2-
dihydrocatechol 7, a chiron that is available in kilogram if not
tonne quantities through the whole-cell biotransformation of
bromobenzene,14 into a hexacyclic compound, 8, that
incorporates most of the structural elements of vindoline.
■ RESULTS AND DISCUSSION
Our initial eﬀorts to deploy compound 7 as a starting material
for the enantioselective preparation of the vindoline framework
are shown in Scheme 1 and started with its regio- and stereo-
selective conversion, using established protocols, into the
previously reported15,16 bromoconduritol monoacetonide 9
(95% yield over two steps). Selective monoprotection of the
allylic hydroxyl group within this last compound could be
achieved by treating it with tert-butyldimethylsilyl chloride
(TBS-Cl) in the presence of imidazole. The product, 10
(89%),16 of this process was then reacted with chloromethyl-
methyl ether (MOM-Cl) in the presence of 4-(N,N-dimethyl-
amine)pyridine (DMAP) and N,N-di-isopropylethylamine
(Hünig’s base) to give the fully protected conduritol 11
(75%) that could itself be allylated in a Suzuki−Miyaura cross-
coupling reaction with the commercially available boronate
ester 12. The product thus formed was immediately subjected
to treatment with tetra-n-butylammonium ﬂuoride (TBAF) and
so delivering the allylic alcohol 13 in 94% yield over the two
steps involved.
Oxidation of compound 13 with the Dess−Martin period-
inane (DMP)17 in the presence of sodium bicarbonate aﬀorded
the rather unstable 2-cyclohexen-1-one 14 (83%). Despite
much eﬀort, we were unable to carry this last compound
forward in any useful fashion. For example, futile attempts were
made to eﬀect the conjugate addition of ethyl-containing
nucleophiles to this potential Michael acceptor with trapping of
the resulting enolate so as to generate compounds such as
triﬂate 15.18
Given the lack of success associated with eﬀorts to establish
the ethyl-bearing quaternary carbon center of vindoline through
conjugate addition processes such as that shown in Scheme 1,
other means for doing so were pursued. During the course of
work concerned with the total synthesis of other alkaloids, we
found that the Eschenmoser−Claisen rearrangement of various
3-substituted 2-cyclohexen-1-ols provided a uniquely eﬀective
means of establishing the necessary β,β,β-trisubstituted acetic
acid derivative.19 Accordingly we sought to apply this same
Figure 2. Metabolites 4 and 7, previously prepared vindoline analogue
6, its precursor 5, and target compound 8.
Scheme 1. Synthesis of 2-Cyclohexen-1-one 14
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protocol in the present setting, and the successful outcomes of
our doing so are shown in Scheme 2. The opening stages of the
reaction sequence were focused on the construction of the
requisite 3-substituted 2-cyclohexen-1-ol and involved, as part
of that process, the conversion of the cis-1,2-dihydrocatechol 7
into the previously reported epoxide 16,20 a process that can
now be readily conducted on a rather large scale. Phosphoric
acid catalyzed ring opening of the latter compound using acetic
acid as the nucleophile proceeded in a completely regioselective
manner and with inversion of conﬁguration at the allylic
carbon. The resulting alcohol was immediately protected as the
corresponding MOM-ether 1719 (74% over two steps) under
standard conditions. Cross-coupling of compound 17 with
ethylboronic acid in the presence of tetrakis(triphenyl-
phospine)palladium(0) and reaction of the resulting ethyl-
substituted cyclohexene with methanolic potassium carbonate
(so as to complete the partial cleavage of the acetate residue
observed in the ﬁrst step) aﬀorded the allylic alcohol 18 (63%)
sought as the substrate for the Eschenmoser−Claisen
rearrangement.
When compound 18 was treated with N,N-dimethyl-
acetamide dimethyl acetal in reﬂuxing toluene the rearrange-
ment reaction proceeded in the anticipated manner, so
providing the β,β,β-trisubstituted acetic acid amide 19 in 94%
yield. The assignment of the illustrated stereochemistry at the
quaternary carbon within compound 19 is based on the well-
recognized capacity of the Eschenmoser−Claisen rearrange-
ment to faithfully transform an allylic alcohol of deﬁned
stereochemistry into a product that reﬂects this.19 On reduction
with lithium triethylborohydride, amide 19 aﬀorded the
corresponding alcohol that was immediately subjected to an
Appel reaction21 using molecular iodine in the presence of
triphenylphosphine. This delivered the unstable iodide 20 in
85% yield. In the necessary ﬁnal step of the side-chain
homologation of rearrangement product 19, compound 20 was
treated with potassium cyanide. However, this reaction did not
proceed entirely as expected. The close spatial relationship
Scheme 2. Synthesis of Quaternary Carbon-Containing 2-Cyclohexen-1-one 25
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between the iodine-bearing carbon and the nearer of the two
acetonide oxygens in substrate 20 resulted in an intramolecular
nucleophilic substitution reaction involving these two centers
with the oxonium ion so-formed being attacked by the cyanide
ion to aﬀord the tetrahydrofuran 21 (18%) as well as the
chromatographically separable, direct substitution product 22
(73%). Cleavage of the MOM-ether unit within compound 22
could be achieved using aqueous hydrogen bromide, but this
was accompanied by partial hydrolysis of the acetonide residue.
As a result it was more eﬀective to treat a solution of substrate
22 in 2,2-DMP/methanol with HBr in order to smoothly
generate (i.e. without accompanying cleavage of the acetonide
unit) the allylic alcohol 23.
Compound 23 was immediately oxidized, using manganese
dioxide, to the corresponding enone 24 which was obtained in
82% overall yield from precursor 22. Johnson-type α-
iodination22 of compound 24 was readily achieved using
molecular iodine in the presence of pyridine, so generating the
substrate, 25 (quant.), needed for the indole and piperidine
annulation processes that would thereby establish the AB- and
D-ring systems of the developing vindoline framework.
During the course of studies on the synthesis of the alkaloid
limaspermidine23 we identiﬁed a two-step protocol that enabled
the simultaneous annulation of indole and piperidine ring
systems to a γ,γ-disubstituted 2-aryl-2-cyclohexen-1-one and
sought to apply this methodology in the present setting.
Accordingly, compound 25 was engaged in a palladium-
catalyzed Ullmann cross-coupling reaction24 with the commer-
cially available aryl iodide 26 (Scheme 3) and so delivering the
α-arylated cyclohexenone 27 (92%). Compound 27 could be
engaged in a reductive cyclization process using dihydrogen in
the presence of Raney cobalt,25 thereby producing the indole/
piperidine 28 (85%) embodying the ABCD-tetracyclic ring
system of vindoline.
In principle, there are various possible pathways available for
the annulation of the required E-ring of vindoline to the
tetracyclic framework of compound 28, perhaps the most
notable being that deployed by Heathcock26 during the course
of a synthesis of the alkaloid aspidospermadine. Given our
successful exploitation of this protocol in various contexts,23,27
we sought to apply it in the present case but without success.
So, while the N-α-chloroacetamide derivative of compound 28
was readily prepared it could not be engaged in the required 5-
exo-tet cyclization reaction.
The eventually successful E-ring annulation process is shown
in Scheme 4 and began with the hydroxyethylation of the
piperidine nitrogen of compound 28 using 2-bromoethanol as
the electrophile28 and potassium carbonate as the base.
Mesylation of the product β-aminoalcohol 29 under the
Crossland−Servis conditions29 provided the anticipated and
Scheme 3. Annulation of the A-, B-, and D-Rings to 2-Cyclohexen-1-one 25
Scheme 4. Establishing the E-Ring of Vindoline
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somewhat unstable sulfonate ester 30 that was immediately
treated with potassium tert-butoxide.30 As a result the desired
pentacycle 31 (92% from 29) was obtained. At this point, we
sought to exploit the isoindole subunit embedded within this
last compound for the purposes of inserting relevant additional
substituents into the vindoline framework. Reductive methyl-
ation of imine 31 was readily achieved by treating it with
formaldehyde in the presence of sodium cyanoborohydride and
generating the N-methylindoline 8 in 80% yield. The
assignment of the illustrated stereochemistry at C3 in this
product has been made on the basis that only the cis-mode of
fusion between rings B and C is feasible. In a somewhat more
unusual transformation, successive treatment of substrate 31
with tert-butyllithium and then Mander’s reagent31 aﬀorded the
reductively N-carbomethoxylated compound 32 (70%) rather
than the hoped for imine-containing and C3-carbomethoxy-
lated product. In this conversion (viz. 31 → 32), the tert-
butyllithium is most likely serving as a hydride source32 and
with the resulting N-lithiated indoline then reacting with the
added electrophile to deliver the observed product. All the
spectral data derived from the ﬁnal products 8 and 32 were in
complete accord with the assigned structures.
■ CONCLUSIONS
The reaction sequences detailed herein enhance the prospects
of being able to transform the homochiral metabolite (1S,6R)-
5-ethyl-1,6-dihydroxycyclohexa-2,4-diene-1-carboxylic acid (4)
into vindoline. Perhaps the greatest challenge in doing so is the
devising of a protocol for introducing the carbon−carbon
double bond present in the D-ring of the natural product. That
said, Boger has identiﬁed potent vinblastine analogues that lack
the Δ6,7-double bond within the vindoline subunit,11d and so it
might be reasonable to conclude that this is not such a
substantial issue in terms of generating active compounds. The
outcome of studies focused on elaborating compound 4 into
vindoline and various active analogues, including those
embodying a ﬁve-membered D-ring,11d will be reported in
due course.
■ EXPERIMENTAL SECTION
General Experimental Procedures. Unless otherwise speciﬁed,
proton (1H) and carbon (13C) NMR spectra were recorded at room
temperature in base-ﬁltered CDCl3 on a spectrometer operating at 400
MHz for protons and 101 MHz for carbon nuclei. The signal due to
residual CHCl3 appearing at δH 7.26 and the central resonance of the
CDCl3 “triplet” appearing at δC 77.0 were used to reference
1H and
13C NMR spectra, respectively. 1H NMR data are recorded as follows:
chemical shift (δ) [multiplicity, coupling constant(s) J (Hz), relative
integral] where multiplicity is deﬁned as s = singlet; d = doublet; t =
triplet; q = quartet; m = multiplet or combinations of the above.
Infrared spectra (νmax) were recorded on an FTIR spectrometer.
Samples were analyzed as thin ﬁlms on KBr plates. Optical rotations
were recorded in the indicated solvent at 20 °C. Low-resolution ESI
mass spectra were recorded on a single quadrupole liquid chromato-
graph−mass spectrometer, while high-resolution measurements were
conducted on a time-of-ﬂight instrument. Low- and high-resolution EI
mass spectra were recorded on a magnetic-sector machine. Analytical
thin layer chromatography (TLC) was performed on aluminum-
backed 0.2 mm thick silica gel 60 F254 plates. Eluted plates were
visualized using a 254 nm UV lamp and/or by treatment with a
suitable dip followed by heating. These dips included phosphomolyb-
dic acid/ceric sulfate/sulfuric acid (conc.)/water (37.5 g/7.5 g/37.5 g/
720 mL) or potassium permanganate/potassium carbonate/5%
sodium hydroxide aqueous solution/water (3 g/20 g/5 mL/300
mL). Flash chromatographic separations were carried out following
protocols deﬁned by Still et al.33 with silica gel 60 (40−63 μm) as the
stationary phase and using the AR- or HPLC-grade solvents indicated.
Starting materials, reagents, drying agents, and other inorganic salts
were generally commercially available and used as supplied.
Tetrahydrofuran (THF), methanol, and dichloromethane were dried
using a solvent puriﬁcation system that is based upon a technology
originally described by Grubbs et al.34 Petroleum spirit refers to that
hydrocarbon fraction boiling in the range between 40 and 60 °C.
Where necessary, reactions were performed under an atmosphere of
nitrogen.
(((3aS,4S,5R,7aS)-7-Bromo-4-(methoxymethoxy)-2,2-dimethyl-
3a,4,5,7a-tetrahydrobenzo[d][1,3]dioxol-5-yl)oxy)(tert-butyl)-
dimethylsilane (11). A magnetically stirred solution of compound
1016 (9.84 g, 25.9 mmol) in dichloromethane (50 mL) maintained
under an atmosphere of nitrogen at room temperature was treated,
successively, with Hünig’s base (27.1 mL, 155.7 mmol, 6 mol equiv),
DMAP (3.17 g, 25.9 mmol, 1 mol equiv), and freshly prepared MOM-
Cl (9.85 mL, 130.0 mmol, 5 molar equiv). After 18 h the reaction
mixture was quenched via the slow addition of NaHCO3 (150 mL of a
saturated aqueous solution), and the separated aqueous phase was
extracted with dichloromethane (1 × 100 mL). The combined organic
phases were washed with NH4Cl (1 × 150 mL of a saturated aqueous
solution), then dried (Na2SO4), ﬁltered, and concentrated under
reduced pressure. The residue thus obtained was subjected to ﬂash
chromatography (silica, 1:20 v/v ethyl acetate/petroleum spirit
elution), and concentration of the relevant fractions (Rf = 0.4 in
1:10 v/v ethyl acetate/petroleum spirit) aﬀorded bromide 11 (8.24 g,
75%) as a clear, colorless oil, [α]D = −80.2 (c = 0.7, CHCl3). 1H NMR
(400 MHz, CDCl3) δ 6.06 (d, J = 2.8 Hz, 1H), 4.82 (d, J = 6.7 Hz,
1H), 4.72 (d, J = 6.7 Hz, 1H), 4.64 (d, J = 5.4 Hz, 1H), 4.44 (dd, J =
5.4 and 1.1 Hz, 2H), 4.07 (app. t, J = 4.3 Hz, 1H), 3.39 (s, 3H), 1.43
(s, 3H), 1.40 (s, 3H), 0.90 (s, 9H), 0.11 (s, 3H), 0.10 (s, 3H); 13C
NMR (101 MHz, CDCl3) δ 132.7, 122.4, 110.1, 97.1, 76.8, 75.8, 75.5,
68.0, 55.7, 27.6, 26.2, 25.8, 18.1, − 4.8 (two signals overlapping); IR
(KBr) νmax 2931, 2892, 2857, 1643, 1472, 1371, 1254, 1117, 1079,
1040, 968, 874, 836, 777 cm−1; MS (ESI, + ve) m/z 447 and 445 [(M
+ Na)+, 100 and 93% respectively]; HRMS (ESI, + ve) [M + Na]+
calcd for C17H31
79BrNaO5Si 445.1022, found 445.1022.
(3aR,4R,5R,7aR)-7-Allyl-4-(methoxymethoxy)-2,2-dimethyl-
3a,4,5,7a-tetrahydrobenzo[d][1,3]dioxol-5-ol (13). A vigorously
stirred solution of bromide 11 (600 mg, 1.42 mmol) in degassed
benzene (20 mL) maintained under an atmosphere of nitrogen at
room temperature was treated with Na2CO3 (5 mL of a 2 M aqueous
solution that had been degassed by sonicating it for 0.25 h under an
atmosphere of nitrogen at room temperature). The ensuing two-phase
system was treated with Pd(PPh3)4 (162 mg, 0.14 mmol, 0.1 mol
equiv) and boronate ester 12 (400 μL, 2.13 mmol, 1.5 mol equiv) and
then heated under reﬂux for 18 h. The cooled reaction mixture was
diluted with water (10 mL), and the separated aqueous phase was
extracted with diethyl ether (2 × 50 mL). The combined organic
extracts were dried (Na2SO4), ﬁltered, and then concentrated under
reduced pressure. The brown residue thus obtained was dissolved in
THF (25 mL), and the solution so formed was treated, at room
temperature, with TBAF (4.26 mL of a 1 M solution in THF, 4.26
mmol, 3 mol equiv). The resulting mixture was stirred for 18 h and
then diluted with diethyl ether (10 mL) and NaHCO3 (20 mL of a
saturated aqueous solution). The separated aqueous phase was
extracted with diethyl ether (2 × 50 mL), and the combined organic
extracts were then dried (Na2SO4), ﬁltered, and concentrated under
reduced pressure. The black residue thus obtained was subjected to
ﬂash chromatography (silica, 1:3 v/v ethyl acetate/petroleum spirit
elution), and concentration of the relevant fractions (Rf = 0.35 in 1:1
v/v ethyl acetate/petroleum spirit) aﬀorded alcohol 13 (336 mg, 94%)
as a clear, colorless oil, [α]D = −95.5 (c = 1.0, CHCl3). 1H NMR (300
MHz, CDCl3) δ 5.83 (m, 1H), 5.62 (d, J = 4.4 Hz, 1H), 5.14 (m, 1H),
5.08 (d, J = 1.3 Hz, 1H), 4.78 (ABq, J = 6.7 Hz, 2H), 4.51 (d, J = 5.9
Hz, 1H), 4.42 (app. t, J = 6.3 Hz, 1H), 4.30 (broad s, 1H), 3.88 (dd, J
= 6.7 and 3.5 Hz, 1H), 3.40 (s, 3H), 3.02−2.81 (complex m, 2H), 2.74
(d, J = 6.0 Hz, 1H), 1.41 (s, 3H), 1.37 (s, 3H); 13C NMR (75 MHz,
CDCl3) δ 137.8, 134.7, 124.9, 117.3, 109.3, 96.9, 77.9, 74.6, 74.2, 65.4,
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55.7, 37.7, 27.7, 26.1; IR (KBr) νmax 3445, 2985, 2993, 2869, 1638,
1433, 1380, 1370, 1236, 1217, 1153, 1107, 1054, 1029, 917, 875 cm−1;
MS (ESI, + ve) m/z 293 [(M + Na)+, 100%]; HRMS (ESI, + ve) [M +
Na]+ calcd for C14H22NaO5 293.1365, found 293.1365.
(3aR,4S,7aR)-7-Allyl-4-(methoxymethoxy)-2,2-dimethyl-3a,7a-
dihydrobenzo[d][1,3]dioxol-5(4H)-one (14). A magnetically stirred
solution of alcohol 13 (118 mg, 0.47 mmol) in dichloromethane (12
mL) was cooled to 0 °C and then treated with NaHCO3 (600 mg, 7.04
mmol, 15 mol equiv) and DMP (600 mg, 1.41 mmol, 3 mol equiv).
After 2 h the reaction mixture was treated with Na2S2O3 (10 mL of a
saturated aqueous solution) and stirred for a further 0.5 h at 0 °C. The
separated aqueous phase was extracted with dichloromethane (3 × 10
mL), and the combined organic phases were dried (Na2SO4), ﬁltered,
and then concentrated under reduced pressure at 25 °C. The residue
thus obtained was subjected to ﬂash chromatography (silica, 1:3 v/v
ethyl acetate/petroleum spirit elution), and concentration of the
relevant fractions (Rf = 0.75 in 1:1 v/v ethyl acetate/petroleum spirit)
aﬀorded enone 14 (105 mg, 83%) as a clear, pale-yellow oil, [α]D =
−315.0 (c = 0.4, C6H6). 1H NMR (400 MHz, C6H6) δ 5.81 (s, 1H),
5.52 (m, 1H), 4.98−4.89 (complex m, 2H), 4.92 (d, J = 6.6 Hz, 1H),
4.67 (d, J = 6.6 Hz, 1H), 4.45 (d, J = 6.4 Hz, 1H), 4.30−4.20 (complex
m, 2H), 3.26 (s, 3H), 2.81 (dd, J = 16.8 and 6.5 Hz, 1H), 2.68 (dd, J =
16.8 and 7.4 Hz, 1H), 1.34 (s, 3H), 1.22 (s, 3H); 13C NMR (101
MHz, C6D6) δ 194.4, 154.7, 133.0, 126.0, 118.7, 110.7, 96.3, 77.5, 76.6,
73.8, 55.5, 38.4, 27.9, 26.5; IR (KBr) νmax 2987, 2935, 2894, 1698,
1635, 1455, 1382, 1372, 1219, 1153, 1072, 1035, 919, 858 cm−1; MS
(ESI, + ve) m/z 291 [(M + Na)+, 100%]; HRMS (ESI, + ve) [M +
H]+ calcd for C14H21O5 269.1389, found 269.1395.
(3aR,4R,5S,7aR)-7-Ethyl-4-(methoxymethoxy)-2,2-dimethyl-
3a,4,5,7a-tetrahydrobenzo[d][1,3]dioxol-5-ol (18). A vigorously
stirred solution of bromide 1719 (1.00 g, 2.85 mmol) in degassed
benzene (40 mL) maintained at room temperature under an
atmosphere of nitrogen was treated with K2CO3 (10 mL of a degassed
2 M aqueous solution). The ensuing two-phase system was treated
with Pd(PPh3)4 (659 mg, 0.57 mmol, 0.2 equiv) and ethyl boronic acid
(632 mg, 8.55 mmol, 3 equiv) and then heated under reﬂux for 18 h.
The cooled reaction mixture was diluted with water (20 mL), and the
separated aqueous phase was extracted with ethyl acetate (2 × 100
mL). The combined organic extracts were then dried (Na2SO4),
ﬁltered, and concentrated under reduced pressure, and the brown
residue thus obtained was dissolved in methanol (50 mL). The
resulting solution was treated with K2CO3 (ca. 100 mg) and the
mixture so formed was stirred at room temperature for 18 h, then
diluted with ethyl acetate (150 mL), and washed with brine (1 × 100
mL). The separated aqueous phase was extracted with ethyl acetate (3
× 50 mL), and the combined organic extracts were then dried
(Na2SO4), ﬁltered, and concentrated under reduced pressure. The
brown residue thus obtained was subjected to ﬂash chromatography
(silica, 1:3 → 1:1 v/v ethyl acetate/petroleum spirit gradient elution),
and concentration of the relevant fractions (Rf = 0.5 in 1:1 v/v ethyl
acetate/petroleum spirit) aﬀorded alcohol 18 (468 mg, 63%) as a pale-
yellow oil, [α]D = +23.3 (c = 0.7, CHCl3).
1H NMR (400 MHz,
CDCl3) δ 5.51 (m, 1H), 4.83 (ABq, J = 6.8 Hz, 2H), 4.50 (d, J = 6.3
Hz, 1H), 4.15 (dd, J = 8.5 and 6.3 Hz, 1H), 4.05 (m, 1H), 3.89 (d, J =
3.2 Hz, 1H), 3.45 (s, 3H), 2.35−2.18 (complex m, 1H), 2.16−2.06
(complex m, 1H), 1.47 (s, 3H), 1.38 (s, 3H), 1.08 (t, J = 7.4 Hz, 3H)
(signal due to OH group proton not observed); 13C NMR (101 MHz,
CDCl3) δ 136.9, 125.2, 109.9, 97.9, 84.2, 76.4, 74.9, 69.3, 55.8, 28.1,
26.1, 25.8, 11.5; IR (KBr) νmax 3438, 2984, 2935, 1457, 1371, 1244,
1218, 1153, 1109, 1072, 1042, 868 cm−1; MS (EI, 70 eV) m/z 258
(M+•, 2%), 243 [(M − •CH3)+, 13], 196 (8), 155 (10), 145 (100);
HRMS (EI) (M − •CH3)+ calcd for C12H19O5 243.1232, found
243.1232.
2-((3aR,4R,7R,7aS)-4-Ethyl-7-(methoxymethoxy)-2,2-dimethyl-
3a,4,7,7a-tetrahydrobenzo[d][1,3]dioxol-4-yl)-N,N-dimethyl-
acetamide (19). A stirred solution of alcohol 18 (3.33 g, 12.9 mmol)
in toluene (190 mL) maintained under a nitrogen atmosphere at room
temperature was treated with N,N-dimethylacetamide dimethyl
acetal35 (19 mL, 128.91 mmol, 10 equiv). The ensuing solution was
heated under reﬂux for 120 h, and then the cooled reaction mixture
was concentrated under reduced pressure. The dark brown oil thus
obtained was subjected to ﬂash chromatography (silica, 1:1 → 2:1 v/v
ethyl acetate/petroleum spirit gradient elution), and concentration of
the relevant fractions (Rf = 0.5 in 2:1 v/v ethyl acetate/petroleum
spirit) aﬀorded amide 19 (3.97 g, 94%) as a pale-yellow oil, [α]D =
−36.0 (c = 0.5, CHCl3). 1H NMR (400 MHz, CDCl3) δ 5.83 (dd, J =
10.3 and 1.9 Hz, 1H), 5.70 (dd, J = 10.3 and 2.0 Hz, 1H), 4.86 (d, J =
6.7 Hz, 1H), 4.73 (d, J = 6.7 Hz, 1H), 4.27−4.16 (complex m, 3H),
3.40 (s, 3H), 2.99 (s, 3H), 2.90 (s, 3H), 2.57 (d, J = 16.0 Hz, 1H), 2.34
(d, J = 16.0 Hz, 1H), 1.96−1.71 (complex m, 2H), 1.44 (s, 3H), 1.34
(s, 3H), 0.87 (t, J = 7.5 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ
171.0, 135.9, 125.7, 107.9, 95.4, 79.5, 78.1, 74.4, 55.4, 41.2, 37.7, 36.4,
35.4, 30.3, 27.1, 25.0, 8.7; IR (KBr) νmax 2935, 1651, 1394, 1380, 1212,
1150, 1099, 1042, 917 cm−1; MS (EI, 70 eV) m/z 327 (M+•, 12%),
312 (18), 282 (23), 266 (100), 208 (45); HRMS (ESI, + ve) [M +
Na]+ calcd for C17H29NNaO5 350.1943, found 350.1944.
2-((3aR,4R,7R,7aS)-4-Ethyl-7-(methoxymethoxy)-2,2-dimethyl-
3a,4,7,7a-tetrahydrobenzo[d][1,3]dioxol-4-yl)ethan-1-ol (Product
of Reduction of Compound 19). A magnetically stirred solution of
amide 19 (6.00 g, 20.04 mmol) in THF (150 mL) maintained at 0 °C
under an atmosphere of nitrogen was treated, in one portion, with
Et3BHLi (60 mL of a 1 M solution in THF, 60.13 mmol, 3 equiv).
After 4 h methanol was added, dropwise via Pasteur pipette, to the
reaction mixture until gas evolution had ceased [CAUTION]. The
ensuing solution was concentrated under reduced pressure, and the
residue thus obtained subjected to ﬂash chromatography (silica, 1:3→
1:1 v/v ethyl acetate/petroleum spirit gradient elution). Concentration
of the relevant fractions (Rf = 0.4 in 1:1 v/v ethyl acetate/petroleum
spirit) aﬀorded the title product (5.74 g, quantitative) as a clear,
colorless oil, [α]D = −40.0 (c = 0.5, CHCl3). 1H NMR (400 MHz,
CDCl3) δ 5.74 (dd, J = 10.2 and 3.0 Hz, 1H), 5.48 (dd, J = 10.2 and
1.8 Hz, 1H), 4.83 (d, J = 6.7 Hz, 1H), 4.73 (d, J = 6.7 Hz, 1H), 4.19
(m, 2H), 4.07 (m, 1H), 3.69 (td, J = 6.4 and 1.4 Hz, 2H), 3.40 (s, 3H),
2.41 (broad s, 1H), 1.87 (m, 1H), 1.72 (m, 1H), 1.64−1.39 (complex
m, 2H), 1.47 (s, 3H), 1.36 (s, 3H), 0.86 (t, J = 7.5 Hz, 3H); 13C NMR
(101 MHz, CDCl3) δ 135.3, 126.3, 108.0, 95.6, 79.2(3), 79.1(7), 74.1,
59.1, 55.4, 40.9, 37.9, 32.2, 27.3, 25.5, 8.5; IR (KBr) νmax 3436, 2935,
2886, 1462, 1380, 1242, 1213, 1151, 1099, 1044, 918, 877 cm−1; MS
(ESI, + ve) m/z 309 [(M + Na)+, 100%]; HRMS (ESI, + ve) [M +
Na]+ calcd for C15H26NaO5 309.1678, found 309.1678.
(3aR,4R,7R,7aS)-4-Ethyl-4-(2-iodoethyl)-7-(methoxymethoxy)-
2,2-dimethyl-3a,4,7,7a-tetrahydrobenzo[d][1,3]dioxole (20). A mag-
netically stirred solution of the above-mentioned product alcohol (480
mg, 1.67 mmol), PPh3 (658 mg, 2.51 mmol, 1.5 equiv), and imidazole
(228 mg, 3.35 mmol, 2 equiv) in THF (20 mL) maintained under an
atmosphere of nitrogen at 0 °C was treated, in one portion, with a
solution of molecular iodine (637 mg, 2.51 mmol, 1.5 equiv) in THF
(5 mL). The ensuing mixture was allowed to warm to room
temperature over 4 h, then diluted with diethyl ether (20 mL), and
quenched with NaHCO3/Na2S2O3 (50 mL of a 1:1 v/v mixture of
saturated aqueous solutions). The separated aqueous phase was
extracted with diethyl ether (3 × 40 mL), and the combined organic
phases were dried (Na2SO4), ﬁltered, and then concentrated under
reduced pressure. The yellow residue thus obtained was subjected to
ﬂash chromatography (silica, 1:20→ 1:10 v/v ethyl acetate/petroleum
spirit gradient elution), and concentration of the relevant fractions (Rf
= 0.3 in 1:10 v/v ethyl acetate/petroleum spirit) aﬀorded iodide 20
(563 mg, 85%) as a clear, yellow oil, [α]D = −110.0 (c = 0.5, CHCl3).
1H NMR (400 MHz, CDCl3) δ 5.79 (dd, J = 10.3 and 2.4 Hz, 1H),
5.45 (dd, J = 10.3 and 1.9 Hz, 1H), 4.86 (d, J = 6.7 Hz, 1H), 4.74 (d, J
= 6.7 Hz, 1H), 4.21−4.12 (complex m, 2H), 4.00 (d, J = 6.1 Hz, 1H),
3.41 (s, 3H), 3.26−3.12 (complex m, 2H), 2.22−2.05 (complex m,
2H), 1.58−1.40 (complex m, 2H), 1.47 (s, 3H), 1.35 (s, 3H), 0.87 (t, J
= 7.5 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 133.8, 127.7, 108.1,
95.6, 79.3, 78.4, 74.3, 55.5, 44.1, 40.6, 31.6, 27.2, 25.1, 8.5, 1.3; IR
(KBr) νmax 2929, 1461, 1380, 1213, 1151, 1100, 1042, 918, 873 cm
−1;
MS (EI, 70 eV) m/z 396 (M+•, 3%), 381 (16), 309 (100), 296 (93),
277 (43), 267 (94); HRMS (EI) M+• calcd for C15H25IO4 396.0798,
found 396.0795.
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2-(((3aR,6R,7S,7aR)-3a-Ethyl-6-(methoxymethoxy)-2,3,3a,6,7,7a-
hexahydrobenzofuran-7-yl)oxy)-2-methylpropanenitrile (21) and
3-((3aR,4R,7R,7aS)-4-Ethyl-7-(methoxymethoxy)-2,2-dimethyl-
3a,4,7,7a-tetrahydrobenzo[d][1,3]dioxol-4-yl)propanenitrile (22). A
solution of iodide 20 (495 mg, 1.25 mmol) in DMF (20 mL)
maintained under an atmosphere of nitrogen at room temperature was
treated, in one portion, with KCN (814 mg, 12.50 mmol, 10 equiv).
The resulting suspension was stirred at 40 °C for 18 h, then cooled,
diluted with water (20 mL), and extracted with diethyl ether (3 × 50
mL). The combined organic phases were dried (Na2SO4), ﬁltered, and
then concentrated under reduced pressure. The resulting light-yellow
oil was subjected to ﬂash chromatography (silica, 1:5 → 1:3 v/v ethyl
acetate/petroleum spirit gradient elution) to aﬀord two fractions, A
and B.
Concentration of fraction A [Rf = 0.2(4) in 1:5 v/v ethyl acetate/
petroleum spirit] aﬀorded furan 21 (66 mg, 18%) as a clear, colorless
oil, [α]D = −80.6 (c = 0.5, CHCl3). 1H NMR (400 MHz, CDCl3) δ
5.70 (dd, J = 10.3 and 1.8 Hz, 1H), 5.39 (dd, J = 10.3 and 1.8 Hz, 1H),
4.75 (ABq, J = 6.7 Hz, 2H), 4.31 (d, J = 8.5 Hz, 1H), 4.07 (s, 1H),
3.92−3.82 (complex m, 2H), 3.67 (m, 1H), 3.40 (s, 3H), 1.90−1.75
(complex m, 2H), 1.65 (s, 3H), 1.64, (m, 2H), 1.61 (s, 3H), 0.99 (td, J
= 7.6 and 1.3 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 131.7, 128.1,
121.4, 97.2, 82.7, 78.2, 73.1, 70.7, 66.9, 55.5, 50.0, 38.3, 30.6, 28.6,
27.2, 10.0; IR (KBr) νmax 2965, 2938, 2881, 1463, 1386, 1173, 1152,
1104, 1061, 917, 842, 774 cm−1; MS (ESI, + ve) m/z 318 [(M + Na)+,
100%]; HRMS (ESI, + ve) [M + Na]+ calcd for C16H25NNaO4
318.1681, found 318.1681.
Concentration of fraction B [Rf = 0.2(6) in 1:5 v/v ethyl acetate/
petroleum spirit] aﬀorded compound 22 (281 mg, 73%) as a clear,
colorless oil, [α]D = −67.2 (c = 0.5, CHCl3). 1H NMR (400 MHz,
CDCl3) δ (d, J = 10.2, 1H), 5.42 (d, J = 10.2, 1H), 4.79 (ABq, J = 6.7
Hz, 2H), 4.20−4.12 (complex m, 2H), 4.01 (m, 1H), 3.41 (s, 3H),
2.51−2.28 (complex m, 2H), 1.87 (m, 2H), 1.61−1.40 (complex m,
2H), 1.47 (s, 3H), 1.35 (s, 3H), 0.88 (t, J = 7.5 Hz, 3H); 13C NMR
(101 MHz, CDCl3) δ 133.3, 128.4, 120.4, 108.2, 95.6, 79.1, 78.4, 73.9,
55.4, 41.2, 31.9, 31.1, 27.2, 25.2, 12.9, 8.4; IR (KBr) νmax 2931, 2246,
1737, 1654, 1462, 1381, 1261, 1242, 1213, 1151, 1099, 1042, 918, 873,
799, 518 cm−1; MS (ESI, + ve) m/z 318 [(M + Na)+, 100%]; HRMS
(ESI, + ve) [M + Na]+ calcd for C16H25NNaO4 318.1681, found
318.1681.
3-((3aR,4R,7R,7aS)-4-Ethyl-7-hydroxy-2,2-dimethyl-3a,4,7,7a-
tetrahydrobenzo[d][1,3]dioxol-4-yl)propanenitrile (23). A solution
of ether 22 (1.77 g, 5.95 mmol) in 2,2-DMP (50 mL) was treated with
methanol (5 mL) and then HBr (10 drops of a 48% aqueous solution).
The ensuing mixture was stirred at room temperature for 4 h, then
diluted with diethyl ether (25 mL), and quenched with NaHCO3 (50
mL of a saturated aqueous solution). The separated aqueous phase was
extracted with diethyl ether (2 × 50 mL), and the combined organic
phases were dried (Na2SO4), ﬁltered, and then concentrated under
reduced pressure. The yellow residue thus obtained was subjected to
ﬂash chromatography (silica, 1:1 v/v ethyl acetate/petroleum spirit
elution), and concentration of the relevant fractions (Rf = 0.3) aﬀorded
nitrile 23 (1.23 g, 82%) as a clear, pale-yellow oil, [α]D = −97.3 (c =
0.6, CHCl3).
1H NMR (400 MHz, CDCl3) δ 5.80 (dd, J = 10.2 and 2.3
Hz, 1H), 5.38 (dd, J = 10.2 and 2.6 Hz, 1H), 4.25−4.20 (complex m,
1H), 4.05−4.00 (complex m, 2H), 2.48−2.19 (complex m, 2H), 1.85
(dd, J = 8.7 and 7.5 Hz, 2H), 1.60−1.41 (complex m, 3H), 1.45 (s,
3H), 1.36 (s, 3H), 0.88 (t, J = 7.5 Hz, 3H); 13C NMR (101 MHz,
CDCl3) δ 132.8, 130.1, 120.4, 108.4, 80.9, 78.3, 69.8, 41.5, 32.4, 31.1,
27.4, 25.2, 13.0, 8.5; IR (KBr) νmax 3444, 2968, 2936, 2247, 1460,
1381, 1242, 1219, 1164, 1067, 1043, 873, 793 cm−1; MS (ESI, + ve)
m/z 274 [(M + Na)+, 100%]; HRMS (ESI, + ve) [M + Na]+ calcd for
C14H21NNaO3 274.1419, found 274.1419.
3-((3aR,4R,7aR)-4-Ethyl-2,2-dimethyl-7-oxo-3a,4,7,7a-tetra-
hydrobenzo[d][1,3]dioxol-4-yl)propanenitrile (24). A magnetically
stirred solution of nitrile 23 (1.23 g, 4.88 mmol) in dichloromethane
(50 mL) maintained at room temperature was treated with
Attenburrow MnO2
36 (4.24 g, 48.80 mmol, 10 equiv). The resulting
suspension was stirred for 18 h and then ﬁltered through a pad of
diatomaceous earth that was washed with dichloromethane (2 × 50
mL). The combined ﬁltrates were concentrated under reduced
pressure, and the brown residue thus obtained was subjected to
ﬂash chromatography (silica, 1:10 v/v diethyl ether/dichloromethane
elution); concentration of the relevant fractions (Rf = 0.5) aﬀorded
enone 24 (1.22 g, quantitative) as a clear, pale-yellow oil, [α]D = −45.3
(c = 0.6, CHCl3).
1H NMR (400 MHz, CDCl3) δ 6.54 (dd, J = 10.4
and 2.3 Hz, 1H), 6.14 (d, J = 10.4 Hz, 1H), 4.32 (d, J = 4.8 Hz, 1H),
4.22 (dd, J = 4.8 and 2.3 Hz, 1H), 2.60 (m, 1H), 2.43 (m, 1H), 2.19−
2.07 (complex m, 1H), 2.07−1.97 (complex m, 1H), 1.62 (ABq, J =
7.5 Hz, 2H), 1.39 (s, 3H), 1.31 (s, 3H), 0.96 (t, J = 7.5 Hz, 3H); 13C
NMR (101 MHz, CDCl3) δ 195.7, 152.4, 127.8, 119.8, 109.4, 79.7,
74.8, 41.7, 32.1, 31.6, 27.4, 26.0, 12.7, 8.4; IR (KBr) νmax 2929, 2247,
1685, 1460, 1374, 1227, 1164, 1079, 872, 795 cm−1; MS (EI, 70 eV)
m/z 249 (M+•, 4%), 234 (71), 192 (50), 162 (60), 100 (100); HRMS
(EI) M+• calcd for C14H19NO3 249.1365, found 249.1367.
3-((3aR,4R,7aR)-4-Ethyl-6-iodo-2,2-dimethyl-7-oxo-3a,4,7,7a-
tetrahydrobenzo[d][1,3]dioxol-4-yl)propanenitrile (25). A solution
of enone 24 (1.20 g, 4.81 mmol) in chloroform (10 mL) maintained at
room temperature was treated with pyridine (10 mL) and then
molecular iodine (4.89 g, 19.25 mmol, 4 equiv). The ensuing mixture
was stirred for 24 h, then diluted with dichloromethane (30 mL), and
quenched with Na2S2O3 (60 mL of a saturated aqueous solution). The
separated aqueous phase was extracted with dichloromethane (2 × 50
mL), and the combined organic phases were dried (Na2SO4), ﬁltered,
and concentrated under reduced pressure. The yellow residue thus
obtained was subjected to ﬂash chromatography (silica, 1:3 v/v ethyl
acetate/petroleum spirit elution), and concentration of the relevant
fractions (Rf = 0.5 in 1:1 v/v ethyl acetate/petroleum spirit) aﬀorded
iodoenone 25 (1.81 g, quantitative) as a clear, pale-yellow oil, [α]D =
−61.6 (c = 0.5, CHCl3). 1H NMR (400 MHz, CDCl3) δ 7.32 (d, J =
2.0 Hz, 1H), 4.49 (d, J = 4.6 Hz, 1H), 4.27 (dd, J = 4.6 and 2.1 Hz,
1H), 2.60 (ddd, J = 16.9, 10.1, and 5.9 Hz, 1H), 2.45 (ddd, J = 16.9,
10.1, and 5.8 Hz, 1H), 2.16 (ddd, J = 14.0, 10.1, and 5.8 Hz, 1H), 2.02
(ddd, J = 14.0, 10.1, and 5.8 Hz, 1H), 1.67−1.60 (complex m, 2H),
1.39 (s, 3H), 1.29 (s, 3H), 0.99 (t, J = 7.5 Hz, 3H); 13C NMR (101
MHz, CDCl3) δ 189.5, 160.9, 119.4, 110.0, 101.1, 79.7, 73.9, 45.9,
31.8, 31.2, 27.4, 25.9, 12.7, 8.6; IR (KBr) νmax 2984, 2935, 2247, 1694,
1596, 1460, 1383, 1372, 1227, 1080, 871, 785, 739 cm−1; MS (EI, 70
eV) m/z 375 (M+•, 40%), 360 (41), 346 (61), 318 (25), 248 (24), 162
(30), 134 (51), 100 (100), 93 (67); HRMS (EI) M+• calcd for C14H18
INO3 375.0331, found 375.0332.
3-((3aR,4R,7aR)-4-Ethyl-6-(4-methoxy-2-nitrophenyl)-2,2-di-
methyl-7-oxo-3a,4,7,7a-tetrahydrobenzo[d][1,3]dioxol-4-yl)-
propanenitrile (27). Iodoenone 25 (1.70 g, 4.53 mmol), Cu powder
(2.86 g, 45.30 g.atom, 10 equiv), aryl iodide 26 (1.90 g, 6.80 mmol, 1.5
equiv), CuI (863 mg, 4.53 mmol, 1 equiv) and Pd(dppf)Cl2•CH2Cl2
(367 mg, 0.45 mmol, 0.1 equiv) were added to a ﬂask that was
maintained under an atmosphere of nitrogen. DMSO (80 mL) was
then added to the mixture and the resulting suspension stirred
vigorously at 70 °C for 2 h. The cooled reaction mixture was quenched
with NH4Cl (80 mL of a half-saturated aqueous solution) and
extracted with ethyl acetate (4 × 150 mL) using a small amount of
brine to break up any emulsion that was encountered. The combined
organic phases were dried (Na2SO4), ﬁltered, and then concentrated
under reduced pressure, and the resulting brown residue was subjected
to ﬂash chromatography (silica, 1:3→ 1:1 v/v ethyl acetate/petroleum
spirit gradient elution). Concentration of the relevant fractions (Rf =
0.5 in 1:1 v/v ethyl acetate/petroleum spirit) aﬀorded compound 27
(1.67 g, 92%) as a clear, yellow oil, [α]D = −155.6 (c = 0.5, CHCl3).
1H NMR (400 MHz, CDCl3) δ 7.60 (d, J = 2.6 Hz, 1H), 7.24 (d, J =
8.4 Hz, 1H), 7.16 (dd, J = 8.4 and 2.6 Hz, 1H), 6.50 (d, J = 2.1 Hz,
1H), 4.53 (d, J = 4.9 Hz, 1H), 4.32 (dd, J = 4.9 and 2.1 Hz, 1H), 3.89
(s, 3H), 2.71−2.61 (complex m, 1H), 2.61−2.52 (complex m, 1H),
2.18 (ddd, J = 14.1, 9.2, and 6.4 Hz, 1H), 2.10 (ddd, J = 14.1, 9.2, and
6.2 Hz, 1H), 1.78 (dd, J = 14.3 and 7.5 Hz, 1H), 1.71 (dd, J = 14.3 and
7.5 Hz, 1H), 1.41 (s, 3H), 1.36 (s, 3H), 1.06 (t, J = 7.5 Hz, 3H); 13C
NMR (101 MHz, CDCl3) δ 193.5, 160.1, 148.7, 147.4, 137.9, 132.5,
122.9, 120.0, 109.5(4), 109.5(0), 79.9, 75.7, 56.0, 41.4, 32.9, 32.5, 27.3,
25.8, 13.1, 8.7; IR (KBr) νmax 2981, 2937, 2246, 1687, 1618, 1532,
1352, 1303, 1270, 1227, 1080, 1047, 874, 816, 789 cm−1; MS (EI, 70
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eV) m/z 400 (M+•, 23%), 385 (8), 371 (16), 343 (12), 189 (100);
HRMS (EI) M+• calcd for C21H24N2O6 400.1634, found 400.1632.
Compound 28. A solution of arylenone 27 (1.10 g, 2.75 mmol) in
methanol (100 mL) maintained at room temperature was treated with
p-TsOH•H2O (2.37 g, 13.74 mmol, 5 equiv) and freshly prepared
Raney cobalt25 (2.20 g, 200% by weight). The ﬂask containing the
suspension thus formed was ﬁtted with a balloon of H2 and the
contents stirred at 40 °C for 18 h. The resulting mixture was cooled
and then ﬁltered through a plug of basic alumina that was washed with
methanol (3 × 50 mL). The combined ﬁltrates were concentrated
under reduced pressure, and the brown residue thus obtained was
subjected to ﬂash chromatography (silica, 1:10 v/v methanol/
dichloromethane →1:20 v/v ammoniacal methanol/dichloromethane
elution). Concentration of the relevant fractions (Rf = 0.65 in 1:10 v/v
ammoniacal methanol/dichloromethane) aﬀorded amine 28 (833 mg,
85%) as a clear, pale-yellow oil, [α]D = +10.4 (c = 0.5, C6H6).
1H
NMR (400 MHz, CDCl3) δ 8.02 (s, 1H), 7.61 (d, J = 8.5 Hz, 1H),
6.82 (d, J = 2.2 Hz, 1H), 6.79 (dd, J = 8.5 and 2.2 Hz, 1H), 5.15 (d, J =
5.1 Hz, 1H), 4.37 (dd, J = 5.1 and 1.4 Hz, 1H), 3.85−3.76 (complex
m, 2H), 3.80 (s, 3H), 3.19 (d, J = 14.0 Hz, 1H), 2.77 (app. t, J = 12.5
Hz, 1H), 2.19−1.95 (complex m, 2H), 1.72 (m, 1H), 1.62−1.53
(complex m, 1H), 1.41 (s, 3H), 1.39−1.31 (complex m, 1H), 1.29−
1.17 (complex m, 1H), 1.16 (s, 3H), 0.86 (t, J = 7.6 Hz, 3H); 13C
NMR (101 MHz, CDCl3) δ 156.7, 137.9, 130.0, 120.9, 120.3, 110.0,
109.7, 94.8, 83.7, 74.8, 70.7, 56.1, 55.7, 46.6, 36.7, 33.9, 31.3, 28.3,
26.7, 24.1, 7.8; IR (KBr) νmax 3400, 2930, 1629, 1462, 1369, 1234,
1202, 1157, 1052, 1013, 807 cm−1; MS (ESI, + ve) m/z 357 [(M +
H)+, 100%]; HRMS (ESI, + ve) [M + H]+ calcd for C21H29N2O3
357.2178, found 357.2178.
N-α-Chloroacetyl Derivative of Compound 28. A stirred
solution of amine 28 (30 mg, 0.08 mmol) in dry dichloromethane (5
mL) maintained at 0 °C under an atmosphere of nitrogen was treated
with freshly distilled triethylamine (23 μL, 0.17 mmol, 2 equiv) and
freshly distilled α-chloroacetyl chloride (10 μL, 0.13 mmol, 2 equiv).
After 1 h the reaction mixture was quenched with NaHCO3 (10 mL of
a saturated aqueous solution), and the separated aqueous phase was
extracted with dichloromethane (2 × 15 mL). The combined organic
phases were dried (Na2SO4), ﬁltered, and then concentrated under
reduced pressure, and the yellow residue thus obtained was subjected
to ﬂash chromatography (silica, 1:3→ 1:1 v/v ethyl acetate/petroleum
spirit gradient elution). Concentration of the relevant fractions (Rf =
0.5 in 1:1 v/v ethyl acetate/petroleum spirit) aﬀorded the title amide
(18 mg, 49%) as an unstable, yellow oil, [α]D = −191.2 (c = 0.5,
C6H6).
1H NMR (400 MHz, C6D6) δ 7.49 (d, J = 8.8 Hz, 1H), 7.32 (s,
1H), 6.93 (dd, J = 8.8 and 1.7 Hz, 1H), 6.67 (broad s, 1H), 5.92 (s,
1H), 4.64 (d, J = 7.5 Hz, 1H), 4.10 (d, J = 7.5 Hz, 1H), 3.74 (ABq, J =
11.7 Hz, 2H), 3.50 (s, 3H), 3.46 (s, 1H), 3.07 (d, J = 13.5 Hz, 1H),
2.69 (dd, J = 13.5 and 3.1 Hz, 1H), 1.86−1.65 (complex m, 3H),
1.56−1.45 (complex m, 1H), 1.50 (s, 3H), 1.39−1.26 (complex m,
1H), 1.35 (s, 3H), 1.14 (t, J = 7.6 Hz, 3H); 13C NMR (101 MHz,
C6D6) δ (mixture of rotamers) 165.7, 157.6, 138.9, 128.6, 120.5, 120.1,
110.9, 110.2, 109.9, 95.6, 79.7, 68.4, 55.3(2), 55.2(9), 50.5, 42.5, 41.6,
40.7, 26.3, 25.9, 25.8, 25.4, 24.9, 21.0, 8.9, 1.4; IR (KBr) νmax 3303,
2935, 1632, 1451, 1381, 1282, 1254, 1209, 1158, 1045, 875, 733 cm−1;
MS (EI, 70 eV) m/z 434 and 432 (M+•, 15 and 41% respectively), 397
(100), 374 (26), 354 (64); HRMS (EI) M+• calcd for C23H29
35ClN2O4
432.1816, found 432.1816.
Compound 29. A stirred solution of amine 28 (530 mg, 1.49
mmol) in ethanol (200 mL) maintained at room temperature under an
atmosphere of nitrogen was treated with K2CO3 (2.05 g, 14.86 mmol,
10 equiv) and 2-bromoethanol (1.06 mL, 14.86 mmol, 10 equiv). The
ensuing solution was heated under reﬂux for 18 h, then cooled, and
concentrated under reduced pressure to ca. one-eighth of its original
volume. The residue thus obtained was diluted with dichloromethane
(175 mL) and washed with NaHCO3 (100 mL of a half-saturated
solution). The separated aqueous phase was extracted with dichloro-
methane (2 × 150 mL), and the combined organic phases were dried
(Na2SO4), ﬁltered, and then concentrated under reduced pressure to
yield a yellow oil. Subjection of this material to ﬂash chromatography
(silica, 1:10 v/v ammoniacal methanol/dichloromethane elution) and
concentration of the relevant fractions (Rf = 0.2) aﬀorded ethanol-
amine 29 (573 mg, 96%) as a white foam, [α]D = −38.0 (c = 0.5,
CHCl3).
1H NMR (400 MHz, CDCl3) δ 9.10 (s, 1H), 7.45 (d, J = 8.7
Hz, 1H), 6.89 (d, J = 2.1 Hz, 2H), 6.77 (dd, J = 8.7 and 2.1 Hz, 1H),
5.22 (d, J = 6.6 Hz, 1H), 4.33 (d, J = 6.6 Hz, 1H), 3.79 (s, 3H), 3.53−
3.44 (complex m, 1H), 3.28 (broad s, 1H), 3.09 (m, 2H), 2.66−2.27
(complex m, 3H), 2.09−1.93 (complex m, 1H), 1.70−1.48 (complex
m, 2H), 1.40 (s, 6H), 1.12−0.92 (complex m, 2H), 0.91−0.80
(complex m, 1H), 0.73 (t, J = 7.5 Hz, 3H); 13C NMR (101 MHz,
CDCl3) δ 156.7, 137.5, 130.9, 122.4, 119.4, 110.5, 109.6, 95.0, 82.0,
69.8, 62.4, 56.7, 55.6, 54.1, 51.8, 41.3, 32.4, 31.7, 27.1, 24.8, 22.4, 8.0
(signal due to one carbon obscured or overlapping); IR (KBr) νmax
3243, 2926, 1628, 1567, 1504, 1460, 1377, 1279, 1263, 1203, 1161,
1054, 1036, 881, 816, 732 cm−1; MS (ESI, + ve) m/z 401 [(M + H)+,
100%]; HRMS (ESI, + ve) [M + H]+ calcd for C23H33N2O4 401.2440,
found 401.2440.
Compound 31. A stirred solution of compound 29 (100 mg, 0.25
mmol) and freshly distilled Hünig’s base (97 μL, 0.75 mmol, 3 equiv)
in dry dichloromethane (5 mL) maintained at −5 °C (ice/salt bath)
under a nitrogen atmosphere was treated with freshly distilled
methanesulfonyl chloride (40 μL, 0.50 mmol, 2 equiv). The ensuing
mixture was maintained at −5 °C for 2 h and then quenched with
NaHCO3 (10 mL of a saturated aqueous solution). The separated
aqueous phase was extracted with dichloromethane (2 × 15 mL), and
the combined organic phases were dried (Na2SO4), ﬁltered, and
concentrated under reduced pressure. The ensuing clear, yellow, and
unstable oil (presumed to contain ester 30) was dissolved in dry THF
(5 mL), and the resulting solution placed under a nitrogen
atmosphere. While being maintained at room temperature the solution
was treated, in one portion, with t-BuOK (112 mg, 1.00, 4 equiv). The
ensuing mixture was stirred for 1 h, then diluted with diethyl ether (5
mL), and quenched with water (10 mL). The separated aqueous phase
was extracted with diethyl ether (2 × 20 mL), and the combined
organic phases were dried (Na2SO4), ﬁltered, and then concentrated
under reduced pressure to yield a yellow oil. Subjection of this material
to ﬂash chromatography (silica, 1:20 v/v methanol/dichloromethane
elution) and concentration of the relevant fractions (Rf = 0.4) aﬀorded
isoindole 31 (88 mg, 92%) as a white foam, [α]D = −168.8 (c = 0.9,
CHCl3).
1H NMR (400 MHz, CDCl3) δ 7.23 (d, J = 8.2 Hz, 1H), 7.16
(d, J = 2.4 Hz, 1H), 6.78 (dd, J = 8.2 and 2.4 Hz, 1H), 5.27 (d, J = 8.0
Hz, 1H), 4.44 (dd, J = 8.0 and 2.0 Hz, 1H), 3.84 (s, 3H), 3.18−3.10
(complex m, 2H), 2.88 (m, 1H), 2.51−2.30 (complex m, 3H), 2.09
(m, 1H), 1.83 (dd, J = 14.2 and 5.1 Hz, 1H), 1.63 (s, 3H), 1.61−1.56
(complex m, 2H), 1.39 (s, 3H), 1.12 (td, J = 13.6 and 5.8 Hz, 1H),
0.55−0.41 (complex m, 5H); 13C NMR (101 MHz, CDCl3) δ 185.9,
159.6, 154.3, 140.5, 121.4, 112.5, 111.1, 106.9, 85.1, 78.9, 75.7, 60.1,
55.5, 55.1, 52.1, 38.0, 34.9, 31.5, 28.9, 24.9, 24.2, 23.5, 7.3; IR (KBr)
νmax 2957, 2929, 2770, 2715, 1617, 1590, 1577, 1481, 1441, 1376,
1369, 1321, 1277, 1261, 1209, 1146, 1049, 879, 815 cm−1; MS (ESI, +
ve) m/z 383 [(M + H)+, 100%]; HRMS (ESI, + ve) [M + H]+ calcd
for C23H31N2O3 383.2335, found 383.2336.
Compound 8. A vigorously stirred solution of isoindole 31 (20
mg, 0.05 mmol) in acetic acid/acetonitrile (5 mL of a 1:10 v/v
mixture) maintained at room temperature was treated with form-
aldehyde (2.5 mL of a 37% aqueous solution). The resulting slurry was
treated, in small portions, over 1 h, with NaBH3CN (30 mg, 0.25
mmol, 10 equiv). After a further 1 h the reaction mixture was treated
with brine/Na2CO3 (10 mL of a 1:1 v/v mixture of saturated
solutions), and the separated aqueous phase was extracted with ethyl
acetate (3 × 20 mL). The combined organic phases were dried
(Na2SO4), ﬁltered, and then concentrated under reduced pressure to
yield a milky residue that was subjected to ﬂash chromatography
(silica, 1:20 v/v ammoniacal methanol/dichloromethane elution).
Concentration of the relevant fractions (Rf = 0.5) aﬀorded indoline 8
(18 mg, 89%) as a white foam, [α]D = +48.8 (c = 1.0, CHCl3).
1H
NMR (400 MHz, CDCl3) δ 6.94 (d, J = 8.1 Hz, 1H), 6.25 (dd, J = 8.1
and 2.3 Hz, 1H), 6.02 (d, J = 2.3 1H), 4.53 (d, J = 7.4, Hz, 1H), 4.15−
4.10 (complex m, 1H), 3.77 (s, 3H), 3.38 (d, J = 2.6 Hz, 1H), 3.08−
3.01 (complex m, 2H), 2.83 (s, 3H), 2.36−2.21 (complex m, 1H),
2.15−2.05 (complex m, 2H), 2.03−1.94 (complex m, 1H), 1.90−1.73
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(complex m, 3H), 1.52 (s, 3H), 1.44−1.36 (complex m, 1H), 1.34 (s,
3H), 1.23−1.01 (complex m, 3H), 0.49 (t, J = 7.4 3H); 13C NMR
(101 MHz, CDCl3) δ 160.3, 152.3, 123.1, 107.6, 103.3, 94.9, 92.3,
78.6, 75.5, 74.4, 74.3, 55.3, 54.8, 53.7, 49.6, 44.1, 36.4, 35.0, 31.9, 30.2,
26.1, 24.5, 23.3, 7.5; IR (KBr) νmax 2930, 1618, 1496, 1456, 1375,
1263, 1224, 1172, 1089, 1055, 899 cm−1; MS (EI, 70 eV) m/z 398
(M+•, 54%), 262 (35), 124 (100); HRMS (EI) M+• calcd for
C24H34N2O3 398.2569, found 398.2571.
Compound 32. A magnetically stirred solution of isoindole 31 (20
mg, 0.05 mmol) in diethyl ether (4 mL) maintained under a nitrogen
atmosphere was cooled to −78 °C and then treated with t-BuLi (67 μL
of a 1.5 M solution, 0.10 mmol, 2 equiv). After 1 h the reaction
mixture was treated with freshly distilled Mander’s reagent31 (7 μL,
0.08 mmol, 1.5 equiv), and the resulting mixture was allowed to stir at
−78 °C for a further 0.25 h and then was quenched with NaHCO3 (10
mL of a saturated aqueous solution). The separated aqueous phase was
extracted with diethyl ether (2 × 20 mL), and the combined organic
phases were dried (Na2SO4), ﬁltered, and then concentrated under
reduced pressure. The clear, yellow oil thus obtained was submitted to
ﬂash chromatography (silica, 1:20 v/v methanol/dichloromethane →
1:20 v/v ammoniacal methanol/dichloromethane gradient elution),
and concentration of the relevant fractions (Rf = 0.6 in 1:20 v/v
ammoniacal methanol/dichloromethane) aﬀorded carbamate 32 (16
mg, 70%) as a white foam, [α]D = −29.2 (c = 0.5, CHCl3). 1H NMR
(400 MHz, CD3OD) δ 7.29 (broad s, 1H), 7.11 (d, J = 8.3 Hz, 1H),
6.60 (dd, J = 8.3 and 2.4 Hz, 1H), 4.36 (d, J = 5.2 Hz, 1H), 4.04
(broad s, 2H), 3.83 (s, 3H), 3.78 (s, 3H), 3.11 (broad s, 2H), 2.43−
2.16 (complex m, 3H), 2.15−1.95 (complex m, 2H), 1.89 (d, J = 14.2
Hz, 1H), 1.67−1.47 (complex m, 2H), 1.58 (s, 3H), 1.39−1.31
(complex m, 1H), 1.35 (s, 3H), 1.15−1.04 (complex m, 2H), 0.73 (t, J
= 7.5 Hz, 3H); 13C NMR (101 MHz, CD3OD) δ 161.3, 156.0, 142.9,
131.8, 124.3, 110.3, 110.1, 104.0, 80.7, 79.7, 72.0, 71.6, 55.9, 54.7, 53.8,
53.3, 53.2, 42.1, 38.0, 33.8, 33.0, 28.0, 26.1, 24.4, 7.8; IR (KBr) νmax
2929, 2779, 1713, 1614, 1499, 1454, 1386, 1312, 1250, 1212, 1158,
1065, 861 cm−1; MS (EI, 70 eV) m/z 442 (M+•, 21%), 367 (8), 342
(7), 262 (15), 124 (100); HRMS (EI) M+• calcd C25H34N2O5
442.2468, found 442.2463.
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Abstract – The angularly substituted tetrahydrocarbazole 13, which is readily 
obtained from cyclohexane-1,4-dione monoethylene ketal (6) using Fischer indole 
chemistry, has been converted into the isothiocyanate 16. Photolysis of this last 
compound affords, via an intramolecular hetero-[2+2]cycloaddition reaction, the 
pentacyclic "-thiolactam 17 that incorporates the ABCE ring substructure of 
natural products 1–3. Attempts to effect a two-carbon homologation of the 
four-membered ring within compound 17, and thereby establish the D-ring, failed. 
The azide 20, also obtained from compound 13, forms the cyclic imine 21 on 
thermolysis in refluxing toluene and the readily derived enamide 23 engages in a 
Au(I)-catalysed 6-endo-dig cyclisation reaction to give compound 24 embodying 
the ABCDE ring system of the title alkaloids. 
INTRODUCTION 
Members of the Vinca class of alkaloid have been the subject of extensive synthetic studies.1 These are 
ongoing and have been prompted by the fascinating molecular architectures of such natural products and, 
in certain instances, their attendant and significant biological properties.1,2 For example, the pentacyclic 
vindoline (1) is the principal alkaloid found in the plant Catharanthus roseus and a biogenetic precursor 
to the co-occurring but much less abundant indole-indoline-containing systems vinblastine (2) and 
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vincristine (3), compounds that are currently being used in the clinical treatment of various human 
cancers because of their potent antimitotic properties.1,2 It is this situation, combined with the prospect 
that they might be effective in other therapeutic settings,1 that has prompted extensive (and notably 
successful) studies directed toward the total synthesis of compounds such as 1–31 as well as various 
derivatives3,4 (including ones incorporating “deep-seated” modifications) that continue to display 
significant biological activities. 
 
Some time ago we noted5 that the cyclohexa-3,5-diene-1,2-diol 4, which is readily obtained in 
enantiomerically pure form through the whole-cell biotransformation of m-ethyltoluene, bears a strong 
structural resemblance to the highly functionalised C-ring of the alkaloids 1–3. Accordingly, we sought to 
identify protocols that might allow for the elaboration of functionalised cyclohexanes such as metabolite 
4 into the ABCDE framework associated with these natural products.6 As a result, we now describe the 
outcomes of a model study that provides usefully functionalised forms of the ABC-ring system and to 
which the DE substructure (or a potential precursor to it) can be appended. The sequence involves the 
starting C-ring-containing compound being fused with the A- and B-rings using Fischer indole chemistry 
and the resulting ABC-substructure being annulated using either hetero-[2+2]cycloaddition or 
Au(I)-mediated cyclisation reactions. The study reported here has certain parallels with ones in which we 
have been seeking to develop methods for the synthesis of the closely related Aspidosperma alkaloids.7,8 
 
RESULTS AND DISCUSSION 
The assembly of the pivotal ABC-ring-containing system is shown in Scheme 1 and uses phenylhydrazine 
(5) and cyclohexane-1,4-dione monoethylene ketal (6) as substrates for the initial Fischer indole synthesis 
with the latter destined to become incorporated as the C-ring of the target framework. From this point, 
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chemical manipulations of product 79 (94%) were focused on the introduction of relevant functionality 
onto the C-ring including that considered appropriate for creating the five-membered E-ring. To such ends, 
compound 7 was treated with n-butyllithium, copper(I) iodide then allyl bromide and so providing the 
previously reported10 C3-allylated isoindole 8 (88%) that was subjected to reductive methylation using 
formaldehyde in the presence of sodium cyanoborohydride. 
 
Scheme 1 
The N-methylindoline 9 (87%) so-formed was exposed to aqueous hydrochloric acid in THF thereby 
cleaving the associated ketal moiety and thus affording cyclohexane 10 (92%), the structure of which was 
confirmed by single-crystal X-ray analysis (see Experimental section for details). Reaction of latter 
compound with potassium hydride then Comins’ reagent11 (a process believed to proceed under 
conditions of thermodynamic control) resulted in the essentially completely regioselective formation of 
enol triflate 11 (89%), the allyl side-chain of which could be oxidatively cleaved through successive 
treatment with a potassium osmate/potassium ferricyanide/DABCO12 mixture then sodium metaperiodate. 
The aldehyde 12 (85%) so-formed was treated with tert-butylamine (so as to effect temporary protection 
of the carbonyl moiety) and then with the Gilman-type reagent generated through reaction of 
85
 
 
 
 
ethylmagnesium bromide with copper(I) cyanide. By such means, and after aqueous work-up, the pivotal 
and ethyl-substituted cyclohexene 13 (83%) was obtained. 
At this point, two quite distinct strategies were pursued in efforts to convert, via DE-ring annulation, 
compound 13 into the pentacyclic ring system associated with the Vinca alkaloids. The first of these 
sought to exploit intramolecular and hetero-[2+2]cycloaddition chemistry for this purpose and with the 
intention of engaging any product azetidine in a two carbon-homologation reaction so as to form the 
six-membered D-ring. To such ends, and as shown in Scheme 2, the oxime derived from aldehyde 13 was 
reduced with zinc in acetic acid13 under conditions of ultrasonication to give the 1°-amine 14 in 90% yield 
and the structure of which was confirmed by single-crystal X-ray analysis of the readily derived oxalate 
salt. Reaction of this amine with Boc2O in the presence of DMAP14 gave the corresponding isocyanate 15 
in 89% yield while treatment of the same substrate with carbon disulfide and Boc2O in the presence of 
triethylamine and DMAP15 gave the stable and thus fully characterisable isothiocyanate 16 in 82% yield. 
A variety of conditions was explored in an effort to engage compounds 15 and 16 in an intramolecular 
hetero-[2+2]cycloaddition reaction.16,17 Simply heating solutions of these compounds at a range of 
different temperatures up to 211 °C (using nitrobenzene as solvent) failed, as did treating them with 
variety of catalysts, including ones that it was thought might promote “open-shell” cycloaddition 
reactions.18 Ultimately, irradiation of a benzene solution of the isothiocyante 16 for 1 h at 18 °C resulted 
(Scheme 2) in the formation of the "-thiolactam 17 (14%). Analogous treatment of isocyanate 15 failed to 
produce the equivalent "-lactam 18. The spectral data recorded on compound 17 were in complete accord 
with the assigned structure. In particular, the 13C NMR spectrum displayed a resonance at #C 219.1 that is 
assigned to the newly installed "-thiolactam carbonyl carbon while the infra-red spectrum contained a 
strong and characteristic C=S stretching band at 1412 cm–1. 
 
Scheme 2 
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Despite considerable experimentation, including an investigation of flow photochemical techniques,19 the 
yield of the "-thiolactam 17 could never be raised above the ca. 14% level. The formation of elemental 
sulfur was a persistent feature of all those reactions leading to compound 17 and independent irradiation 
of this material resulted in its relatively rapid decomposition (with accompanying formation of sulfur). 
This situation coupled with an inability to identify an effective two-carbon homologation protocol that 
would generate the required six-membered D-ring from the thio-"-lactam lead to the abandonment of the 
hetero-[2+2]cycloaddition approach just described. 
The second strategy examined in an effort to annulate the D- and E-rings to the ABC-framework of 
aldehyde 13 is shown in Scheme 3 and involved, as the first step, its reduction to the corresponding 
alcohol that was then converted into the mesylate 19. As a result of its instability, this last compound was 
immediately treated with sodium azide in DMF and so producing the anticipated (and stable) compound 
20 in 88% yield (from 13). With compound 20 to hand efforts were made to engage the associated azide 
and alkenic residues in cyclisation processes that would lead to the construction of the required E-ring. In 
the event, and in anticipation of effecting an intramolecular [3+2]cycloaddition reaction between these 
two functionalities,7b,c azide 20 was heated at reflux in toluene for 4 h (Scheme 3). However, rather than 
the expected triazene being isolated, imine 21 was obtained as the major product of reaction20 and as a 
single diastereoisomer of undefined configuration at the ethyl-bearing centre. This was accompanied by 
small amounts of the isomeric but rather unstable enamine that was readily converted into imine 21 and 
its epimer on sustained contact with silica gel. When compound 21 was treated with acryloyl chloride in 
the presence of triethylamine then the crystalline amide 22 was obtained in 90% yield and its structure 
confirmed by single-crystal X-ray analysis. While various attempts to effect the cyclisation of this 
compound and thus form the D-ring of the Vinca alkaloids were unsuccessful, when the similarly derived 
propiolamide 23 (82% from 20) was treated with Echavarran’s gold(I) catalyst21 in the presence of 
p-TsOH•H2O then a 6-endo-dig cyclisation22 took place and thus providing, after aqueous work-up, the 
rather unstable pentacyclic compound 24. This was obtained in ca. 33% yield. The assignment of the 
structure of compound 24 follows from the derived spectral data. Most notably, the 400 MHz 1H NMR 
spectrum of this material displayed an AX spin system (#H = 6.54 and 5.99, J = 10.2 Hz) arising from the 
mutually coupled protons of the newly formed cyclic double bond. The signals due to the sp-hybridised 
carbons of precursor 23 (observed at #C 78.4/77.2 and 69.5/69.0 – pairing due to the presence of amide 
rotamers) were no longer evident in the 13C NMR spectrum of product 24 which displayed a total of 
twenty resonances including one at #C 93.3 that is attributed to the hydroxy-substituted and sp3-hybridised 
carbon formed as a result of water adding to the N-acyliminium ion generated during the cyclisation event. 
The infra-red spectrum of compound 24 displayed prominent absorption bands at 3352, 1657 and 1601 
cm–1 that are attributed to the associated hydroxyl, lactam carbonyl and C=C moieties, respectively. 
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Scheme 3 
 
Extensive efforts, including those involving the use of other gold catalysts, the use of stoichiometric 
amounts of the original one and/or derivatives of the substrate in which the triple bond was capped by a 
methyl or a trimethylsilyl group, failed to improve the yield of this type of cyclisation reaction. The use of 
both a gold(I) species and an acid was clearly pivotal for the success of the conversion 23 ! 24 since in 
the absence of one or other of these reagents no cyclisation product was observed. 
Despite the modest yields associated with the last step of the reaction sequence shown in Scheme 3, the 
chemistry reported therein is now being applied in an effort to effect the conversion 4 ! 1 while the 
scope and limitations of the Au(I)-catalysed cyclisation of N-(cyclohex-1-en-1-yl)propiolamides (as 
exemplified by the conversion of compound 23 into isomer 24) and related compounds is also being 
investigated. Results will be reported in due course. 
In closing, it is worth noting that since Trost and Quancard23 have demonstrated the conversion 7 ! 8 can 
be carried out enantioselectively (66% ee)24 the protocols reported here could be used to make compounds 
17 and 24, as well as various of their precursors, in chiral, non-racemic form.25 
EXPERIMENTAL 
General Experimental Procedures. Unless otherwise specified, proton (1H) and carbon (13C) NMR 
spectra were recorded at room temperature in base-filtered CDCl3 on a Varian spectrometer operating at 
400 MHz for proton and 100 MHz for carbon nuclei or on a Bruker Avance 800 machine operating at 800 
MHz for proton and 200 MHz for carbon nuclei. 1H NMR data are reported as follows: chemical shift (!) 
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[multiplicity, coupling constant(s) J (Hz), relative integral] where multiplicity is defined as: s = singlet; d 
= doublet; t = triplet; q = quartet; m = multiplet or combinations of the above. The signal due to residual 
CHCl3 appearing at !H 7.26 and the central resonance of the CDCl3 “triplet” appearing at !C 77.0 were 
used to reference 1H and 13C NMR spectra, respectively. Infrared spectra ($max) were recorded on a 
Perkin–Elmer 1800 Series FTIR Spectrometer. Samples were analysed as thin films on KBr plates. 
Low-resolution ESI mass spectra were recorded on a single quadrupole liquid chromatograph-mass 
spectrometer, while high-resolution measurements were conducted on a time-of-flight instrument. Low- 
and high-resolution EI mass spectra were recorded on a magnetic-sector machine. Melting points were 
measured on an Optimelt™ automated melting point system and are uncorrected. Analytical thin layer 
chromatography (TLC) was performed on aluminum-backed 0.2 mm thick silica gel 60 F254 plates as 
supplied by Merck. Eluted plates were visualised using a 254 nm UV lamp and/or by treatment with a 
suitable dip followed by heating. These dips included phosphomolybdic acid : ceric sulfate : sulfuric acid 
(conc.) : water (37.5 g : 7.5 g : 37.5 g : 720 mL) or potassium permanganate : potassium carbonate : 5% 
sodium hydroxide aqueous solution : water (3 g : 20 g: 5 mL : 300 mL). Flash chromatographic 
separations were carried out following protocols defined by Still et al.26 with silica gel 60 (40–63 µm) as 
the stationary phase and using the AR- or HPLC-grade solvents indicated. Starting materials and reagents 
were generally available from the Sigma–Aldrich, Merck, TCI, Strem or Lancaster Chemical Companies 
and were used as supplied. Drying agents and other inorganic salts were purchased from the AJAX, BDH 
or Unilab Chemical Companies. Tetrahydrofuran (THF), MeOH and CH2Cl2 were dried using a Glass 
Contour solvent purification system that is based upon a technology originally described by Grubbs et 
al.27 Where necessary, reactions were performed under a nitrogen atmosphere. 
 
Specific Experimental Procedures and Product Characterisation 
Compound 9. A magnetically stirred solution of compound 810 (2.50 g, 9.2 mmol) in MeCN/AcOH (250 
mL of a 10:1 v/v mixture) maintained at 18 °C was treated with H2CO (125 mL of a 37% aqueous 
solution). NaBH3CN (2.92 g, 46.5 mmol) was then added in equal portions over 0.16 h and the ensuing 
mixture stirred at 18 °C for 0.5 h before being quenched with Na2CO3 (100 mL of a saturated aqueous 
solution). The separated aqueous phase was extracted with EtOAc (3 % 100 mL) and the combined 
organic phases dried (Na2SO4) then filtered and concentrated under reduced pressure at 40 °C. The 
light-yellow oil thus obtained was subjected to flash chromatography (silica, 1:5 v/v EtOAc/hexane 
elution) and concentration of the appropriate fractions (Rf = 0.65 in 1:3 v/v EtOAc/hexane) afforded 
compound 9 (2.30 g, 87%) as a golden-coloured oil (Found: M+•, 285.1729. C18H23NO2 requires M+•, 
285.1729). 1H NMR (400 MHz, CDCl3) ! 7.10 (dt, J = 7.8 and 1.2 Hz, 1H), 7.03 (dd, J = 7.4 and 1.2 Hz, 
1H), 6.72 (dt, J = 7.4 and 1.2 Hz, 1H), 6.56 (d, J = 7.8 Hz, 1H), 5.76 (m, 1H), 5.08 (d, J = 16.8 Hz, 1H), 
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5.00 (d, J = 10.2 Hz, 1H), 4.03–3.95 (complex m, 2H), 3.93–3.87 (complex m, 2H), 3.02 (app t, J = 3.3 
Hz, 1H), 2.82 (dd, J = 14.6 and 9.1 Hz, 1H), 2.70 (s, 3H), 2.62 (dd, J = 14.6 and 5.6 Hz, 1H), 2.04–1.81 
(complex m, 4H), 1.71 (dd, J = 14.6 and 2.3 Hz, 1H), 1.58–1.53 (complex m, 1H); 13C NMR (100 MHz, 
CDCl3) ! 151.7, 136.8, 135.9, 127.3, 121.7, 118.2, 117.0, 108.3, 108.2, 67.9, 64.4, 63.8, 47.0, 42.4, 39.3, 
33.4, 29.1, 20.8; "max 2953, 2878, 1605, 1481, 1373, 1302, 1274, 1158, 1130, 1113, 1073, 979, 918, 741 
cm–1; Mass spectrum (EI, 70 eV) m/z 285 (M+•, 38%), 244 (100), 200 (40), 182 (30), 157 (19), 144 (41), 
99 (68). 
Compound 10. A magnetically stirred solution of compound 9 (10.10 g, 35.4 mmol) in THF (375 mL) 
containing HCl (375 mL of 10% aqueous solution) was stirred at 18 °C for 4 h then quenched with 
Na2CO3 (250 mL of a saturated aqueous solution) and the separated aqueous phase was extracted with 
CH2Cl2 (3 % 150 mL). The combined organic phases were dried (Na2SO4), filtered and concentrated under 
reduced pressure. The brown solid thus obtained was subjected to flash chromatography (silica, 1:3 v/v 
EtOAc/hexane elution). Concentration of the appropriate fractions (Rf = 0.4) afforded a white solid, 
recrystallisation (EtOAc) of which afforded compound 10 (7.86 g, 92%) as a white, crystalline solid, mp 
82–83 °C (Found: M+•, 241.1469. C16H19NO requires M+•, 241.1467). 1H NMR (400 MHz, CDCl3) ! 7.08 
(dt, J = 7.7 and 1.3 Hz, 1H), 6.93 (dd, J = 7.4 and 1.3 Hz, 1H), 6.65 (dt, J = 7.4 and 1.0 Hz, 1H), 6.42 (dd, 
J = 7.7 and 1.0 Hz, 1H), 5.66 (m, 1H), 5.12 (dd, J = 2.6 and 0.6 Hz, 1H), 5.08 (dd, J = 6.1 and 0.6 Hz, 
1H), 3.48 (app. t, J = 3.8 Hz, 1H), 2.78 (s, 3H), 2.55 (d, J = 6.0 Hz, 2H), 2.53–2.48 (complex m, 1H), 
2.41–2.32 (complex m, 2H), 2.23–2.14 (complex m, 2H), 2.06–1.98 (complex m, 1H); 13C NMR (100 
MHz, CDCl3) ! 211.2, 151.5, 133.8, 133.4, 128.4, 122.4, 118.9, 117.7, 106.4, 67.2, 48.9, 48.6, 45.0, 34.5, 
32.6, 23.5; "max 2964, 2932, 2861, 1709, 1603, 1447, 1464, 1421, 1302, 1227, 1214, 1155, 1001, 935, 749, 
460 cm–1. Mass spectrum (EI, 70 eV) m/z 241 (M+•, 27%), 200 (100), 144 (69). 
Compound 11. KH (1.70 g of a 30% dispersion in mineral oil, 12.7 mmol) contained in a two-necked 
round-bottomed flask and maintained under a nitrogen atmosphere was washed with hexane (2 % 5 mL) 
before being dried under vacuum then suspended in anhydrous THF (100 mL). While being stirred 
magnetically at ca. 18 °C the suspension was treated, dropwise, with a solution of ketone 10 (2.05 g, 8.5 
mmol) in THF (30 mL) (CAUTION: evolution of hydrogen gas). After 1 h a solution of Comins’ reagent 
(5.00 g, 12.7 mmol) in THF (30 mL) was added dropwise over 0.17 h. The reaction mixture thus obtained 
was stirred for a further 1 h and then quenched with NH4Cl (150 mL of a 1:1 v/v mixture of a saturated 
aqueous solution and water). The separated aqueous layer was washed with EtOAc (3 % 100 mL) and the 
combined organic washings then dried (Na2SO4) filtered and concentrated under reduced pressure. The 
brown oil thus obtained was subjected to flash chromatography (silica, 1:19 v/v EtOAc/hexane elution) 
and concentration of the appropriate fractions (Rf = 0.8 in 1:5 v/v EtOAc/hexane) afforded compound 11 
(2.82 g, 89%) as a clear, colourless oil (Found: M+•, 373.0963. C17H18F3NO3S requires M+•, 373.0960). 1H 
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NMR (400 MHz, CDCl3) ! 7.13 (dt, J = 7.8 and 1.2 Hz, 1H), 7.04 (dd, J = 7.3 and 0.8 Hz, 1H), 6.73 (dt, 
J = 7.3 and 0.8 Hz, 1H), 6.51 (broadened d, J = 7.8 Hz, 1H), 5.76 (m, 1H), 5.55 (d, J = 2.1 Hz, 1H), 5.14 
(s, 1H), 5.11 (dd, J = 6.5 and 1.6 Hz, 1H), 3.34 (app. t, J = 3.8 Hz, 1H), 2.71 (s, 3H), 2.67–2.53 (complex 
m, 3H), 2.22–2.11 (complex m, 2H), 2.03–1.94 (complex m, 1H); 13C NMR (100 MHz, CDCl3) ! 151.6, 
148.8, 133.5, 132.5, 128.6, 122.5, 122.3, 118.5, 118.5 (partially obscured q, J = 320 Hz), 118.4, 108.1, 
67.3, 48.3, 42.7, 32.9, 23.1, 21.6; "max (KBr) 2956, 1605, 1486, 1416, 1245, 1211, 1142, 1024, 913, 867, 
745, 606 cm–1; Mass spectrum (EI, 70 eV) m/z 373 (M+•, 38%), 332 (100), 250 (22), 199 (84), 171 (96), 
144 (27), 143 (41). 
Compound 12. A vigorously stirred suspension of triflate 11 (3.00 g, 8.0 mmol) in tert-butanol/water 
(100 mL of a 1:1 v/v mixture) maintained at 18 °C was treated with K2CO3 (3.33 g, 24.1 mmol), 
K3Fe(CN)6 (7.92 g, 24.1 mmol), DABCO (450 mg, 4.01 mmol) and K2OsO4•2H2O (147 mg, 0.4 mmol). 
The resulting slurry was stirred for a further 1 h then treated with Na2SO3 (100 mL of a saturated aqueous 
solution) and after 0.25 h diluted with EtOAc (50 mL). The separated aqueous phase was extracted with 
EtOAc (3 % 75 mL) and the combined organic phases then dried (Na2SO4), filtered and concentrated 
under reduced pressure. The yellow oil thus obtained was dissolved acetone/water (100 mL of a 1:1 v/v 
mixture) and the resulting solution stirred at 18 °C then treated with NaIO4 (3.43 g, 16.0 mmol) and 
stirred for 0.5 h before being filtered (to remove the ensuing white precipitate). The filtrate was extracted 
with EtOAc (3 % 50 mL) and the combined organic phases then dried (Na2SO4), filtered and concentrated 
under reduced pressure. The residue thus obtained was subjected to flash chromatography (silica, 1:3 v/v 
EtOAc/hexane elution) and concentration of the relevant fractions (Rf = 0.6 in 1:3 v/v EtOAc/hexane) 
afforded triflate 12 (2.56 g, 85%) as a clear, colourless oil (Found: M+•, 375.0751. C16H16F3NO4S requires 
M+•, 375.0752). 1H NMR (400 MHz, CDCl3) ! 9.74 (app. t, J = 2.6 Hz, 1H), 7.16 (dt, J = 7.8 and 1.2 Hz, 
1H), 7.07 (d, J = 7.4 Hz, 1H), 6.75 (dt, J = 7.4 and 1.2 Hz, 1H), 6.53 (d, J = 7.8 Hz, 1H), 5.73 (s, 1H), 
3.42 (m, 1H), 2.85 (ABq, J = 15.8 Hz, 2H), 2.73 (s, 3H), 2.61 (m, 1H), 2.26 (m, 1H), 2.15 (m, 1H), 1.98 
(m, 1H); 13C NMR (100 MHz, CDCl3) ! 200.2, 151.2, 149.3, 130.8, 129.2, 122.6, 120.7, 118.8, 118.4 
(partially obscured q, J = 319 Hz) 108.4, 67.9, 51.0, 46.8, 32.7, 23.3, 21.3; "max (KBr) 2867, 1722, 1605, 
1486, 1416, 1246, 1211, 1141, 1028, 895, 752, 609 cm–1; Mass spectrum (EI, 70 eV) m/z 375 (M+•, 81%), 
332 (85), 199 (92), 171 (100), 170 (48), 143 (46). 
Compound 13. A magnetically stirred solution of triflate 12 (2.28 g, 6.07 mmol) in THF (50 mL) 
maintained at 18 °C under a nitrogen atmosphere was treated with dried 4 Å molecular sieves (2.30 g) 
then tert-butylamine (670 µL, 466 mg, 6.38 mmol) and the resulting mixture stirred for 1 h. In a separate 
flask a magnetically stirred suspension of CuCN (2.72 g, 30.4 mmol) in THF (50 mL) maintained under a 
nitrogen atmosphere was cooled to –78° C then treated with EtMgBr (10.1 mL of a 3 M solution in Et2O, 
30.3 mmol). The ensuing mixture was warmed to 0 °C and stirred at this temperature for 0.17 h (turns 
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black). The original mixture containing triflate 12 and tert-butylamine was filtered, under a nitrogen 
atmosphere, to remove the molecular sieves that were washed with THF (3 % 10 mL). The combined 
filtrates were added to the abovementioned black reaction mixture derived from CuCN and EtMgBr and 
the resulting mixture was stirred for 2 h at 18 °C and then treated with NH4Cl (100 mL of a saturated 
aqueous solution). The separated aqueous layer was extracted with EtOAc (3 % 75 mL) and the combined 
organic phases dried (Na2SO4), filtered then concentrated under reduced pressure. The brown oil thus 
obtained was subjected to flash chromatography (silica, 1:5 v/v EtOAc/hexane elution) and concentration 
of the relevant fractions (Rf = 0.5) afforded alkene 13 (1.29 g, 83%) as a clear, colourless oil that 
solidified below 0 °C (Found: M+•, 255.1625. C17H21NO requires M+•, 255.1623). 1H NMR (400 MHz, 
CDCl3) ! 9.71 (app. t, J = 3.5 Hz, 1H), 7.10 (dt, J = 7.9 and 1.3 Hz, 1H), 7.05 (dd, J = 7.4 and 1.3 Hz, 
1H), 6.70 (t, J = 7.4 Hz, 1H), 6.47 (d, J = 7.9 Hz, 1H), 5.34 (s, 1H), 3.42 (m, 1H), 2.73 (s, 3H), 2.70 
(broadened s, 2H), 2.18–2.07 (complex m, 1H), 2.02–1.72 (complex m, 5H), 0.97 (t, J = 7.5 Hz, 3H); 13C 
NMR (100 MHz, CDCl3) ! 202.7, 151.2, 140.5, 134.2, 128.1, 122.3, 118.0, 107.5, 77.2, 69.1, 52.5, 46.3, 
32.5, 30.4, 23.7, 21.3, 12.0; "max 2961, 2931, 1719, 1604, 1485, 1298, 1275, 1022, 739 cm–1; Mass 
spectrum (EI, 70 eV) m/z 255 (M+•, 15%), 212 (100). 
Compound 14. A magnetically stirred solution of aldehyde 13 (110 mg, 0.43 mmol) in MeOH/water (21 
mL of a 6:1 v/v mixture) maintained at 18 °C under a nitrogen atmosphere was treated with sodium 
acetate (71 mg, 0.87 mmol) and NH2OH•HCl (45 mg, 0.65 mmol). The ensuing mixture was stirred at 
18 °C for 1.5 h then concentrated under reduced pressure. The resulting white paste was dissolved in 
acetic acid (25 mL) and the solution thus formed treated with activated Zn dust (564 mg, 8.63 mg.atom) 
and the resulting suspension subjected to sonication for 2 h after which time it was concentrated under 
pressure until approximately 5 mL of material remained. This residue was treated with Na2CO3 (50 mL of 
a saturated aqueous solution) then extracted with CH2Cl2 (3 % 50 mL). The combined organic phases were 
dried (Na2SO4) and filtered before being concentrated under reduced pressure. The light-yellow oil thus 
obtained was subjected to flash chromatography (silica, 1:10 v/v ammonia saturated MeOH/CH2Cl2 
elution) and concentration of the appropriate fractions (Rf = 0.3) gave compound 14 (99 mg, 90%) as clear, 
colourless oil (Found: M+•, 256.1931. C17H24N2 requires M+•, 256.1939). 1H NMR (400 MHz, CDCl3) ! 
7.05 (t, J = 7.9 Hz, 1H), 6.99 (d, J = 7.6 Hz, 1H), 6.65 (t, J = 7.6 Hz, 1H), 6.43 (d, J = 7.9 Hz, 1H), 5.15 (s, 
1H), 3.35 (broadened s, 1H), 2.78–2.67 (complex m, 2H), 2.72 (s, 3H), 2.17–2.06 (complex m, 1H), 
2.00–1.85 (complex m, 5H), 1.80–1.68 (complex m, 2H), 1.59 (broad s, 2H), 0.94 (t, J = 7.5 Hz, 3H); 13C 
NMR (100 MHz, CDCl3) ! 151.6, 139.1, 136.2, 127.4, 124.3, 122.3, 117.6, 107.2, 68.8, 46.9, 43.4, 38.5, 
32.8, 30.5, 23.3, 22.2, 12.1; "max 3356, 2960, 2927, 1603, 1486, 1462, 1297, 1273, 1121, 1022, 737 cm–1; 
Mass spectrum (EI, 70 eV) m/z 256 (M+•, 49%), 213 (37), 212 (100), 196 (22), 183 (22), 182 (24). 
A solution of a sample of amine 14 in MeOH was treated with one molar equivalent of oxalic acid in 
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MeOH and the resulting solution allowed to stand in an uncapped vial at 18 °C until such time as crystals 
appeared (mp 140–141 °C). One of these was submitted for single-crystal X-ray analysis, details of which 
are provided below. 
Compound 15. A magnetically stirred solution of Boc2O (26 mg, 0.12 mmol) in MeCN (8 mL) 
maintained at 18 °C under a nitrogen atmosphere was treated with DMAP (11 mg, 0.09 mmol). Stirring 
was continued for 0.08 h then a solution of amine 14 (20 mg, 0.08 mmol) in MeCN (2 mL) was added in 
one portion. The resulting mixture was stirred at 18 °C for 0.16 h then treated with NH4Cl (25 mL of a 
saturated aqueous solution). The separated aqueous phase was extracted with CH2Cl2 (3 % 25 mL) and the 
combined organic phases then dried (Na2SO4), filtered and concentrated under reduced pressure. The 
light-yellow oil thus obtained was subjected to flash chromatography (silica, 1:10 v/v EtOAc/hexane 
elution) and concentration of the appropriate fractions (Rf = 0.6) afforded isocyanate 15 (17 mg, 89%) as 
a clear, colourless oil (Found: M+•, 282.1729. C18H22N2O requires M+•, 282.1732). 1H NMR (400 MHz, 
CDCl3) ! 7.07 (t, J = 8.0 Hz, 1H), 6.96 (d, J = 7.7 Hz, 1H), 6.67 (t, J = 7.7 Hz, 1H), 6.44 (d, J = 8.0 Hz, 
1H), 5.13 (s, 1H), 3.38–3.24 (complex m, 3H), 2.71 (s, 3H), 2.16–2.01 (complex m, 3H), 2.00–1.87 
(complex m, 3H), 1.83–1.66 (complex m, 2H), 0.95 (t, J = 7.3 Hz, 3H); 13C NMR (100 MHz, CDCl3) ! 
151.4, 140.3, 134.9, 127.8, 123.1, 122.2, 121.9, 117.8, 107.3, 68.5, 46.6, 40.8, 39.5, 32.7, 30.5, 23.4, 22.2, 
12.0; "max (KBr) 2962, 2930, 2264, 1804, 1604, 1486, 1459, 1372, 1297, 1273, 1071, 1037, 740 cm–1; 
Mass spectrum (EI, 70 eV) m/z 282 (M+•, 31%), 213 (30), 212 (100), 183 (22). 
Compound 16. A magnetically stirred solution of amine 14 (59 mg, 0.23 mmol) in EtOH (4 mL) 
maintained at 18 °C under a nitrogen atmosphere was treated with triethylamine (35 µL, 25 mg, 0.25 
mmol) and CS2 (140 µL, 175 mg, 2.30 mmol). The resulting mixture was stirred at 18 °C for 0.5 h then 
cooled to 0° C and treated, dropwise, with a solution of Boc2O (55 mg, 0.25 mmol) in EtOH (1 mL). A 
solution of DMAP (5 mg, 0.05 mmol) in EtOH (1 mL) was added immediately thereafter. The ensuing 
mixture was maintained at 0° C for 0.08 h then warmed to 18 °C and stirred at this temperature for 0.5 h. 
At this point the reaction mixture was concentrated under reduced pressure and the white paste thus 
obtained subjected to flash chromatography (silica, 5:95 v/v EtOAc/hexane elution). Concentration of the 
appropriate fractions (Rf = 0.6 in 1:10 v/v EtOAc/hexane) afforded isothiocyanate 16 (56 mg, 82%) as a 
clear, colourless oil that solidified on standing at 5 °C (Found: M+•, 298.1503. C18H22N2S requires M+•, 
298.1504). 1H NMR (400 MHz, CDCl3) ! 7.08 (dt, J = 7.7 and 1.3 Hz, 1H), 6.95 (dd, J = 7.3 and 1.3 Hz, 
1H), 6.68 (dt, J = 7.3 and 1.0 Hz, 1H), 6.44 (broadened d, J = 7.7 Hz, 1H), 5.14 (s, 1H), 3.52 (m, 2H), 
3.35 (dd, J = 5.3 and 3.3 Hz, 1H), 2.73 (s, 3H), 2.16–2.07 (complex m, 3H), 2.01–1.90 (complex m, 3H), 
1.81 (dt, J = 16.7 and 5.0 Hz, 1H), 1.75–1.68 (complex m, 1H), 3.08 (t, J = 7.5, 3H); 13C NMR (100 MHz, 
CDCl3) ! 151.3, 140.8, 134.3, 129.8, 128.0, 122.7, 122.1, 117.8, 107.4, 68.3, 46.6, 41.6, 39.1, 32.6, 30.5, 
23.5, 22.2, 12.0; "max 2928, 2185, 2102, 1958, 1603, 1485, 1297, 1021, 741 cm–1; Mass spectrum (EI, 70 
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eV) m/z 298 (M+•, 47%), 213 (32), 212 (100). 
Compound 17. A magnetically stirred solution of isothiocyanate 16 (50 mg, 0.17 mmol) in benzene (10 
mL) contained in a Pyrex™ vessel at 18 °C under a nitrogen atmosphere was irradiated with a high 
pressure mercury vapour lamp for 1 h then concentrated under reduced pressure and the resulting yellow 
paste subjected to flash chromatography (silica, 1:10 v/v EtOAc/hexane elution). Concentration of the 
appropriate fractions (Rf = 0.4) afforded !-thiolactam 17 (7 mg, 14%) as a clear, pale-yellow oil (Found: 
M+•, 298.1505. C18H22N2S requires M+•, 298.1504). 1H NMR (800 MHz, CDCl3) ! 7.16 (dt, J = 7.6 and 1.2 
Hz, 1H), 7.11 (dd, J = 7.4 and 1.2 Hz, 1H), 6.78 (dt, J = 7.4 and 1.0 Hz, 1H), 6.54 (broadened d, J = 7.6 
Hz, 1H), 3.94 (m, 1H), 3.66 (s, 1H), 3.43 (ddd, J = 14.6, 9.5 and 4.9 Hz, 1H), 3.10 (app. t, J = 3.0 Hz, 1H), 
2.85 (ddd, J = 16.5, 9.5 and 7.1 Hz, 1H), 2.69 (s, 3H), 2.29 (m, 1H), 1.93 (m, 1H), 1.79 (dt, J = 13.8 and 
3.3 Hz, 1H), 1.70–1.59 (complex m, 3H), 1.55–1.52 (complex m, 1H), 0.88 (t, J = 7.4 Hz, 3H); 13C NMR 
(100 MHz, CDCl3) ! 219.1, 153.0, 133.4, 128.5, 122.0, 118.6, 107.9, 72.6, 71.3, 57.0, 49.5, 45.9, 44.4, 
33.2, 28.3, 25.2, 20.1, 8.4; "max (KBr) 2925, 1605, 1487, 1412, 1297, 1273, 1232, 1023, 908, 752 cm–1; 
Mass spectrum (EI, 70 eV) m/z 298 (M+•, 31%), 213 (25), 212 (100). 
Compound 20. A magnetically stirred solution of aldehyde 13 (590 mg, 2.31 mmol) in MeOH (50 mL) 
maintained at 18 °C under a nitrogen atmosphere was treated, in one portion, with NaBH4 (96 mg, 2.54 
mmol). After 0.25 h the reaction mixture was diluted with water (50 mL) and extracted with EtOAc (3 % 
50 mL). The combined organic phases were dried (Na2SO4), filtered and concentrated under reduced 
pressure to give a clear, colourless oil that was dissolved in CH2Cl2 (50 mL). The solution thus obtained 
was cooled to 0 °C and, after the establishment of a nitrogen atmosphere, was treated with triethylamine 
(390 µL, 283 mg, 2.7 mmol) and methanesulfonyl chloride (200 µL, 296 mg, 2.58 mmol). The ensuing 
mixture was stirred at 0 °C for 0.25 h then quenched with water (25 mL) containing NaHCO3 (5 drops of 
a saturated aqueous solution). The separated aqueous phase was extracted with CH2Cl2 (3 % 50 mL) and 
the combined organic phases dried (Na2SO4), filtered and concentrated under reduced pressure. The 
yellow oil thus obtained was dissolved in DMF (25 mL) and while being maintained with magnetic 
stirring at 18 °C under a nitrogen atmosphere was treated with sodium azide (450 mg, 6.92 mmol). After 
24 h the reaction mixture was diluted with water (25 mL) and extracted with EtOAc (3 % 50 mL). The 
combined organic phases were then dried (Na2SO4) and filtered before being concentrated under reduced 
pressure. The light-yellow oil thus obtained was subjected to flash chromatography (silica, 1:20 v/v 
EtOAc/hexane elution) and concentration of the relevant fractions (Rf = 0.5 in 1:10 v/v EtOAc/hexane) 
afforded azide 20 (580 mg, 88%) as a clear, colourless oil (Found: M+•, 282.1845. C17H22N4 requires M+•, 
282.1844). 1H NMR (400 MHz, CDCl3) ! 7.09 (dt, J = 7.7 and 1.1 Hz, 1H), 6.99 (dd, J = 7.4 and 1.2 Hz, 
1H), 6.69 (t, J = 7.4 Hz, 1H), 6.46 (broadened d, J = 7.7 Hz, 1H), 5.15 (s, 1H), 3.38 (m, 1H), 3.30 (m, 2H), 
2.73 (s, 3H), 2.18–2.10 (complex m, 1H), 2.04–1.92 (complex m, 5H), 1.94–1.70 (complex m, 2H), 0.97 
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(t, J = 7.3 Hz, 3H); 13C NMR (100 MHz, CDCl3) ! 151.5, 140.1, 135.0, 127.8, 123.3, 122.2, 117.7, 107.3, 
68.5, 47.9, 46.6, 37.8, 32.7, 30.5, 23.4, 22.1, 12.0; "max 2925, 2094, 1604, 1486, 1459, 1374, 1297, 1273, 
1120, 1021, 738 cm–1; Mass spectrum (EI, 70 eV) m/z 282 (M+•, 43%), 213 (28), 212 (100). 
Compound 21. A magnetically stirred solution of azide 20 (570 mg, 2.02 mmol) in toluene (60 mL) 
maintained under a nitrogen atmosphere was heated at reflux for 5 h then cooled to 18 °C and 
concentrated under reduced pressure. The yellow oil thus obtained was dissolved in EtOAc (20 mL) and 
the solution so formed passed through a short plug of TLC-grade silica gel that was washed with EtOAc 
(250 mL). The combined filtrates were concentrated under reduced pressure to give imine 21 and 
associated isomers (513 mg, quantitative) as a light-yellow oil (Found: M+•, 254.1783. C17H22N2 requires 
M+•, 254.1783). 1H NMR (400 MHz, CDCl3) ! (major isomer) 7.13 (t, J = 7.8 Hz, 1H), 6.75 (d, J = 6.9 Hz, 
1H), 6.64 (t, J = 6.9 Hz, 1H), 6.47 (d, J = 7.8 Hz, 1H), 3.95 (dd, J = 15.1 and 8.6 Hz, 1H), 3.79–3.70 
(complex m, 1H), 3.45 (m, 1H), 2.81 (s, 3H), 2.11–1.90 (complex m, 7H), 1.44–1.31 (complex m, 2H), 
0.97 (t, J = 7.2 Hz, 3H); 13C NMR (100 MHz, CDCl3) ! (major isomer) 180.3, 149.9, 132.7, 128.4, 122.0, 
117.5, 107.3, 74.9, 62.1, 57.5, 41.0, 40.8, 31.8, 27.1, 25.0, 23.8, 11.7; "max 2931, 2861, 1638, 1603, 1480, 
1446, 1372, 1215, 1123, 1019, 741 cm–1; Mass spectrum (EI, 70 eV) m/z 254 (M+•, 61%), 159 (25), 158 
(100), 144 (28). 
Compound 22. A magnetically stirred solution of imine 21 and its associated isomers (176 mg, 0.69 
mmol) and triethylamine (100 µL, 72.6 mg, 0.69 mmol) in CH2Cl2 (25 mL) was cooled to 0 °C while 
being maintained atmosphere of nitrogen. Acryloyl chloride (62 µL, 68 mg, 0.75 mmol) was then added 
dropwise and the ensuing mixture stirred at 0 °C for 0.5 h before being treated with NaHCO3 (25 mL of a 
saturated aqueous solution). The separated aqueous phase was extracted with CH2Cl2 (3 % 20 mL) and the 
combined organic phases were then dried (Na2SO4), filtered and concentrated under reduced pressure. The 
yellow residue thus obtained was subjected to flash chromatography (silica, 1:1 v/v EtOAc/hexane 
elution) and concentration of the relevant fractions (Rf = 0.4) gave a white solid, recrystallisation (1:5 v/v 
EtOAc/hexane) of which afforded compound 22 (194 mg, 91%) as a white, crystalline solid, mp 
144–148 °C (Found: (M+•, 308.1893. C20H24N2O requires M+•, 308.1889). 1H NMR (400 MHz, CDCl3) ! 
7.08 (t, J = 7.5 Hz, 1H), 6.60–6.30 (complex m, 4H), 6.21 (dd, J = 17.2 and 9.7 Hz, 1H), 5.54 (d, J = 10.4 
Hz, 1H), 4.07 (m, 1H), 3.55 (m, 2H), 2.79 (s, 3H), 2.33–2.20 (complex m, 2H), 2.09–1.80 (complex m, 
5H), 1.70 (m, 1H), 0.94 (t, J = 7.6 Hz, 3H); 13C NMR (100 MHz, CDCl3) # 165.5, 150.9, 134.2, 132.7, 
129.6, 128.2, 128.0, 127.0, 122.3, 118.0, 107.2, 69.0, 50.3, 43.8, 35.5, 32.9, 25.4, 23.5, 22.5, 10.9; "max 
(KBr) 2934, 1650, 1614, 1485, 1412, 1365, 1275, 1024, 956, 792, 742 cm–1; Mass spectrum (EI, 70 eV) 
m/z 308 (M+•, 100 %), 293 (23), 280 (48), 279 (45), 265 (21), 253 (40), 239 (30), 224 (25), 210 (41), 202 
(32), 158 (52), 144 (48). 
Compound 23. A magnetically stirred solution of 3-(trimethylsilyl)propynoic acid (112 mg, 0.79 mmol) 
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and DMF (5 µL, 4.7 mg, 0.06 mmol) in CH2Cl2 (10 mL) maintained at 18 °C under a nitrogen atmosphere 
was treated with oxalyl chloride (68.5 µL, 101.3 mg, 0.80 mmol) After 0.5 h half (5 mL) of the solution 
thus formed was added to a magnetically stirred solution of imine 21 and its associated isomers (100 mg, 
0.33 mmol) and Hünig’s base (210 µL) in CH2Cl2 (20 mL) maintained at 0 °C under a nitrogen 
atmosphere. After a further 1 h the remaining half (5 mL) of the original solution was added to the second 
solution and stirring of the resulting mixture continued at 0 °C for a further 1 h. The reaction mixture was 
then quenched by the slow addition of NaHCO3 (40 mL of a saturated aqueous solution). The separated 
aqueous phase was extracted with CH2Cl2 (3 % 25 mL) and the combined organic phases were dried 
(Na2SO4), filtered and then concentrated under reduced pressure. The thick brown oil thus obtained was 
dissolved in THF/water (20 mL of a 4:1 v/v mixture) and the resulting and magnetically stirred solution 
was treated with Na2CO3 (20 drops of a saturated aqueous solution). After 1 h the reaction mixture was 
diluted with EtOAc (20 mL) and the separated aqueous phase extracted with EtOAc (3 % 25 mL). The 
combined organic phases were dried (Na2SO4), filtered and then concentrated under reduced pressure to 
give a brown oil that was subjected to flash chromatography (silica, 10:30:1 v/v/v EtOAc/hexane/CH2Cl2 
elution). Concentration of the appropriate fractions (Rf = 0.35 in 1:3 v/v EtOAc/hexane) afforded 
propiolamide 23 (98 mg, 82% from 20) as a clear, light-yellow oil (Found: M+•, 306.1731. C20H22N2O 
requires M+•, 306.1732). 1H NMR (400 MHz, CDCl3) (mixture of rotamers) ! 6.93 (m, 1H), 6.60 (m, 1H), 
6.45 (m, 1H), 6.29 (m, 1H), 3.99–3.85 (complex m, 1H), 3.68 (m, 0.3H), 3.38–3.26 (complex m, 1.7H), 
3.03 (s, 0.3H), 2.68 (s, 0.7H), 2.63 (s, 3H), 2.17–1.40 (complex m, 8H), 0.88–0.82 (complex m, 3H); 13C 
NMR (100 MHz, CDCl3) ! (mixture of rotamers) 152.7, 150.6, 150.5, 150.2, 134.4, 134.1, 131.8, 129.8, 
129.3, 129.1, 128.2, 128.1, 122.2, 121.9, 118.0, 117.8, 107.2, 78.4, 77.2, 69.5, 69.0, 50.7, 50.4, 46.7, 44.1, 
35.9, 35.6, 32.6, 32.3, 26.9, 26.1, 25.0, 23.6, 22.1, 21.7, 11.1, 10.8; "max 3214, 2930, 2103, 1626, 1481, 
1374, 1289, 1156, 1115, 741 cm–1; Mass spectrum (EI, 70 eV) m/z 306 (M+•, 72%), 278 (60), 277 (60), 
250 (50), 158 (100), 144 (63), 139 (60), 124 (88). 
Compound 24. A magnetically stirred solution of propiolamide 23 (20 mg, 0.07 mmol) in CH2Cl2 (10 
mL) maintained under a nitrogen atmosphere at 18 °C was treated with p-TsOH•H2O (12 mg, 0.06 mmol) 
and the resulting solution stirred for 0.16 h then (MeCN)[(2-biphenyl)di-tert-butylphosphine]gold(I) 
hexafluoroantimonate (6 mg, 0.008 mmol, 11 mole %) added to it. After 18 h the reaction mixture was 
treated with NaHCO3 (25 mL of a saturated aqueous solution) and the separated aqueous phase extracted 
with CH2Cl2 (3 % 25 mL). The combined organic phases were then dried (Na2SO4), filtered and 
concentrated under reduced pressure. The resulting light-yellow oil was subjected to flash 
chromatography (silica, 1:2 v/v acetone/hexane) and concentration of the appropriate fractions (Rf = 0.2) 
afforded a solid that upon crystallisation (1:1 v/v CH2Cl2/hexane) gave compound 24 (7.0 mg, 33%) as 
fine, white needles (no mp, decomposition above 50 °C) [Found: (M+H)+, 325.1917. C20H24N2O2 requires 
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(M+H)+, 325.1916]. 1H NMR (400 MHz, CDCl3) ! 7.62 (d, J = 7.5 Hz, 1H), 7.13 (t, J = 7.8 Hz, 1H), 6.67 
(t, J = 7.5 Hz, 1H), 6.54 (d, J = 10.2 Hz, 1H), 6.42 (d, J = 7.8 Hz, 1H), 5.99 (d, J = 10.2 Hz, 1H), 3.86 (dd, 
J = 12.3 and 9.7 Hz, 1H), 3.50 (m, 1H), 3.22 (m, 1H), 2.77 (s, 3H), 2.65 (s, 1H), 2.38 (m, 1H), 2.09 (m, 
1H), 1.76–1.57 (complex m, 6H), 0.82 (t, J = 8.0 Hz, 3H); 13C NMR (100 MHz, CDCl3) ! 162.2, 150.5, 
146.5, 131.2, 128.1, 126.1, 122.5, 117.9, 106.7, 93.3, 68.1, 58.2, 44.0, 41.5, 32.2, 31.5, 27.6, 21.7, 19.0, 
7.5; "max 3352, 2934, 1657, 1601, 1480, 1446, 1373, 1331, 1299, 1234, 1156, 1067, 1025, 912, 859, 816, 
754, 737 cm–1; Mass spectrum (ESI, +ve) m/z 347 (63%), 325 [(M+H)+,100], 307 (92). 
 
Crystallographic Studies 
Compound 10: C16H19NO, Mr = 241.33, T = 200 K, triclinic, space group P#, Z = 2, a = 7.2598(3), b = 
8.6985(3), c = 11.4581(5) Å; " = 100.373(2)°, ! = 103.087(3)°, # = 103.087(3)°; V = 665.75(5) Å3, Dx = 
1.204 g cm–3, 3051 unique data (2$max = 55°), R = 0.041 [for 2437 reflections with I > 2.0&(I)]; Rw = 
0.105 (all data), S = 0.98. 
Oxalate Salt of Compound 14 [C17H23N2]+[C2HO4]– ·CH3OH, M = 376.45, T = 200 K, orthorhombic, 
space group Pbca, Z = 8, a = 11.1600(5), b = 13.6169(5), c = 27.9681(13) Å; V = 4250.2(3) Å3, Dx = 
1.177 g cm–3, 3737 unique data (2$max = 50°), R = 0.144 [for 1554 reflections with I > 2.0&(I)]; Rw = 
0.438 (all data), S = 1.00. 
Compound 22: C20H24N2O, Mr = 308.42, T = 200 K, monoclinic, space group P21/c, Z = 4, a = 8.7799(1), 
b = 14.6530(2), c = 13.2854(2) Å; ! = 100.9286(9)°; V = 1678.19(4) Å3, Dx = 1.221 g cm–3, 4907 unique 
data (2$max = 60.2°), R = 0.044 [for 3971 reflections with I > 2.0&(I)]; Rw = 0.114 (all data), S = 0.98. 
 
Structure Determination. Images were measured on a Nonius Kappa CCD diffractometer (MoK', 
graphite monochromator, ( = 0.71073 Å) and data extracted using the DENZO package.28 Structure 
solution was by direct methods (SIR92).29 The structures of compounds 10, the oxalate salt of 14 and 22 
were refined using the CRYSTALS program package.30 Atomic coordinates, bond lengths and angles, and 
displacement parameters have been deposited at the Cambridge Crystallographic Data Centre [CCDC nos. 
990090 (10), 990091 (oxalate salt of 14), and 990092 (22)]. These data can be obtained free-of-charge via 
www.ccdc.cam.ac.uk/data_request/cif, by emailing data_request@ccdc.cam.ac.uk, or by contacting The 
Cambridge Crystallographic Data Centre, 12 Union Road, Cambridge CB2 1EZ, UK; fax: +44 1223 
336033. 
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SUPPORTING INFORMATION 
Copies of the 1H and 13C NMR spectra for compounds 9–17 and 20–24, together with the ORTEPs arising 
from the single-crystal X-ray analyses of compound 10, the oxalate salt of compound 14, and compound 
22 can be obtained, as a pdf, through the HETERORESOURCE website of the journal. 
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Abstract 
The whole-cell biotransformation of mono-nuclear aromatic compounds using certain genetically-
engineered micro-organisms that over-express the enzyme toluene dioxygenase (TDO) allows for the 
large scale production of compounds known as cis-1,2-dihydrocatechols.  These metabolites, which are 
normally obtained in enantiomerically pure form, can be manipulated, by chemical means, in a range of 
distinct (and predictable) ways with the result that they have proven to be especially versatile starting 
materials for the assembly of a range of structurally diverse and biologically active systems.  Herein we 
describe, on a case-by-case basis, the recent applications of various combinations of TDO-mediated and 
chemical steps in so-called chemoenzymatic total syntheses of a range of organic compounds with 
therapeutic potential. 
 
 
 
Introduction 
Chemical space (viz. the space spanned by all 
possible small molecules and chemical 
compounds) is essentially infinite.1 The 
challenge, then, has been to access the most 
meaningful or useful parts of it.  Nature has 
provided critical inspirations.  So, 3.8 billion 
years of evolution has produced a global 
molecular library of unsurpassed size, 
structural diversity and functional value – our 
planet’s chemome.2,3,4 Humankind has sought 
to “mine” this bioactive molecule resource 
for its benefit and such endeavors have been 
spectacularly successful as evidenced by the 
existence of the remarkable array of 
medicines, materials and agrochemicals that 
underpin society as we know it today.  As a 
result the world we live in has been 
transformed.  This is evidenced by our 
exploitation of drugs with household names 
such as penicillin, morphine and Taxol®.  
There are many additional but perhaps less 
well-known examples.  For instance, organ 
transplant surgery would fail completely 
without the post-operative application of the 
chemome-derived anti-rejection drugs such 
FK506 and cyclosporin A.5 Similarly, a 
significant number of agents that control 
agricultural pests, and so helping to ensure 
both the security and efficiency of world food 
production, have also come from Nature/the 
global chemome.6  
 
Despite such successes, enormous challenges 
remain.  So-called unmet scientific and 
societal needs include those arising from the 
development of resistance to current 
therapies (perhaps seen most prominently in 
the area of antibiotics7) and, in the 
agrochemical sector, pest-control agents.8 In 
addition, there is a desperate need for small 
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molecule entities that provide, inter alia, 
effective control of neurodegenerative 
diseases and diabetes in a globally aging 
population, for ones that treat certain types of 
refractory cancers and for others that 
effectively modulate mammalian and other 
immune systems. 
 
After forays into areas such as combinatorial 
chemistry,9 major players in the 
pharmaceutical industry, sometimes in 
partnerships with Government-funded 
agencies, are returning to interrogation of the 
chemome (or at least portions thereof) as a 
means for productively probing chemical and 
thence biological space.10  There are a number 
of reasons for such moves10 including the 
recognition that, for example, the current 
pharmaceutical industry is built on <10% of 
the biosynthetic capacity of the microbial 
world, one that continues to show a 
remarkable ability to deliver biologically 
relevant small molecules.11 
 
Occurring in tandem with these trends is the 
emergence of a plethora of new techniques 
and concepts concerned with the generation 
of biologically relevant molecular diversity 
involving the use of, inter alia, techniques of de 
novo biosynthesis for producing functionally 
annotated chemome components,12 the 
creation of new metabolic pathways,12 
synthetic fermentation,13 and activity-directed 
synthesis.14  Simultaneously, new synergies are 
being recognized between in vitro, in vivo and in 
silico studies of drug metabolism 15 and thus 
allowing for much more efficient/rapid 
assessments of the utility of certain 
compounds as molecular probes, drugs 
and/or agrochemicals. 
 
The development of new methods and 
protocols for effecting the chemical synthesis 
of biologically active natural products and 
various analogues remain important parts of 
the range of activities concerned with 
exploiting components of the global 
chemome for therapeutic and other purposes.  
At least two motivations drive such efforts, 
the first being the need to address issues of 
supply.  Thus, it is often the case that 
secondary metabolites2 are only available in 
miniscule amounts from their natural source 
with the result that insufficient material is 
available for development purposes. 
Chemical synthesis is often the best method 
for addressing such issues.  Secondly, truly 
useful chemical syntheses offer the capacity to 
generate analogues of the natural product that 
would not normally be available through 
manipulation of the natural product itself.  
 
This article, which is based on a lecture 
presented by the senior author at the 
University of Sydney as part of the RSNSW’s 
2014 Liversidge Award, details work being 
undertaken at the Australian National 
University on the exploitation of certain 
chemoenzymatic methods for the synthesis of 
biologically active natural products and their 
analogues.  The work is presented according 
to the class of natural product being targeted 
as well as the structural and chemical 
relationships between them. 
 
Results and discussion 
The term chemoenzymatic synthesis used in 
this article, and elsewhere,16 refers to the 
assembly of target compounds using a 
combination of chemical and enzymatic 
techniques.  While there are many variations 
on this theme that reflect the extraordinarily 
diverse range of chemical and enzymatic 
transformations available these days, the 
specific form of the latter that applies here 
involves the whole-cell biotransformation of 
a range of simple and readily available 
aromatic compounds of the general form 1 
(Scheme 1) into the corresponding cis-1,2-
dihydrocatechols (2).16  When genetically 
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engineered micro-organisms such as E. coli 
JM109 (pDTG601)17 are used for such 
purposes, these metabolites can be readily 
produced at kilogram scales and are often 
obtained in >99.95 enantiomeric excess (ee).  
In the illustrated cases the enzyme 
responsible for these conversions is toluene 
dioxygenase (TDO) but a number of related 
ones are known including biphenyl 
dioxygenase, naphthalene dioxygenase and 
toluate dioxygenase.  The end result is that a 
remarkable suite of cis-1,2-dihydrocatechols 
and related metabolites is known - these 
number in the many hundreds at the present 
time.16c  Given the capacities to produce 
numerous mutants, and thus expand the 
range of substrates that can be 
biotransformed, the possible extensions of 
such processes would appear to be vast.  A 
further fascinating aspect of them is the 
“chemoselectivities” they can display.  So, for 
example, styrene (1, X = CH=CH2) is 
converted into the triene 2 (X = CH=CH2), a 
process wherein the aromatic ring is oxidised 
in preference to the exocyclic olefin, a 
functional group selectivity that cannot be 
achieved by any of the strictly chemical 
methods known at the present time.18 
 
 
 
Scheme 1 
 
The utility of the cis-1,2-dihydrocatechols (2) 
as starting materials in chemical synthesis has 
taken some time to be recognised in a 
broader sense.  Various groups, especially 
those led by Ley in the UK19 and Hudlicky in 
North America,16a,d have carried out the 
pioneering work in the area.  Such studies 
established the reactivity “patterns” shown in 
Figure 1 as well as attendant hazards arising 
from the dehydrative re-aromatisation of 
these substrates20 and the propensity of 
certain derivatives, most notably the 
corresponding acetonides, to engage in 
normally unproductive Diels-Alder (DA) 
dimerization reactions.21 
 
 
 
Figure 1 
 
Our own contributions in the area began in 
the late 1980s22 and in the intervening period 
we have been able to establish a series of total 
syntheses (Figure 2) that emphasise the 
extraordinary range of natural product targets 
available through manipulation of these 
metabolites.  Some specific examples arising 
from our recent research are discussed on a 
case-by-case basis in the following sections. 
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Figure 2 
 
The Ribisins 
Ribisins A-D were isolated by Fukuyama and 
co-workers from Phellinus ribis (Schmach.) 
Quél (Hymenochaetaceae),23 a fungus used in 
traditional medicine for various purposes.  
Using a range of spectroscopic methods they 
were assigned structures 3-6 (Figure 3), 
respectively, and shown to enhance neurite 
outgrowth in PC12 cells at ca. 1 µM 
concentrations.  As such they have potential 
for development as agents for the treatment 
of certain neurological disorders. 
 
 
 
 
 
Figure 3 
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Given the structural resemblance of the 
polyoxygenated cyclohexane ring of these 
natural products to the cis-1,2-
dihydrocatechols 2 (X = Br) we sought a 
means for effecting the relevant chemical 
conversions.  The route used for establishing 
a synthesis of compound 5, the structure 
assigned to ribisin C and the most active 
compound in the series, is shown in Scheme 
2.24  
 
 
 
 
 
Scheme 2 
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The opening stages of this reaction sequence 
are typical of the manner in which the cis-1,2-
dihydrocatechols can be manipulated and 
involve the initial conversion of compound 2 
(X = Br) into the corresponding acetonide 
and the regio- and stereo-selective 
epoxidation of the latter to give the oxirane 7.  
Treatment of compound 7 with aqueous 
mineral acid resulted in a regioselective ring-
opening reaction to afford the trans-diol 8 that 
could be bis-O-methylated under 
conventional conditions and the resulting 
acetonide was then cleaved, again under 
conventional conditions, to give the cis-diol 9 
that embodies most of the key elements of 
the Eastern hemisphere of target 3.  
Compound 9 could be engaged in a Suzuki-
Miyaura cross-coupling reaction with the 
commercially available boronate ester 10 and 
two products thereby formed, namely the bis-
phenol 11 and the dihydrobenzofuran 12.  
Product 12 is presumably formed through 
cyclisation of the initially produced cross-
coupling product while congener 11 arises 
from successive loss of the elements of water 
and methanol (no particular order implied) 
from the same intermediate.  The lone 
hydroxyl group within compound 11 could be 
protected as the corresponding α-chloro-
acetate 13, a necessary step because of the 
looming introduction of a second hydroxyl 
group as the precursor to the ketone moiety.  
The use of the α-chloroacetate as a protecting 
group proved essential as in the final step of 
the reaction sequence attempts to remove the 
less labile parent acetate resulted in 
decomposition of the substrate. Epoxidation 
of compound 13 using m-chloroperbenzoic 
acid (m-CPBA) led, presumably via 
spontaneous rearrangement of the initially 
formed oxirane, to the benzofuran alcohol 14 
that could be oxidised to the corresponding 
ketone 15 under Swern conditions.  Cleavage 
of the α-chloroacetate residue within this last 
compound was accomplished using zinc 
acetate in methanol and thus forming the 
target compound 5.  While all the usual 
spectroscopic data acquired on compound 5 
matched those reported for ribisin C, the 
specific rotation derived from the synthetic 
material was of the same magnitude but the 
opposite sign to that reported for the natural 
product.  The implications are clear – the 
structure of ribisin C is represented by 
structure ent-5 rather than 5. Since we 
required an authentic sample of ribisin C (ent-
5) for biological testing, a synthesis of it was 
pursued.  This could be achieved (Scheme 3) 
using the same starting material and many of 
the same transformations as employed in 
generating its enantiomer (5).  A key step of 
the fourteen-stage reaction sequence involved 
the inversion of configuration at C3 within a 
derivative of compound 2 (X = Br) using 
Mitsunobu chemistry.  As a result ribisin C 
was obtained and all of the derived data, 
including the specific rotation, matched those 
reported for the natural product. 
 
 
 
Scheme 3 
 
Extensions of this sort of chemistry enabled 
the synthesis of all of the structures originally 
assigned to the ribisins and thus revealed that 
while ribisins A and D are constituted as 
originally described23 that attributed to 
congener B is, like C, incorrect.25 The true 
structures of all the ribisins are shown in 
Figure 4 with the corrected stereocentres 
within compounds B (16) and C (ent-5) 
highlighted in red. Extensive biological 
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evaluations of the ribisins and the range of 
congeners prepared during the course of our 
synthetic studies are now underway. 
 
 
 
Figure 4 
 
Analogues of Galanthamine 
Ribisin D (6) bears a “provocative” structural 
resemblance to the ABC ring-system of the 
alkaloid galanthamine (17) that is used in 
many countries for the symptomatic 
treatment of Alzheimer’s disease (Figure 5).26  
As such we were prompted to explore means 
by which the chemistry described above 
could be adapted so as to produce 
compounds bearing greater similarities to 
galanthamine (or, in the first instance at least, 
the enantiomer thereof). 
 
 
 
Figure 5 
 
An efficient reaction sequence leading to a 
dioxygenated derivative of ent-galanthamine is 
shown in Scheme 427 and involves an initial 
reaction of the abovementioned oxirane 7 
with p-methoxybenzyl alcohol (p-MBOH) in 
the presence of boron trifluoride diethyl 
etherate to generate the anticipated addition 
product that upon treatment, in a second 
step, with methanol containing pyridinium p-
toluenesulfonate (PPTS) affords triol 18.  This 
last compound could be converted into the 
corresponding Ley ketal 1928 through 
treatment with 2,2,3,3-tetramethoxybutane 
(2,2,3,3-TMB) in the presence of p-
toluenesulfonic acid (p-TsOH)/trimethyl 
orthoformate (TMOF) and Suzuki-Miyaura 
cross-coupling of this with the boronate ester 
20 (produced directly from o-methoxyphenol 
using a C-H functionalization protocol) 
afforded the arylated cyclohexene 21. This last 
compound that was itself engaged in an 
intramolecular Mitsunobu reaction using di-
iso-propyl azodicarboxylate (DIAD) to afford 
the dihydrobenzofuran 22. 
 
Despite the potential for aromatisation 
(through simple double-bond migration), 
compound 22 could be engaged in an 
Eschenmoser-variant of the Claisen 
rearrangement reaction using the dimethyl 
acetal of N,N-dimethylacetamide29 and thus 
affording the angularly substituted ABC-ring 
analogue 23 of ent-galanthamine. Over three 
conventional steps compound 23 could be 
converted into its mono-methylated 
counterpart 24.  The last compound 
participated in a Pictet-Spengler cyclisation 
reaction on exposure to a mixture of 
paraformaldehyde and trifluoroacetic acid 
(TFA) and the presumably first-formed 
product 25 underwent cleavage of the Ley 
acetal residue to give diol 26 as the only 
isolable product of reaction.  Compound 26, 
representing a dioxygenated derivative of ent-
galanthamine (ent-17), and various congeners 
that have been prepared using related reaction 
sequences are currently being subjected to 
evaluation as inhibitors of the neurologically 
significant enzyme acetylcholine esterase 
(AChE). 
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Scheme 4 
 
It is worth noting, at this point, that the 
enantiomer of certain of the cis-1,2-
dihydrocatechols described above are also 
available.30  So, for example, biotransform-
ation of p-iodotoluene or p-iodobromo- 
benzene [27a (X = Me) and 27b (X = Br), 
respectively] (Scheme 5) using E. coli JM109 
(pDTG601) affords metabolite 28 that upon 
exposure to dihydrogen in the presence of 
palladium on carbon undergoes 
hydrogenolytic cleavage of the associated C-I 
bond and thus delivering either cis-1,2-
dihydrocatechol ent-2 (X = Me) or ent-2 (X = 
Br). 
 
Scheme 5 
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The Opiates 
Morphine and its congener codeine are 
members of opiate family. They are used 
extensively for the management of pain and 
represent the most widely applied and highest 
grossing medicines in the world today.31 Their 
structural complexity means that for the 
moment, at least, opiates such as morphine 
are obtained from natural sources and then 
derivatized by simple chemical means so as to 
produce related drugs.  Nevertheless, much 
progress has been made in terms of 
developing commercially viable total 
syntheses of these systems. Hudlicky and co-
workers have defined the current “gold 
standard” in the area.32  Given the tantalising 
structural resemblance between the readily 
available compound 23 and ent-codeine (29) 
(Figure 6) we are now attempting to modify 
the synthesis of the former so as to access the 
latter.  This will likely involve introducing the 
necessary additional two-carbon unit by using 
a variant of boronate ester 20 and completing 
the synthesis of the less functionalised 
cyclohexane ring within target 29 using an 
intramolecular SNʹ′ reaction that 
simultaneously cleaves the Ley acetal subunit. 
 
 
Figure 6 
 
Vinblastine, Vincristine and Vindoline 
Vinblastine (30) and vincristine (31) (Figure 
7) are indole-indoline-based alkaloids derived 
from various plant sources, perhaps most 
notably the Madagascan rosy periwinkle.33 
They are used in the clinical treatment of 
non-Hodgkin’s lymphomas as well as 
testicular, breast and lung cancers.  These 
compounds are derived in vivo from the 
significantly more abundant and co-occurring 
alkaloid vindoline (32).  Given the 
development of direct, chemically based and 
“bio-inspired” methods for effecting the 
conversion of this simpler compound into 
alkaloids 30 and 31, vindoline has become the 
focus of considerable attention as a synthetic 
target.34 
 
Our own efforts in this area have been 
inspired by the observation (Figure 8)35 that 
the mutant organism P. putida BGXM1 can 
effect, in an enantioselective fashion, the 
whole-cell biotransformation of abundant m-
ethyltoluene (33) into the carboxylic acid diol 
34 that bears a striking resemblance to the 
highly functionalised C-ring of vindoline. 
Accordingly, a recent focus of some of our 
work in the area of chemoenzymatic synthesis 
has been on identifying methods for 
converting this metabolite into vindoline (32) 
and thence into vinblastine (30) and 
vincristine (31). 
 
 
 
 
Figure 7 
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Figure 8 
 
The model study outlined in Scheme 6 has 
provided encouragement.36 Thus, the cis-1,2-
dihydrocatechol 2 (X = Br), representing a 
model for congener 34, was converted, by the 
means described earlier, into the oxirane 7.  
Treatment of this last compound with acetic 
acid in the presence of mineral acid afforded a 
trans-diol mono-ester that was protected 
under standard conditions as the 
corresponding MOM-ether and thus 
affording compound 35 that could be cross-
coupled with ethyl boronic acid in the 
presence of a Pd[0] catalyst to give, after 
completing cleavage of the acetate residue 
using methanolic potassium carbonate, the 
allylic alcohol 36. This last compound was 
engaged in a sluggish Eschenmoser-Claisen 
rearrangement reaction to give amide 37, the 
side-chain of which could be elaborated, over 
three steps, into the nitrile 38. Over a further 
three conventional steps this was converted 
into the α-iodocyclohexenone 39 that itself 
served as a substrate for a palladium-catalysed 
Ullmann cross-coupling reaction37 with o-
iodonitroarene 40 and so delivering the α-
arylated cyclohexenone 41. On exposure to 
dihydrogen in the presence of Raney cobalt38 
and a proton source compound 41 engaged in 
a series of chemoselective reductions and two 
cyclisation reactions with the result that the 
tetracyclic compound 42 was formed.  The 
completion of the synthesis of the pentacyclic 
framework of vindoline proved straight-
forward and involved reaction of the last 
compound with 2-bromoethanol in the 
presence of base, mesylation of the resulting 
alcohol 43 and treatment of the sulfonate 
ester so formed with potassium tert-butoxide 
to generate the isoindole 44.   
 
In an effort to introduce the carbomethoxy 
group associated with alkaloid 32, compound 
44 was subjected to successive treatment with 
tert-butyllithium then Mander’s reagent 
(NCCO2Me).39 However, rather than 
obtaining the hoped-for C-carbomethoxy-
lated imine, carbamate 45 was produced, 
presumably by a pathway whereby the tert-
butyllithium acts as a hydride source40 with 
the resulting indoline anion then reacting (at 
nitrogen) with the added electrophile.  Efforts 
are now underway to adapt these chemistries 
so as to convert metabolite 34 into vindoline.  
The most challenging issue associated with 
doing so will be finding a means for 
introducing the C-C double bond 
incorporated within the D-ring of target 32. 
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Scheme 6 
The Protoilludanes 
The title sesquiterpenes embody a distinctive 
tricyclic framework wherein a central 
cyclohexane ring is annulated, in an angular 
arrangement, to both a four- and a five-
membered ring.41  The protoilludane aryl 
ester (+)-armillarivin (46) (Figure 9) has been 
found in the edible sugar mushroom 
Armillaria mellea42 while representative 
additional natural products in this family 
include 4743 and 4844 that are derived from 
the saprotrophic wood decomposing fungus 
Granulobasidium vellereum (Ellis & Cragin) 
Jülich. 
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Figure 9 
 
 
In 2013 we described the first and thus far 
only total synthesis of (+)-armillarivin.45 A key 
element of our approach (Scheme 7) was an 
initial high-pressure promoted and completely 
regio- and stereo-selective Diels-Alder 
reaction between the cis-1,2-dihydrocatechol 2 
(X = Me) and cyclopentenone.46  Relatively 
conventional but rather extensive 
manipulations of the resulting adduct lead to 
the cyclopentannulated bicyclo[2.2.2]octen-
one 49 that engaged, as a second pivotal step 
of the synthesis, in a photochemically-
promoted 1,3-acyl migration reaction (Givens 
rearrangement)47 to afford the tricyclic isomer 
50.  This last compound, which embodies the 
tricyclic protoilludane framework, was readily 
manipulated over just three steps to deliver 
(+)-armillarivin.  The structure of this 
synthetically produced material was 
confirmed by single-crystal X-ray analysis and 
all the derived spectroscopic data, including 
specific rotation, matched those reported for 
the natural product.  
 
Subjection of the acetonide derivative of 
compound 2 (X = Me) to a Diels-Alder 
reaction with cyclopentenone affords, via 
addition of the dienophile to the face of the 
diene opposite to that “occupied” by the 
hydroxyl groups, cyclopentannulated bicyclo- 
[2.2.2]octenones that are enantiomerically 
related to those obtained by the pathway 
described immediately above.  In essence, 
then, by controlling the facial selectivity of 
such cycloaddition reactions either 
enantiomeric form of the relevant Diels-Alder 
adduct can be obtained. 
 
 
 
 
 
Scheme 7 
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By such means we have recently been able to 
complete total syntheses of the enantiomeric 
forms of the protoilludanes 47 and 4848 and 
thus confirming, for the first time, the 
structures assigned to them. 
 
Platencin 
The Diels-Alder cycloaddition chemistry 
involving cis-1,2-dihydrocatechols as the 4π-
component can be effectively extended to 
intramolecular variants. This is perhaps best 
exemplified in our recently completed first- 
and second-generation chemoenzymatic 
syntheses of platencin (51),49,50 a compound 
isolated from Streptomyces platensis MA7327 
that acts as a potent and dual inhibitor of 
FabH and FabF, key enzymes associated with 
fatty acid biosynthesis in bacteria (Figure 
10).51  By virtue of its novel structure and 
modes of action, platencin is regarded as an 
important new lead in the development of 
urgently needed, next-generation anti-
bacterial agents.52  
 
In our first generation synthesis of compound 
51 (Scheme 8),49 the acetonide derivative, 52, 
of the cis-1,2-dihydrocatechol 2 (X = I) was 
engaged in a Stille cross-coupling reaction 
with the Z-configured alkenylstannane 53 to 
give the tetra-ene 54. Substrate 53 was 
prepared in a straightforward manner with 
the stereochemistry at the quaternary carbon 
centre being controlled through the agency of 
a chiral auxiliary. 
 
While compound 54 failed to engage in an 
intramolecular Diels-Alder (IMDA) reaction, 
the readily derived ketone 55 did so when 
heated in refluxing toluene and thus 
affording, in stereochemically pure form, 
adduct 56 embodying the tricarbocyclic core 
of platencin.  Over a further thirteen steps 
compound 56 could be converted into (–)-
platencin (51).  
 
Some of these steps were needed to deal with 
functional group incompatibilities, an issue 
that has been addressed, albeit in a modest 
way, through our recently disclosed second-
generation synthesis.50 In a developing 
collaboration with the Hudlicky group at 
Brock University (Canada), efforts are now 
focussed on a third-generation approach. 
 
 
 
 
 
Figure 10 
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Scheme 8 
 
Conclusions 
Enzymes have an almost unparalleled 
capacity to transform simple organic 
substrates into synthetically more valuable 
ones, especially enantiomerically pure 
compounds (EPCs).  Through the use of 
various genetic engineering, gene shuffling 
and directed evolution techniques the 
opportunities to expand upon the existing 
“library” of metabolites seem almost infinite.  
Furthermore, pathway-engineering techniques 
provide a capacity to produce (mutant) 
organisms that effect, through the 
orchestrated action of a series of enzymes, 
multistep transformations.  The conversion 
of m-ethyltoluene (33) into compound 3435 is 
a case in point and wherein both mono-
oxygenases and dioxygenases act in concert to 
produce a potentially high-value metabolite.  
When combined with the power of chemical 
synthesis (as manifest in the techniques of 
chemoenzymatic synthesis), such bio-
transformations provide a powerful tool kit 
for preparing a wide range of compounds of 
biological relevance.  Ironically, perhaps, 
while microbiologists have a remarkable 
capacity to generate a diversity of low 
molecular weight metabolites (and often at 
multi-kilogram or larger scale) and synthesis 
chemists have an almost insatiable appetite 
for new synthons, the often siloed nature of 
academic research activities results in less than 
desirable overlap of the relevant sets of 
expertise.  Changing this situation can only 
benefit both disciplines. 
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The bromoepoxide 5a, which is obtained from the homochiral and enzymatically derived cis-1,2-dihydrocatechol 1a, is
readily and efficiently transformed into either isomer 8a or the corresponding methoxymethyl-ether 2a. Though both of
these products can be fully characterized, they are somewhat unstable, with the former being converted into the crystalline
enone 3a on standing and the latter readily participating in a Diels–Alder cycloaddition reaction with the potent dienophile
N-phenyl-1,2,4-triazoline-3,5-dione to give adduct 7a. The single-crystal X-ray structures of compounds 3a and 7a are
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Introduction
A range of substituted arenes can be converted into the corre-
sponding cis-1,2-dihydrocatechols using certain mutant forms
of bacteria that express dioxygenase enzymes.[1] Hence, for
example, using Escherichia coli JM109 (pDTG601), bromo-
benzene and chlorobenzene are both bio-transformed, under
whole-cell conditions, into the metabolites 1a and 1b, respec-
tively.[1,2] These types of conversions proceed in essentially
quantitative yield, deliver the cis-1,2-dihydrocatechols in
.99.8% ee, and can be carried out on the kilogram if not the
tonne scale. Furthermore, compounds such as 1a and 1b have
proven to be extraordinarily versatile starting materials in
chemical synthesis as evidenced by their conversion into a wide
range of natural products including carbohydrates, terpenoids,
and alkaloids.[1] A series of reviews that detail much of this type
of work is available.[1] Based on this background, we herein
report simple methods by which the cis-1,2-dihydrocatechol 1a
can be converted into the related diene 2a or the enone 3a,
compounds that are likely to serve as useful new chirons in a
range of settings. The synthesis of the chlorinated analogue, 3b,
of the latter product is also described (Fig. 1).
Results and Discussion
During the course of another project, we had occasion to convert
the cis-1,2-dihydrocatechol 1a, via the corresponding acetonide
4a[3] (Scheme 1), into the previously reported and well-known
epoxide 5a.[3] A ‘streamlined’ procedure for doing so is
described in the Experimental section and this allowed us to
acquire compound 5a in 93% yield on a multi-gram scale. This
epoxide was treated with the anion derived from p-methoxy-
benzyl alcohol (p-MBOH) under the expectation[4] that
the nucleophilic ring-opening product 6a would form and
then, from it, the corresponding ether upon quenching with
methoxymethyl chloride (MOMCl). However, when seemingly
relevant conditions were employed for this purpose, the novel
diene 2a was obtained in 74% yield. All of the spectral data
acquired on this compound were fully consistent with the
assigned structure and this result was confirmed upon single-
crystal X-ray analysis of the Diels–Alder adduct 7a (quantita-
tive.) arising from reaction with 4-phenyl-1,2,4-triazoline-3,5-
dione (PTAD).[5] The derived ORTEP is shown in Fig. 2.
When the reaction mixture, presumed to contain anion 6a,
was quenched with water rather than MOMCl and then worked
up in the usual manner, a light yellow oil was obtained and on
standing, slowly crystallized to give the enone 3a (Scheme 1).
This was obtained in 60% yield as a white, crystalline solid, and
its structure was confirmed by single-crystal X-ray analysis.
When the above-mentioned oil was dissolved in C6D6, and
the resulting solution allowed to stand at ambient temperatures
for extended periods, diene 8a rearranged to isomer 9a, the
associated trans-acetonide moiety of which was slowly cleaved
to give enone 3a. Although rather unstable, compound 9a could
be spectroscopically characterized after partial purification by
flash chromatography. Interestingly, while diene 4a engages in a
X
OH
OH
1
(a: X  Br
 b: X  Cl)
2a
Br
O
O
OMOM
3a
Br
OH
OH
O
3b
Cl
OH
OH
O
Fig. 1. Structures of the starting diols 1a and 1b and the derived synthons
2a, 3a and 3b.
CSIRO PUBLISHING
Aust. J. Chem. 2015, 68, 1467–1471
http://dx.doi.org/10.1071/CH15061
Journal compilation  CSIRO 2015 www.publish.csiro.au/journals/ajc
Full Paper
152
Diels–Alder dimerization reaction,[6] no equivalent process was
observed in the case of congener 8a.
The chloro-analogue, 3b, of compound 3a could be obtained
by analogous means. Thus, the known acetonide derivative,
4b,[7] of diol 1b was treated with m-chloroperoxybenzoic acid
(m-CPBA), thereby generating the epoxide 5b[8] (87% from
1b). Epoxide 5bwas, in turn, treated successively with the anion
derived from p-MBOH and then water. As a result, the chloro-
enone 3b was obtained in 63% yield. No efforts were made to
isolate diene 8b that is presumed to be the late-stage precursor to
product 3b.
The detailed mechanism by which epoxides 5a and 5b are
respectively converted into dienes 8a and 8b remains to be
investigated. Nevertheless, some important observations can be
made in this regard. Thus, when the first steps of the reaction
sequence were attempted in the absence of p-MBOH (i.e.
substrate 5a, for example, was treated with NaH alone and the
reaction mixture quenched withMOMCl), then only the starting
materials were recovered. This outcome could suggest that the
oxyanion 6 is an intermediate in the original process, but
precisely how this would then lose the elements of the added
alcohol (and in a seemingly regioselective manner) is unclear.
A so-called E0 process appears unlikely since a syn-relationship is
normally required between the departing groups (in this case the
C3a hydrogen and the p-MBO anion; Scheme 1).[9,10] Another
possibility is that p-MBOanion simply acts as a base (rather than
a nucleophile) and thereby affects, after quenching of the
resulting anion, the direct conversion of epoxide 5 into isomer
8. This would involve a stereochemically favoured E0 process.
Prompted by such considerations and the studies of Hill and
Bock and Rickborn et al.,[10] a sample of the starting material 5a
was treatedwith lithium di-isopropylamide in THF at 08C for 1 h
and then quenched with MOMBr (MOMCl was not available
when this experiment was conducted). As a result, compound 8a
could be obtained after rapid chromatographic purification in
,50% yield. This was accompanied by traces of MOM-ether
2a. Curiously, when the reaction was quenched with aqueous
sodium bicarbonate (rather than MOMBr), then the starting
epoxide 5awas recovered. All of the spectroscopic data derived
from diene 8a were in complete accord with the assigned
structure. It is appropriate to note that Hudlicky and Trant have
observed[11] a closely related, but less efficient rearrangement.
Conclusion
We are currently exploring the synthetic utility of the new and
readily accessible homochiral synthons 2a, 3a, 3b, and 8a. As an
indication of their potential, we note that the related and enan-
tiomerically pure cyclohexenone 10 (Fig. 3), which has been
prepared by Chida et al. in about 12 steps from D-glucose,[12]
has served as a key intermediate in that group’s recently reported
total synthesis of ()-morphine.[13]
Experimental
General Experimental Procedures
Unless otherwise specified, proton (1H) and carbon (13C) NMR
spectra were recorded at 188C in base-filtered CDCl3 on a
Varian spectrometer operating at 400MHz for proton and
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Fig. 2. ORTEP derived from the single-crystal X-ray analysis of com-
pound 7a (CCDC No. 1045883). Anisotropic displacement ellipsoids
display 30% probability levels. Hydrogen atoms are drawn as circles with
small radii.
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Fig. 3. Structure of synthon 10 prepared from D-glucose. TBS¼ tert-
butyldimethylsilyl
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100MHz for carbon nuclei. For 1HNMR spectra, signals arising
from the residual protio forms of the solvent were used as the
internal standards. 1H NMR data are recorded as follows:
chemical shift (d) (multiplicity, coupling constant(s) J (Hz),
relative integral). Multiplicity is defined as: s¼ singlet; d¼
doublet; t¼ triplet; q¼ quartet; m¼multiplet or combinations
of the above. The signal due to residual CHCl3 appearing at
dH 7.26 ppm and the central resonance of the CDCl3 ‘triplet’
appearing at dC 77.0 ppm were used to reference
1H and 13C
NMR spectra, respectively. Infrared spectra (nmax) were recor-
ded on a Perkin–Elmer 1800 Series Fourier transform infrared
spectrometer. Samples were analyzed as thin films on KBr
plates. Low-resolution electrospray ionization (ESI) mass
spectra were recorded on a Micromass LC-ZMD single quad-
rupole liquid chromatograph–mass spectrometer, whereas high-
resolution measurements were conducted on an LCT Premier
time-of-flight instrument. Low- and high-resolution electron
impact (EI) mass spectra were recorded on an Autospec Premier
Micromass magnetic sector machine. Optical rotations were
recorded in CHCl3 at 208C on a Perkin–Elmer 343 polarimeter.
Melting points were measured on an Optimelt automated
melting point system and are uncorrected. Analytical thin layer
chromatography (TLC) was performed on aluminium-backed
0.2mm thick silica gel 60 F254 plates as supplied by Merck.
Eluted plates were visualized using a 254 nmUV lamp and/or by
treatment with a suitable dip followed by heating. These dips
included phosphomolybdic acid/ceric sulfate/concentrated sul-
furic acid/water (37.5 g : 7.5 g : 37.5 g : 720mL) or potassium
permanganate/potassium carbonate/5% sodium hydroxide
aqueous solution/water (3 g : 20 g : 5mL : 300mL). Flash chro-
matographic separations were carried out following protocols
defined by Still et al.[13] with silica gel 60 (40–63mm) as the
stationary phase and using the analytical reagent (AR)- or
HPLC-grade solvents indicated. Starting materials and reagents
were generally available from the Sigma-Aldrich, Merck,
Tokyo Chemical Industry Co., Ltd (TCI), StremChemicals Inc.,
or Lancaster, andwere used as supplied. Drying agents and other
inorganic salts were purchased from the AJAX, BDH, or Unilab
chemical companies. Diethyl ether (Et2O), N,N-dimethyl-
formamide (DMF), dichloromethane (CH2Cl2), and ethyl acetate
(EtOAc) were dried using a Glass Contour solvent purification
system that is based on a technology originally described by
Grubbs et al.[14] Where necessary, reactions were performed
under an inert atmosphere.
Specific Synthetic Transformations
Compound 5a: A magnetically stirred suspension of compound
1a (15.0 g, 78.5mmol) in Et2O/2,2-dimethoxypropane (2,2-
DMP) (200mL of a 1 : 1 v/v mixture) maintained at room tem-
perature was treated with p-toluenesulfonic acid (p-TsOH)
monohydrate (500mg, 2.6mmol, 0.03 molar equiv.). After 1 h,
the reaction mixture was quenched with NaHCO3 (200mL of a
saturated aqueous solution), and the separated aqueous phase
extracted with Et2O (3 200mL). The combined organic phases
were dried (Na2SO4), filtered, and concentrated under reduced
pressure, and the ensuing brown oil dissolved in CH2Cl2
(200mL). The solution thus obtained, and presumed to contain
acetonide 4a,[3] was cooled to,08C then treated, in one portion,
with m-CPBA (22.9 g, 102.1mmol, 1.3 molar equiv.). The reac-
tion mixture was then shaken vigorously for ,10 s before being
left to stand at 08C for 48 h with occasional shaking during this
period. The suspension thus obtainedwas filtered through a pad of
CeliteTM while still cold, and the filter pad was washed with cold
CH2Cl2 (2 50mL). The combined filtrates were washed with
Na2SO3 (150mL of a saturated aqueous solution) before being
dried (Na2SO4), filtered, and concentrated under reduced pressure
to yield epoxide 5a[3] (18.1 g, 93% over two steps) as a waxy,
white solid. This material, which was spectroscopically identical
to an authentic sample, was of sufficient purity to be used directly
in the reaction sequences described below.
Compound 2a: A magnetically stirred suspension of NaH
(60% dispersion in mineral oil, 2.41 g, 60.3mmol, 1.5 molar
equiv.) in DMF (300mL) was cooled to 08C while being
maintained under an atmosphere of nitrogen, then treated over
0.08 h with a solution of p-MBOH (8.33 g, 60.3mmol, 1.5 molar
equiv.) in DMF (50mL). After 1 h, the temperature of the
reaction mixture was lowered to 108C (ice–salt bath), and a
solution of epoxide 5a (9.93 g, 40.2mmol) in DMF (50mL) was
added to it over 0.08 h. The ensuing mixture was maintained at
108C for 1 h, and resulting the dark green solution was treated,
in one portion, with a chilled (,08C) solution of MOMCl
(13.7mL) in DMF (25mL). After a further 0.25 h, the reaction
mixture was quenched by slow addition of NaHCO3 (100mL
of a half-saturated aqueous solution), then diluted with Et2O
(300mL). The separated aqueous phase was washed with Et2O
(2 300mL), and the combined organic phases were dried
(Na2SO4), filtered, and concentrated under reduced pressure.
The residue thus obtained was subjected to flash chromato-
graphy (silica, 1 : 5 v/v EtOAc/petroleum spirit elution), and
concentration of the relevant fractions (RF 0.3 in 1 : 3 v/v EtOAc/
petroleum spirit) afforded diene 2a (8.66 g, 74%) as a clear,
colourless oil. [a]D 8.08 (c 0.5 in CHCl3). nmax (KBr)/cm1
2991, 2940, 2848, 1687, 1558, 1386, 1298, 1217, 1149, 1133,
1047, 1006, 855, 831, 791, 719. dH (C6D6, 400MHz) 5.76 (ddd,
J 10.0, 2.9, 0.5, 1H), 5.31 (dm, J 10.0, 1H), 4.95 (dm, J 12.0, 1H),
4.77 (dm, J 12.0, 1H), 4.71 (d, J 6.6, 1H), 4.51 (d, J 6.6, 1H), 3.14
(s, 3H), 1.28 (s, 3H), 0.99 (s, 3H). dC (C6D6, 101MHz) 151.2,
129.0, 123.9, 115.8, 95.6, 82.6, 79.8, 77.7, 55.2, 26.5, 24.1. m/z
(EI, 70 eV) 292 and 290 (28% and 33%, Mþ), 230 and 228 (44
and 42), 210 (81), 190 and 188 (98 and 100).m/z (EI) 290.0150;
Mþ requires 290.0154.
Compound 7a: A magnetically stirred solution of diene 2a
(100mg, 0.34mmol) in benzene (5mL) maintained at ,188C
was treated, in small portions, with PTAD until a red colour
persisted. The reaction mixture was concentrated under reduced
pressure and the residue so obtained was subjected to flash
chromatography (silica, 1 : 3 v/v EtOAc/petroleum spirit elu-
tion). Concentration of the relevant fractions (RF 0.25) afforded
a white foam that crystallized from CH2Cl2/hexane to give the
PTAD-adduct 7a (158mg, quantitative) as a white, crystalline
solid, mp 1198C (dec.). [a]D þ97.28 (c 0.5 in CHCl3). nmax
(KBr)/cm1 2937, 1784, 1727, 1575, 1501, 1398, 1225, 1164,
1040, 845, 763, 690. dH (C6D6, 400MHz) 7.48 (m, 2H), 7.01 (m,
2H), 6.93 (m, 1H), 5.93 (d, J 5.6, 1H), 4.97 (dd, J 5.6, 2.5, 1H),
4.26 (d, J 4.0, 1H), 4.22 (m, 1H), 4.20 (d, J 4.0, 1H), 3.92 (m,
1H), 2.95 (s, 3H), 1.77 (s, 3H), 1.25 (s, 3H). dC (C6D6, 101MHz)
156.4, 156.1, 132.0, 129.1, 127.0, 125.8, 118.6, 117.7, 95.9,
95.3, 87.8, 72.4, 56.4, 55.4, 27.6, 25.6 (one signal obscured or
overlapping). m/z (EI, 70 eV) 469 and 467 (both 16%, Mþ),
328 (22), 221 (23), 119 (100). m/z (EI) 467.0511; Mþ requires
467.0515.
Compound 3a: A magnetically stirred suspension of NaH
(60% dispersion in mineral oil, 12mg, 0.30mmol, 1.5 molar
equiv.) in DMF (3mL) maintained under a nitrogen atmosphere
was cooled to 08C, then treated dropwise with a solution of
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p-MBOH (42mg, 0.30mmol, 1.5 molar equiv.) in DMF (1mL).
After stirring at 08C for 1 h, the reaction mixture was cooled to
108C (ice–salt bath), and a solution of epoxide 5a (50mg,
0.20mmol) in DMF (1mL) was then added dropwise. After a
further 1 h (at108C), the resulting dark green reaction mixture
was treated, in one portion, with a chilled solution ofH2O (1mL)
in DMF (1mL). After stirring for a further 0.25 h, the reaction
mixture was quenched by slow addition of NaHCO3 (10mL of a
half-saturated aqueous solution). The ensuing mixture was
diluted with Et2O (20mL), and the separated aqueous phase
extracted with Et2O (2 20mL). The combined organic phases
were then dried (Na2SO4) before being concentrated under
reduced pressure. The residue thus obtained was subjected to
flash chromatography (silica, 1 : 3- 1 : 1 v/v EtOAc/petroleum
spirit gradient elution), and concentration of the relevant frac-
tions (RF 0.25 in 1 : 1 v/v EtOAc/petroleum spirit) afforded a
clear, light yellow and rather unstable oil presumed to contain
compound 8a. On standing in the fridge, crystals began to form
from this oil and after 48 h, the material was triturated with
hexane (2 5mL), and the solids retained after removal of the
solvent were dried under reduced pressure to afford bromoenone
3a (25mg, 60%) as a white, crystalline solid, mp 79.58C (dec.).
[a]D 29.28 (c 0.5 in CH3CN). nmax (KBr)/cm1 3372, 1698,
1601, 1383, 1297, 1110, 1072, 991, 848, 767, 614. dH (CDCl3,
400MHz) 7.37 (dd, J 6.8, 2.5, 1H), 4.18 (d, J 10.9, 1H), 3.99 (m,
1H), 3.73 (br s, 1H), 2.96 (br s, 1H), 2.87 (dt, J 18.7, 4.0, 1H),
2.56 (dddd, J 18.7, 10.0, 2.6, 0.6, 1H). dC (CDCl3, 101MHz)
192.0, 148.4, 120.6, 79.1, 71.4, 34.3. m/z (EI, 70 eV) 208 and
206 (both 8%, Mþ), 190 and 188 (both 18), 161 and 159 (both
22), 148 and 146 (47 and 49), 109 (100), 81 (96), 60 (86). m/z
(EI) 205.9582; Mþ requires 205.9579.
Compound 8a: A magnetically stirred solution of diisopro-
pylamine (252 mL, 1.82mmol) in dry THF (5mL) maintained at
08C was treated with n-BuLi (1.14mL of a 1.6M solution in
hexane, 1.82mmol). The resulting solutionwas stirred at 08C for
0.5 h then cooled at108Cand treated, dropwise, with a solution
of epoxide 5a (300mg, 1.20mmol) in THF (5mL). After 1 h, the
yellow reaction mixture was treated, in one portion, with a
chilled solution ofMOMBr (390mL, 4.80mmol) in THF (5mL).
After a further 0.25 h, the reaction mixture was quenched by
slow addition of NaHCO3 (20mL of a half-saturated aqueous
solution). The resulting mixture was diluted with Et2O (40mL)
and the separated aqueous phase extracted with Et2O
(1 40mL). The combined organic layerswere dried (Na2SO4),
filtered, and concentrated under reduced pressure, and the
ensuing yellow oil was subjected to chromatography (silica,
1 : 4 v/v ethyl acetate/hexane elution) to afford, after concentra-
tion of the relevant fractions (RF 0.6), compound 8a (150mg,
50%) as a clear, colourless oil. [a]D 45.08 (c 1.0 in CHCl3).
nmax (KBr)/cm
1 3400, 2990, 2848, 1686, 1586, 1454, 1385,
1299, 1217, 1133, 1067, 979, 951, 854, 828, 792, 719, 691. dH
(C6D6, 400MHz) 5.70 (dd, J 10.0, 2.9, 1H), 5.17 (dm, J 10.0,
1H), 4.72 (d, J 12.9, 1H), 4.51 (br d, J 12.9, 1H), 1.81 (br s, 1H),
1.31 (s, 3H), 1.01 (s, 3H). dC (CDCl3, 101MHz) 151.4, 128.6,
125.7, 115.9, 83.7, 79.9, 73.8, 26.5, 24.2. m/z (EI, 70 eV) 248
and 246 (both 30%, Mþ), 190 and 188 (both 33), 109 (34), 81
(100). m/z (EI) 245.9894; Mþ requires 245.9892.
Compound 9a: A solution of diene 8a (10mg, 0.04mmol) in
C6D6 (750 mL) was allowed to stand in an NMR tube for 48 h
then concentrated under reduced pressure. The resulting white
solid was subjected to flash chromatography (silica, 1 : 1 v/v
EtOAc/petroleum spirit - EtOAc gradient elution), thus
affording two fractions, A and B.
Concentration of fraction A (RF 0.6 in 1 : 1 v/v EtOAc/
petroleum spirit) afforded compound 9a (3.3mg, 33%) as a
clear, colourless oil. [a]D168.58 (c 0.17 inCHCl3). nmax (KBr)/
cm1 3048, 2984, 1711, 1578, 1382, 1371, 1226, 1138, 1090,
1047, 864, 835, 791, 640. dH (C6D6, 400MHz) 6.15 (dd, J 6.3,
2.4, 1H), 3.39 (d, J 10.8, 1H), 3.27 (app. td, J 10.8, 4.7, 1H), 1.86
(ddd, J 17.3, 6.3, 4.7, 1H), 1.57 (ddd, J 17.3, 9.9, 2.4, 1H), 1.24
(s, 6H). dC (C6D6, 101MHz) 185.4, 144.1, 124.0, 112.2, 82.1,
74.7, 33.1, 27.0, 26.5.m/z (ESIþ) 271 and 269 (98% and 100%,
(M þ Na)þ). m/z (ESI) 268.9788; calcd for C9H1179BrNaO3
268.9784.
Concentration of fraction B (RF 0.1 in 1 : 1 v/v EtOAc/
petroleum spirit) afforded compound 3a (4.5mg, 54%) as a
white, crystalline solid that was identical, in all respects, to the
material obtained as described above.
Compound 5b: The commercially available cis-1,2-
dihydrocatechol 1b was converted into the previously
reported[8] epoxide 5b using essentially the same procedure as
described above for the conversion of 1a into 5a. By such
means the title compound was obtained in 87% yield as
a white, crystalline solid, mp 59–608C. This material was
identical, in all respects, to an authentic sample.
Compound 3b: The transformation of epoxide 5b into
chloroenone 3b was conducted on a 50-mg scale under exactly
the same conditions as those used for the conversion of 5a into
3a. Compound 3b (25mg, 63%) was thereby obtained as a
white, crystalline solid, mp 84.68C (dec.). [a]D 42.28 (c 0.4 in
CHCl3). nmax (KBr)/cm
1 3389, 1700, 1610, 1424, 1329, 1117,
1074, 999, 922, 856, 785, 626. dH (CDCl3, 400MHz) 7.12 (m,
1H), 4.17 (d, J 10.8, 1H), 4.02–3.95 (complexm, 1H), 3.68 (br s,
1H), 2.90 (ddd, J 18.7, 6.8, 5.5, 1H), 2.90 (br s, 1H), 2.60 (ddd,
J 18.7, 10.0, 2.5, 1H). dC (CDCl3, 101MHz) 191.8, 144.1, 130.1,
79.2, 71.5, 32.6. m/z (EI, 70 eV) 164 and 162 (8% and 25%,
Mþ), 144 (29), 133 (45), 116 (75), 115 (68), 81 (63), 60 (100).
m/z (EI) 164.0055; Mþ requires 164.0054.
X-Ray Crystallographic Studies
Crystallographic Data
Compound 3a: C6H7BrO3,M 207.02, monoclinic, space group
C2, a 30.3600(15), b 5.0235(1), c 22.5219(11) A˚,b 124.000(8)8,
V 2847.7(3) A˚3, Z 16, Dc 1.931 g cm
3, T 150K, 2ymax 1448,
4536 unique data, R 0.019 (for 4469 reflections with I. 2.0s(I)),
wR 0.049 (all data), S 1.00.
Compound 7a: C19H20BrN3O6, M 466.29, orthorhombic,
space groupP212121, a 8.8590(1), b 10.8990(1), c 20.9314(1) A˚,
V 2021.02(3) A˚3, Z 4, Dc 1.532 g cm
3, T 150K, 2ymax
1448, 3965 unique data, R 0.022 (for 3911 reflections with
I. 2.0s(I)), wR 0.057 (all data), S 1.00.
Structure Determinations
Images were measured on an Agilent SuperNova CCD dif-
fractometer (CuKa, mirror monochromator, l 1.54184 A˚) and
data were extracted using the CrysAlis package.[15] Structure
solution was by direct methods (SIR92).[16] The structures of
compounds 3a and 7a were refined using the CRYSTALS pro-
gram package.[17] Atomic coordinates, bond lengths and angles,
and displacement parameters have been deposited at the
Cambridge Crystallographic Data Centre (CCDC nos 1045882
and 1045883 for compounds 3a and 7a, respectively). These
data can be obtained free of charge via www.ccdc.cam.ac.uk/
data_request/cif (or from the Cambridge Crystallographic Data
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Centre, 12 Union Road, Cambridge CB2 1EZ, UK; fax: þ44
1223 336 033; email: data_request@ccdc.cam.ac.uk).
Supplementary Material
The anisotropic displacement ellipsoid plot derived from the
single-crystal X-ray structure of compound 3a together with the
1H and 13C NMR spectra of compounds 2a, 3a, 3b, 7a, 8a, and
9a are available on the Journal’s website.
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 S2 
 
 
 
Figure S1: Structure of molecule 1 of compound 3a (CCDC 1045882) with labelling of selected 
atoms. Anisotropic displacement ellipsoids show 30% probability levels. Hydrogen atoms are 
drawn as circles with small radii. 
 
 
 
Figure S2: Structure of molecule 2 of compound 3a (CCDC 1045882) with labelling of selected 
atoms and showing the disorder (Br18, occupancy 0.87;  Br181, occupancy 0.13). Anisotropic 
displacement ellipsoids show 30% probability levels. Hydrogen atoms are drawn as circles with 
small radii. 
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 S3 
 
 
 
Figure S3: Structure of molecule 3 of compound 3a (CCDC 1045882) with labelling of selected 
atoms. Anisotropic displacement ellipsoids show 30% probability levels. Hydrogen atoms are 
drawn as circles with small radii. 
 
 
 
 
Figure S4: Structure of molecule 4 of compound 3a (CCDC 1045882) with labelling of selected 
atoms. Anisotropic displacement ellipsoids show 30% probability levels. Hydrogen atoms are 
drawn as circles with small radii. 
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The Conversion of Levoglucosenone into
Isolevoglucosenone*
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Levoglucosenone (1), a compound that will soon be available in tonne quantities through the pyrolysis of acid-treated
lignocellulosic biomass, has been converted into isolevoglucosenone (2) using Wharton rearrangement chemistry.
Treatment of compound 1 with alkaline hydrogen peroxide gave the g-lactones 5 and 6 rather than the required epoxy-
ketones 3 and/or 4. However, the latter pair of compounds could be obtained by an initial Luche reduction of compound 1,
electrophilic epoxidation of the resulting allylic alcohol 8 and oxidation of the product oxiranes 9 and 10. Independent
treatment of compounds 3 and 4 with hydrazine then acetic acid followed by oxidation of the ensuing allylic alcohols
finally afforded isolevoglucosenone (2). Details of the single-crystal X-ray analyses of epoxy-alcohols 9 and 10 are
reported.
Manuscript received: 18 September 2014.
Manuscript accepted: 15 October 2014.
Published online: 27 January 2015.
Introduction
The pyrolysis ofmineral acid-impregnatedwaste paper provides
a means for generating the 1,6-anhydro-bridged monosaccha-
ride derivative levoglucosenone (1).[1] Indeed, recent refine-
ments of this now rather well-known process mean that
compound 1 will soon be produced in tonne quantities under
pilot plant conditions.[2] Given its origins, chirality, and asso-
ciated functionalities, levoglucosenone is receiving increasing
attention as a sustainably produced and potentially versatile
chiral pool material. Indeed, over the preceding 30 years or so, it
has received significant attention as a starting material in the
chemical synthesis of a range of target compounds including
various biologically active natural products, sugarmimetics, and
agrochemicals. Much of the work in the area has been reviewed
recently.[3] The quasi-enantiomerically related[4] compound
isolevoglucosenone (2),[3a,5] which can be obtained from
D-glucose in four chemical steps,[5b] has received less attention
as a starting point in chemical synthesis, perhaps in part because
its preparation by the means just mentioned has been described
as ‘labour intensive’.[6] Accordingly, the development of simple
methods for effecting the conversion 1- 2 is likely to be useful.
The first attempts to do so were reported in 1986 by Furneaux
and coworkers[7] who demonstrated that the product arising from
the conjugate addition of benzyl alcohol to compound 1 could be
elaborated over a further five steps into isomer 2. More recently,
Witczak et al.[6] detailed a four-step sequence involving, as the
pivotal transformation, a 2,3-sigmatropic rearrangement of an
allylic selenide as a means for effecting the conversion 1- 2.
The Wharton rearrangement reaction often provides a
concise, inexpensive, and operationally simple means for effect-
ing, via the corresponding epoxy-ketones, the 1,3-transposition
of a,b-unsaturated enones.[8] However, this protocol does not
appear to have been explored as a means for converting levoglu-
cosenone into congener 2. Accordingly, we sought to examine
such possibilities and now detail syntheses of the relevant and
stereoisomeric epoxy-ketones 3 and 4 (from compound 1) and
report on their participation in the Wharton rearrangement
reaction (Chart 1).[3]
Results and Discussion
In initial attempts to form epoxy-ketone 3 and/or its isomer 4,
a methanolic solution of levoglucosenone (1) was treated at 08C
with a mixture of aqueous hydrogen peroxide and sodium
hydroxide (Scheme 1). Thin-layer chromatographic analysis of
the reaction mixture after just 0.5 h revealed essentially com-
plete consumption of the starting material and the more-or-less
exclusive formation of a chromatographically less mobile and
*Dedicated to the memory of Sir John ‘Kappa’ Cornforth, a legendary scientist and an inspirational human being.
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non-chromophoric product. After aqueous workup and chro-
matographic purification, a crystalline product was obtained,
and single-crystal X-ray analysis revealed it to be the ether 5[9]
(64%). This presumably arises from conjugate addition of the
elements of methanol to substrate 1 and with the stereochemical
course of the reaction being dictated by the steric demands of
the 1,6-anhydro-bridge that ensure preferential delivery of any
nucleophiles to the a-face of the enone system.
In another attempt to effect the conversion 1- 3 and/or 4,
the first of these compounds was treated with the same reagents
as defined above but now at ambient temperatures and for a
period of 336 h. Such conditions were investigated on the basis
that the formation of ether 5 from levoglucosenone might be a
reversible process and that there could, therefore, be a low
steady-state concentration of the latter compound present in the
reaction mixture that was available to engage in the desired
nucleophilic epoxidation process. In the event, however, the
only products isolated from the reactionmixture proved to be the
previously reported hydroxymethylated butenolide 6[10] (13%)
and the related methanol addition product 7[11] (4%). The
former product is presumably derived from a Baeyer–Villiger
type oxidation of substrate 1 to give an internal ortho-ester
that is itself hydrolyzed under the alkaline conditions. After
g-lactonization and loss of C1 (levoglucosenone numbering) as
a formate ion compound 6 would then be formed. Interestingly,
the present work appears to represent the first time compound 6
has been reported to be formed directly from levoglucosenone
rather than by a two-step process as described byKoseki et al.[10]
That having been said, the latter process is much more efficient.
In light of our inability to prepare epoxy-ketones 3 and/or
4 by direct nucleophilic epoxidation of levoglucosenone, we
elected to apply electrophilic protocols for this same purpose. To
such ends, and as shown in Scheme 2, enone 1 was reduced
under Luche conditions to give, in an almost completely
stereoselective manner, the previously reported allylic alcohol
8[1,12] that was obtained in 91% yield as a white, crystalline
solid.
Epoxidation of the latter compound using m-chloroperben-
zoic acid (m-CPBA) in dichloromethane afforded a chromato-
graphically separable mixture of the diastereoisomeric epoxy
alcohols 9[13] (56%) and 10[12,13] (31%), the structures of which
were both established by single-crystal X-ray analyses.[14]
Clearly, the ‘blocking’ effect of the 1,6-anhydro-bridge within
substrate 8 results in the preferential formation of the a-epoxide
9 although this does not completely overwhelm the directing
capacities of the hydroxyl group with the result that reasonably
significant quantities of the b-epoxide 10 are still formed.
A completely diastereoselective electrophilic epoxidation
reaction was observed (Scheme 3) when the readily derived
acetate 11[15] (90%) of allylic alcohol 8 was subjected to
reaction with m-CPBA in dichloromethane. Specifically, in
the absence of any possible hydroxyl-based directing effects,
the epoxy-acetate 12[15] (73%) is obtained as the only isolable
product of reaction and its structure follows from its conversion
into epoxy-alcohol 9 (96%) on exposure to potassium carbonate
in methanol.
In agreement with earlier observations,[13] compounds 9 and
10 proved to be rather stable species that showed little or no
propensity, at least upon manipulation in organic solvents under
non-basic conditions, to engage in Payne rearrangement reac-
tions and thereby affording the isomeric and so-called Cˇerny´
epoxides.[16] Gratifyingly, when the former compound was
subjected to reaction (Scheme 4) with the Dess–Martin period-
inane (DMP) in dichloromethane containing 10 molar equiva-
lents (with respect to 9) of pyridine, the anticipated epoxy-ketone
3[17] was obtained as a white, crystalline solid in 98% yield.
Treatment of the latter with hydrazine and, after 1 h, with acetic
acid (AcOH) and then allowing the resulting mixture to stand at
room temperature for 24 h afforded a chromatographically
separable mixture of the saturated alcohol 13[18] (23%) and the
anticipated allylic alcohol 14[9] (21%), the structure of which
was confirmed by single-crystal X-ray analysis. The yield of
the latter product could be increased to 45% by reducing the
standing time of the reaction to 2 h.
Product 13 is thought to arise because the precursor epoxy-
ketone 3 contained, despite extensive efforts to remove them,
O
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traces of DMP that oxidizes the hydrazine to di-imide, which
reduces the C¼C bond of the primary product 14 to its saturated
counterpart (i.e. 13). Presumably, the reduced form of the
DMP generated in this process is ‘recycled’ by atmospheric
oxygen.[19] In keeping with such proposals, when a sample
of pure allylic alcohol 14 was treated in a vessel open to the air
with a combination of hydrazine, acetic acid, and 2mol-%
DMP at ambient temperatures for 48 h, compound 13 was
obtained in a yield of 77% (at 62% conversion) after column
chromatography.
The completion of the synthesis of isolevoglucosenone from
epoxy-ketone 3 (Scheme 4) simply involved treating the allylic
alcohol 14 with a suspension of manganese dioxide[20] and 4 A˚
molecular sieves in dichloromethane at 188C for 24 h. After
flash column chromatography, the target enone 2[5–7,21] was
obtained in 65% yield as a clear, colourless oil. The derived
spectral data were in good agreement with those reported
previously. In particular, the NMR data (Table 1) derived from
the material prepared by the route described here proved an
excellent match with those reported[21] by Ogasawara and
coworkers for samples of (þ)-isolevoglucoseone (2) obtained
from 2-vinylfuran using Sharpless asymmetric dihydroxylation
protocols.
The conversion of the epoxy-alcohol 10 into enone 2 fol-
lowed the same pathway (Scheme 5) as used above. Specifical-
ly, the former compound was oxidized to the corresponding and
previously reported epoxy-ketone 4[17] usingDMP and the latter
was then subjected to a Wharton rearrangement reaction by
successive treatment with hydrazine then acetic acid. In keeping
with earlier observations, the use of an extended (24 h) reaction
time led to a chromatographically separable mixture of the
saturated alcohol 15[18] (61%) and its (targeted) unsaturated
counterpart 16[5] (7%). However the latter product could be
obtained as the essentially exclusive product of reaction (57%)
if a shorter reaction period (1 h) was used. Oxidation of com-
pound 16 with manganese dioxide in the presence of 4 A˚
molecular sieves then gave isolevoglucosenone (2), this time
in 62% yield.
Conclusions
A relatively straightforward five-step method for converting
potentially abundant levoglucosenone (1) into isomer 2 has been
developed. The pivotal transformation is the Wharton rear-
rangement of epoxy-ketones 3 and 4 that cannot be formed
directly from compound 1 using nucleophilic epoxidation
procedures because of the intervention of competing Baeyer–
Villiger oxidation reactions. As such, electrophilic epoxidation
of the allylic alcohol 8 derived by 1,2-reduction of compound 1
and oxidation of the resulting epoxy-alcohols was used as the
means for obtaining the necessary epoxy-ketones 3 and 4.
Though all of the compounds described herein have been the
subjects of previous reports, the described reaction sequences
provide a new route to isolevoglucosenone (2) that employs
simple and conventional reagents and with these being deployed
under operationally straightforward conditions. As such, and
given the ease of access to precursor 1, compound 2 should now
be more readily available as a chiron for assembling a range of
biologically relevant molecules.
Experimental
General Experimental Procedures
Unless otherwise specified, proton (1H) and carbon (13C) NMR
spectra were recorded at 188C in base-filtered CDCl3 on a
Varian spectrometer operating at 400 or 500MHz for proton and
O
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Table 1. Comparison of the 13C and 1H NMR data recorded for
isolevoglucosenone (2) obtained by the pathway reported here with
those reported by Ogasawara
13C NMR data for
compound 2 (dC)
1H NMR data for
compound 2 (dH)
Present
workA
OgasawaraB Present workC OgasawaraD
194.5 194.7 7.13 (dd, J 9.8, 3.4, 1H) 7.14 (dd, J 9.9, 3.3, 1H)
147.3 147.5 6.11 (d, J 9.8, 1H) 6.11 (dt, J 9.9, 1.1, 1H)
127.1 127.1 5.81 (d, J 3.4, 1H) 5.82 (dd, J 3.3, 0.5, 1H)
96.1 96.0 4.78 (d, J 6.3, 1H) 4.79 (dt, J 6.3, 1.4, 1H)
79.6 79.6 4.11 (m, 1H) 4.12 (dd, J 8.2, 6.3, 1H)
62.7 62.6 3.66 (dm, J 6.3, 1H) 3.66 (dd, J 8.2, 1.4, 1H)
AData recorded in CDCl3 at 125MHz.
BData obtained from ref. [21a] and recorded in CDCl3 at 150MHz.
CData recorded in CDCl3 at 500MHz.
DData obtained from ref. [21a] and recorded in CDCl3 at 300MHz.
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100 or 125MHz for carbon nuclei. For 1H NMR spectra, signals
arising from the residual protio forms of the solvent were used as
the internal standards. 1H NMR data are recorded as follows:
chemical shift (d) (multiplicity, coupling constant(s) J (Hz),
relative integral), where multiplicity is defined as s¼ singlet,
d¼ doublet, t¼ triplet, q¼ quartet, m¼multiplet, or combina-
tions of the above. The signal due to residual CHCl3 appearing
at dH 7.26 and the central resonance of the CDCl3 ‘triplet’
appearing at dC 77.0 were used to reference
1H and 13C NMR
spectra, respectively. Infrared spectra (nmax) were recorded on a
Perkin–Elmer 1800 Series FTIR spectrometer. Samples were
analyzed as thin films on KBr plates. Low-resolution electro-
spray ionization (ESI) mass spectra were recorded on a Micro-
mass LC-ZMD single quadrupole liquid chromatograph–mass
spectrometer, whereas high-resolution measurements were
conducted on an LCT Premier time-of-flight instrument. Low-
and high-resolution electron impact (EI) mass spectra were
recorded on an Autospec Premier Micromass magnetic-sector
machine. Optical rotations were recorded in CHCl3 at 208C on a
Perkin–Elmer 343 Polarimeter. Melting points were measured
on an Optimelt automated melting point system and are
uncorrected. Analytical thin-layer chromatography (TLC) was
performed on aluminium-backed 0.2mm thick silica gel 60 F254
plates as supplied byMerck. Eluted plates were visualized using
a 254 nm UV lamp and/or by treatment with a suitable dip
followed by heating. These dips included phosphomolybdic
acid : ceric sulfate : sulfuric acid (concentrated) : water
(37.5 g : 7.5 g : 37.5 g : 720mL) or potassium permanganate :
potassium carbonate : 5% sodium hydroxide aqueous solu-
tion : water (3 g : 20 g : 5mL : 300mL). Flash chromatographic
separations were carried out following protocols defined by Still
et al.[22] with silica gel 60 (40–63mm) as the stationary phase
and using the analytical reagent (AR)- or HPLC-grade solvents
indicated. Starting materials and reagents were generally
available fromSigma–Aldrich,Merck, TCI, Strem, or Lancaster
Chemical Companies and were used as supplied. Drying agents
and other inorganic salts were purchased from AJAX, BDH, or
Unilab Chemical Companies. Tetrahydrofuran (THF), metha-
nol, and dichloromethane were dried using a Glass ContourTM
solvent purification system that is based on a technology orig-
inally described by Grubbs et al.[23] Where necessary, reactions
were performed under an inert atmosphere.
Specific Synthetic Transformations
Compound 5: A magnetically stirred solution of levoglucose-
none (1) (100mg, 0.79mmol) in methanol (5mL) was cooled to
08C then treated with hydrogen peroxide (240 mL of a 9.79M
aqueous solution, 2.37mmol) and sodium hydroxide (5 drops of
a 5M aqueous solution). After 0.5 h, the reaction mixture was
diluted with water (5mL) and extracted with ethyl acetate
(3 20mL). The combined organic phases were then dried
(Na2SO4), filtered, and concentrated under reduced pressure.
The yellow residue thus obtained was subjected to flash chro-
matography (silica, 1 : 2 v/v acetone/hexane elution) and con-
centration of the relevant fractions (RF 0.4) gave compound 5
[9]
(81mg, 64%) as awhite, crystalline solid,mp 94.5–95.98C. nmax
(KBr)/cm1 2974, 2908, 2831, 1742, 1210, 1118, 1088, 969,
909, 897, 484. dH (CDCl3, 400MHz) 5.14 (s, 1H), 4.80 (m, 1H),
3.97 (dd, J 7.9, 5.6, 1H), 3.89 (d, J 7.9, 1H), 3.74 (d, J 5.8, 1H),
3.41 (s, 3H), 2.72 (dd, J 17.1, 5.8, 1H), 2.57 (d, J 17.1, 1H). dC
(CDCl3, 100MHz) 198.1, 101.3, 78.6, 74.4, 65.1, 56.6, 36.9.m/z
(ESI,þve) 197 (13%, [MþK]þ), 181 (100%, [MþNa]þ), 159
(79%, [MþH]þ).m/z (HRMSESI (þve)) 181.0447; [MþNa]þ
requires 181.0447.
Compounds 6 and 7: A magnetically stirred solution of
compound 1 (200mg, 1.59mmol) in methanol (5mL) main-
tained at 188Cwas treated with H2O2 (250 mL of a 30% aqueous
solution, 7.93mmol) then NaOH (175 mL of a 0.5M aqueous
solution). After 72 h, additional amounts of H2O2 (100 mL of a
30% aqueous solution, 3.18mmol) andNaOH (70mL of a 0.5M
aqueous solution) were introduced, and stirring continued for a
further 336 h before the reaction mixture was concentrated
under reduced pressure. The light yellow residue obtained was
subjected to flash chromatography (silica, 5 : 4 v/v ethyl acetate/
hexane- 5 : 4 : 0.5 v/v/v ethyl acetate/hexane/methanol gradi-
ent elution) afforded two fractions A and B.
Concentration of fraction A (RF 0.5 in 7 : 2 : 1 v/v/v ethyl
acetate/hexane/methanol) provided compound 7[11] (10mg,
4%) as a light yellow oil. nmax (KBr)/cm
1 3426, 2937, 2834,
1770, 1634, 1368, 1181, 1094, 935. dH (CDCl3, 400MHz) 4.50
(m, 1H), 4.12 (m, 1H), 3.95 (dd, J 12.7, 2.9, 1H), 3.75 (dm, J
12.7, 1H), 3.35 (s, 3H), 2.88 (dm, J 17.1, 1H), 2.55 (dd, J 17.1,
2.9, 1H), 2.40 (broad s, 1H). dC (CDCl3, 125MHz) 175.9 (C),
85.3 (CH), 77.6 (CH), 62.5 (CH2), 56.7 (CH3), 35.4 (CH2). m/z
(ESI, þve) 169 (100%, [M þ Na]þ). m/z (HRMS ESI (þve))
169.0477; [M þ Na]þ requires 169.0477.
Concentration of fraction B (RF 0.4 in 7 : 2 : 1 v/v/v ethyl
acetate/hexane/methanol) provided compound 6[10] (24mg,
13%) as a light yellow oil. nmax (KBr)/cm
1 3400, 2932,
1745, 1602, 1331, 1170, 1112, 1080, 1053, 862, 820. dH (CDCl3,
500MHz) 7.49 (m, 1H), 6.19 (m, 1H), 5.16 (m, 1H), 4.00 (dm, J
12.2, 1H), 3.78 (dd, J 12.2, 4.8, 1H), 2.64 (s, 1H). dC (CDCl3,
75MHz) 173.2 (C), 153.6 (CH), 122.9 (CH), 84.1 (CH), 62.3
(CH2). m/z (EI, 70 eV) 84 (100%, [MHOCH2]þ). m/z
(HRMS ESI (þve)) 137.0215; [M þ Na]þ requires 137.0215.
Compound 8: A solution of compound 1 (1.00 g, 7.93mmol)
in methanol (25mL) maintained at 08C was treated with
CeCl37H2O (3.00 g, 8.05mmol) then (cautiously) with NaBH4
(300mg, 7.93mmol). After stirring for 1 h, the reaction mixture
was concentrated under reduced pressure and the residue thus
obtained was subjected to flash chromatography (silica, 2 : 1 v/v
ethyl acetate/hexane elution). Concentration of the appropriate
fractions (RF 0.5 in 5 : 4 : 1 v/v/v ethyl acetate/hexane/methanol)
afforded compound 8[12] (922mg, 91%) as a white, crystalline
solid, mp 64–668C (lit. 65.6–66.48C[12]). nmax (KBr)/cm
1 3402,
2956, 2891, 1638, 1402, 1347, 1122, 1066, 1045, 979, 821. dH
(CDCl3, 500MHz) 6.10 (dddd, J 9.8, 5.4, 4.4, 1.0, 1H), 5.70 (m,
1H), 5.50 (m, 1H), 4.65 (t, J 4.4, 1H), 4.32 (m, 1H), 3.83 (d, J 6.4,
1H), 3.74 (m, 1H), 2.13 (s, 1H). dC (CDCl3, 125MHz) 130.7
(CH), 129.1 (CH), 101.2 (CH), 71.1 (CH), 70.6 (CH2), 68.7
(CH).m/z (ESI,þve) 151 (100%, [MþNa]þ).m/z (HRMS ESI
(þve)) 151.0371; [M þ Na]þ requires 151.0371.
Compounds 9 and 10: m-CPBA (5.20 g of material of 77%
purity, 23.20mmol) was added to amagnetically stirred solution
of compound 8 (740mg, 5.78mmol) in dichloromethane
(80mL) maintained at 188C. After 96 h, the reaction mixture
was concentrated under reduced pressure and the residue so
obtained subjected to flash chromatography (silica, 1 : 1 v/v
ethyl acetate/hexane - 5 : 4 : 0.3 v/v/v ethyl acetate/hexane/
methanol gradient elution) to deliver two fractions, A and B.
Concentration of fraction A (RF 0.5 in 6 : 3 : 1 v/v/v ethyl
acetate/hexane/methanol) gave compound 10[12,13] (259mg,
31%) as a white, crystalline solid, mp 71–738C (lit. 74.0–
75.28C[12]). [a]D 568 (c 0.5 in methanol). nmax (KBr)/cm1
3365, 2960, 2900, 1423, 1245, 1147, 1063, 973, 916, 816. dH
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(CDCl3, 500MHz) 5.29 (d, J 3.4, 1H), 4.81 (t, J 4.9, 1H), 3.99 (d,
J 6.9, 1H), 3.78 (m, 2H), 3.55 (m, 1H), 3.33 (m, 1H), 2.34 (d, J
9.0, 1H). dC (CDCl3, 125MHz) 97.8 (CH), 71.7 (CH), 66.5
(CH), 63.9 (CH2), 57.3 (CH), 50.2 (CH). m/z (ESI, þve) 167
(100%, [M þ Na]þ. m/z (HRMS ESI (þve)) 167.0320; [M þ
Na]þ requires 167.0320.
Concentration of fraction B (RF 0.4 in 6 : 3 : 1 v/v/v ethyl
acetate/hexane/methanol) gave compound 9[13] (466mg, 56%)
as a white, crystalline solid, mp 158–1608C. [a]D 1298 (c 0.5
in methanol). nmax (KBr)/cm
1 3386, 2973, 2907, 1489, 1414,
1084, 1053, 974, 948, 874, 808, 468. dH (CDCl3, 500MHz) 5.32
(m, 1H), 4.73 (d, J 3.9, 1H), 4.05 (d, J 7.3, 1H), 3.87–3.83
(complexm, 2H), 3.13 (d, J 3.9, 1H), 3.00 (m, 1H), 2.36 (d, J 9.0,
1H). dC (CDCl3, 125MHz) 99.1 (CH), 69.8 (CH), 67.3 (CH2),
65.0 (CH), 51.0 (CH), 50.0 (CH). m/z (ESI, þve) 167 (100%,
[M þ Na]þ. m/z (HRMS ESI (þve)) 167.0320; [M þ Na]þ
requires 167.0320.
Compound 11: A magnetically stirred solution of compound
8 (166mg, 1.30mmol) in pyridine (5mL) maintained at 188C
was treated with acetic anhydride (Ac2O; 500mL, 5.29mmol)
and 4-dimethylaminopyridine (DMAP; 20mg, 0.164mmol).
After 18 h, the reaction mixture was concentrated under reduced
pressure and the resulting light yellow oil was subjected to flash
chromatography (silica, 1 : 1 v/v ethyl acetate/hexane elution).
Concentration of the appropriate fractions (RF 0.5 in 4 : 2.5 : 5.5
v/v/v ethyl acetate/dichloromethane/hexane) afforded com-
pound 11[15] (198mg, 90%) as a clear, colourless oil. [a]D
608 (c 0.4 in methanol). nmax (KBr)/cm1 2965, 2891, 1732,
1372, 1237, 1125, 1043, 983, 900, 884. dH (CDCl3, 500MHz)
6.19 (m, 1H), 5.62 (m, 2H), 5.50 (s, 1H), 4.68 (m, 1H), 3.97 (d, J
6.4, 1H), 3.79 (m, 1H), 2.12 (s, 3H). dC (CDCl3, 125MHz) 170.7
(C), 132.4 (CH), 124.7 (CH), 99.1 (CH), 71.6 (CH), 71.4 (CH2),
71.3 (CH), 21.0 (CH3).m/z (ESI,þve) 193 (100%, [MþNa]þ).
m/z (HRMS ESI (þve)) 193.0470; [M þ Na]þ requires
193.0477.
Compound 12: A magnetically stirred solution of compound
11 (186mg, 1.09mmol) in dichloromethane (20mL) was trea-
ted with m-CPBA (980mg of material of 77% purity,
4.37mmol) and anhydrous NaHCO3 (735mg, 8.75mmol).
After stirring at 188C for 120 h, the reaction mixture was filtered
through a short pad of CeliteTM and the filtrate concentrated
under reduced pressure. The light yellow residue thus obtained
was subjected to flash chromatography (silica, 2 : 1 v/v ethyl
acetate/hexane elution) to afford, after concentration of the
appropriate fractions (RF 0.4 in 8 : 2.5 : 5.5 v/v/v ethyl acetate/
dichloromethane/hexane), compound 12[15] (149mg, 73%) as a
white, crystalline solid, mp 65–678C (lit. 688C[15]). [a]D 1428
(c 0.5 in methanol). nmax (KBr)/cm
1 2969, 2899, 1740, 1435,
1372, 1234, 1142, 1055, 981, 904, 882, 821, 802. dH (CDCl3,
500MHz) 5.44 (m, 1H), 4.86 (m, 1H), 4.75 (d, J 4.4, 1H), 4.13
(d, J 6.3, 1H), 3.89 (m, 1H), 3.16 (m, 1H), 3.01 (m, 1H), 2.15 (s,
3H). dC (CDCl3, 125MHz) 169.8 (C), 97.0 (CH), 69.8 (CH),
67.4 (CH2), 67.1 (CH), 49.7 (CH), 49.2 (CH), 20.8 (CH3). m/z
(ESI, þve) 209 (100%, [M þ Na]þ). m/z (HRMS ESI (þve))
209.0426; [M þ Na]þ requires 209.0426.
Compound 9: A solution of compound 12 (226mg,
1.21mmol) inmethanol (10mL)maintained at 188Cwas treated
with anhydrous K2CO3 (503mg, 3.64mmol) and the ensuing
mixture stirred magnetically for 2 h then filtered through a short
pad of CeliteTM. The filtrate was concentrated under reduced
pressure and the residue subjected to flash chromatography
(silica, 2 : 1 v/v ethyl acetate/hexane elution). Concentration
of the appropriate fractions (RF 0.4 in 8 : 2.5 : 5.5 v/v/v
ethyl acetate/dichloromethane/hexane) afforded compound 9
(168mg, 96%) as a white, crystalline solid that was identical,
in all aspects, to the material obtained from the conversion 8-
9 þ 10.
Compound 3: A solution of compound 9 (466mg,
3.23mmol) in dichloromethane (40mL) was treated with pyri-
dine (2.6mL, 32.14mmol) then with DMP (2.06 g, 4.86mmol)
and the resulting solution stirred at 188C for 18 h before being
concentrated under reduced pressure. Subjection of the resulting
light yellow oil to flash chromatography (silica, 5 : 4 : 0.5 v/v/v
ethyl acetate//hexane/methanol elution) afforded, after concen-
tration of the appropriate fractions (RF 0.5 in 7 : 2 : 1 v/v/v ethyl
acetate/hexane/methanol), compound 3[17] (449mg, 98%) as a
white, crystalline solid, mp 95–968C. [a]D 1938 (c 0.5 in
methanol). nmax (KBr)/cm
1 2971, 2905, 1744, 1407, 1350,
1140, 1103, 1083, 973, 951, 878, 809. dH (CDCl3, 500MHz)
5.17 (d, J 1.9, 1H), 4.99 (m, 1H), 4.04 (d, J 7.3, 1H), 3.89 (m,
1H), 3.51 (m, 1H), 3.30 (m, 1H). dC (CDCl3, 125MHz) 192.0
(C), 99.8 (CH), 70.2 (CH), 65.1 (CH2), 49.9 (CH), 49.1 (CH).
m/z (EI, 70 eV) 141 (3%, [MH]þ), 114 (12), 101 (23), 85
(23), 84 (31), 72 (63), 71 (56), 69 (48), 68 (57), 57 (100). m/z
(HRMS ESI (þve)) 141.0188; [MH]þ requires 141.0188.
Compounds 13 and 14: A magnetically stirred solution of
compound 3 (122mg, 0.86mmol) in methanol (10mL) main-
tained at 188Cwas treated dropwise with hydrazine (3.4mL of a
1.0M THF solution, 3.40mmol) and after 1 h with acetic acid
(250 mL, 4.37mmol). The ensuing mixture was stirred at 188C
for 24 h then concentrated under reduced pressure and the light
yellow oil thus obtained was subjected to flash chromatography
(silica, 1 : 1 v/v ethyl acetate/hexane - 6 : 3 : 0.4 v/v/v ethyl
acetate/hexane/methanol gradient elution) and thereby afford-
ing two fractions, A and B.
Concentration of fraction A (RF 0.5 in 5 : 4 : 1 v/v/v ethyl
acetate/hexane/methanol) gave compound 14[9] (23mg, 21%)
as a white, crystalline solid, mp 59–608C. [a]D þ2098 (c 0.6 in
methanol). nmax (KBr)/cm
1 3390, 2977, 2896, 1640, 1385,
1171, 1096, 1052, 1011, 988, 960, 934, 898, 864, 738, 709. dH
((CD3)2CO, 500MHz) 6.05 (m, 1H), 5.85 (m, 1H), 5.50 (d, J 3.4,
1H), 4.65 (m, 1H), 3.95 (m, 1H), 3.65 (m, 1H), 3.45 (m, 1H),
2.20 (broad s, 1H). dC ((CD3)2CO, 125MHz) 130.4 (CH), 127.7
(CH), 96.0 (CH), 77.8 (CH), 67.8 (CH), 63.4 (CH2). m/z (ESI,
þve) 151 (100%, [M þ Na]þ). m/z (HRMS ESI (þve))
151.0372; [M þ Na]þ requires 151.0371.
Concentration of fraction B (RF 0.4 in 5 : 4 : 1 v/v/v ethyl
acetate/hexane/methanol) gave compound 13[18] (27mg, 24%)
as a white, crystalline solid, mp 46–498C. [a]D 1218 (c 0.6
in methanol). nmax (KBr)/cm
1 3413, 2953, 2894, 1449, 1338,
1179, 1097, 985, 896, 866. dH ((CD3)2CO , 500MHz) 5.37 (s,
1H), 4.35 (m, 1H), 3.82 (m, 2H), 3.63 (m, 1H), 3.58 (broad s,
1H), 1.98–1.83 (complex m, 2H), 1.54–1.48 (complex m, 1H),
1.43–1.37 (complex m, 1H). dC ((CD3)2CO, 125MHz) 102.1
(CH), 78.3 (CH), 67.2 (CH), 66.8 (CH2), 28.4 (CH2), 24.2
(CH2). m/z (ESI, þve) 153 (100%, [M þ Na]þ). m/z (HRMS
ESI (þve)) 153.0529; [M þ Na]þ requires 153.0528.
Compound 14: A magnetically stirred solution of compound
3 (178mg, 1.25mmol) in methanol (18mL) was treated drop-
wise with hydrazine (5mL of a 1.0M solution in THF,
5.00mmol) and after 1 h with acetic acid (430 mL, 7.51mmol).
After a further 2 h, the reaction mixture was concentrated under
reduced pressure and the light brown residue subjected to flash
chromatography (silica, 2 : 1 v/v ethyl acetate/hexane elution).
Concentration of the appropriate fractions (RF 0.5 in 5 : 4 : 1
v/v/v ethyl acetate/hexane/methanol) then gave compound 14
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(72mg, 45%) as awhite, crystalline solid thatwas identical in all
aspects to thematerial obtained as described immediately above.
Compound 4: A magnetically stirred solution of compound
10 (147mg, 1.02mmol) in dichloromethane (20mL) was trea-
ted with pyridine (825mL, 10.20mmol) then with DMP
(649mg, 1.53mmol). After 18 h, the reaction mixture was
concentrated under reduced pressure and the residue subjected
to flash chromatography (silica, 5 : 4 : 0.2 v/v/v ethyl acetate/
hexane/methanol elution). Concentration of the relevant frac-
tions (RF 0.5 in 6 : 3 : 1 v/v/v ethyl acetate/hexane/methanol)
afforded compound 4[17] (143mg, 99%) as a white, crystalline
solid, mp 71–738C. [a]D 488 (c 0.5 in methanol). nmax (KBr)/
cm1 2962, 1700, 1416, 1305, 1100, 1063, 914, 873, 803. dH
(CDCl3, 500MHz) 5.12 (d, J 1.0, 1H), 4.98 (m, 1H), 4.22 (d, J
6.4, 1H), 4.01 (m, 1H), 3.70 (m, 1H), 3.28 (m, 1H). dC (CDCl3,
125MHz) 195.4 (C), 100.1 (CH), 73.0 (CH), 64.8 (CH2), 59.9
(CH), 47.9 (CH).m/z (EI, 70 eV) 141 (2%, [MH]þ), 114 (8),
101 (18), 72 (49), 71 (84), 69 (58), 57 (100). m/z (HRMS (ESI
(þve)) 141.0188; [MH]þ requires 141.0188.
Compounds 15 and 16: A solution of compound 4 (122mg,
0.86mmol) in methanol (10mL) was treated dropwise while
being stirred magnetically at 188C with hydrazine (3.4mL of a
1.0M solution in THF, 3.40mmol). After stirring for a further
1 h, acetic acid (250 mL, 4.367mmol) was added to the reaction
mixture and after a further 24 h, it was concentrated under
reduced pressure. Subjection of the residue thus obtained to
flash chromatography (silica, 1 : 1 v/v ethyl acetate/hexane-
2 : 1 v/v ethyl acetate/hexane gradient elution) afforded two
fractions, A and B.
Concentration of fraction A (RF 0.6 in 5 : 4 : 1 v/v/v ethyl
acetate/hexane/methanol) afforded compound 16[5b] (8mg,
7%) as a clear, colourless oil. [a]D 358 (c 0.6 in methanol).
nmax (KBr)/cm
1 3426, 2975, 2904, 1638, 1376, 1165, 1117,
1080, 1057, 1029, 1008, 979, 957, 902, 854, 718. dH ((CD3)2CO,
500MHz) 5.80 (m, 1H), 5.68 (m, 1H), 5.41 (d, J 2.9, 1H), 4.67
(m, 1H), 4.42 (m, 1H), 4.37 (d, J 4.9, 1H), 4.16 (m, 1H), 3.76 (m,
1H). dC ((CD3)2CO, 125MHz) 131.0 (CH), 128.4 (CH), 96.4
(CH), 76.3 (CH), 68.0 (CH), 62.6 (CH2). m/z (EI, 70 eV) 128
(55%, Mþ), 99 (36), 85 (77), 70 (66), 68 (92), 57 (100). m/z
(HRMS ESI (þve)) 128.0474; Mþ requires 128.0473.
Concentration of fraction B (RF 0.5 in 5 : 4 : 1 v/v/v ethyl
acetate/hexane/methanol) afforded compound 15[18] (68mg,
61%) as a clear, colourless oil. [a]D 558 (c 0.6 in methanol).
nmax (KBr)/cm
1 3415, 2956, 2896, 1435, 1335, 1126, 1062,
1033, 991, 933, 875. dH ((CD3)2CO, 500MHz) 5.33 (s, 1H), 4.25
(t, J 4.4, 1H), 4.09 (m, 2H), 3.83 (m, 1H), 3.56 (m, 1H), 1.85–
1.79 (complex m, 1H), 1.61–1.51 (complex m, 3H). dC
((CD3)2CO, 125MHz) 101.1 (CH), 77.1 (CH), 66.6 (CH),
64.8 (CH2), 31.7 (CH2), 25.9 (CH2). m/z (ESI, þve) 153
(78%, [M þ Na]þ), 127 (100). m/z (HRMS ESI (þve))
153.0531; [M þ Na]þ requires 153.0528.
Compound 16: A magnetically stirred solution of compound
4 (98mg, 0.69mmol) in methanol (15mL) maintained at 188C
was treated dropwise with hydrazine (2.8mL of a 1.0M solution
in THF, 2.80mmol) and after 1 h with acetic acid (340 mL,
5.94mmol). After a further 1 h, the reaction mixture was
concentrated under reduced pressure and the residue thus
obtained subjected to flash chromatography (silica, 2 : 1 v/v
ethyl acetate/hexane elution). Concentration of the appropriate
fractions (RF 0.6 in 5 : 4 : 1 v/v/v ethyl acetate/hexane/methanol)
gave compound 16 (50mg, 57%) as a clear, colourless oil that
was identical in all aspects to the material obtained as described
immediately above.
Compound 2: A magnetically stirred solution of compound
14 (53mg, 0.41mmol) in dichloromethane (25mL) was treated
with molecular sieves (200mg of 4 A˚ material) then with
manganese dioxide (900mg, 10.35mmol). The ensuing mixture
was stirred at 188C for 24 h, then filtered through a short pad of
CeliteTM, and the filtrate concentrated under reduced pressure.
Subjection of the ensuing light yellow oil to flash chroma-
tography (silica, 1 : 2 v/v ethyl acetate/hexane elution) afforded,
after concentration of the appropriate fractions (RF 0.5 in
2 : 2.5 : 5.5 v/v/v ethyl acetate/dichloromethane/hexane), com-
pound 2[5–7,21] (34mg, 65%) as a clear, colourless oil. [a]D
þ4458 (c 1.0 in CHCl3) (lit.þ4258 (c 1.10 in CHCl3)[21b]). nmax
(KBr)/cm1 2965, 2896, 1713, 1694, 1607, 1372, 1251, 1150,
1081, 1026, 970, 937, 891. dH (CDCl3, 500MHz) 7.13 (dd, J 9.8,
3.4, 1H), 6.11 (d, J 9.8, 1H), 5.81 (d, J 3.4, 1H), 4.78 (d, J 6.3,
1H), 4.11 (m, 1H), 3.66 (dm, J 7.8, 1H). dC (CDCl3, 125MHz)
194.5 (C), 147.3 (CH), 127.1 (CH), 96.1 (CH), 79.6 (CH), 62.7
(CH2). m/z (EI, 70 eV) 126 (93%, M
þ), 96 (12), 85 (27), 83
(100), 68 (73), 55 (52). m/z (HRMS ESI (þve)) 126.0316; Mþ
requires 126.0317.
Using the oxidation protocol described immediately above,
compound 16 (82mg, 0.64mmol) was also converted into
compound 2 (50mg, 62%).
X-Ray Crystallographic Studies
Crystallographic Data
Compound 5, C7H10O4, M 158.15, T 200K, orthorhombic,
space group P212121, a 6.6938(2), b 9.2713(3), c 12.0635(4) A˚,
V 748.66(4) A˚3, Z 4, Dc 1.403 g cm
3, 1019 unique data (2ymax
558), R 0.044 (for 894 reflections with I. 2.0s(I)), wR 0.108
(all data), S 0.99.
Compound 9, C6H8O4, M 144.13, T 150K, orthorhombic,
space group P212121, a 6.4568(1), b 9.4927(1), c 10.0291(8) A˚,
V 614.71(1) A˚3, Z 4, Dc 1.557 g cm
3, 1209 unique data (2ymax
144.88), R 0.021 (for 1204 reflections with I. 2.0s(I)), wR
0.056 (all data), S 1.02.
Compound 10, C6H8O4, M 144.13, T 150K, monoclinic,
space group P21, a 6.1348(1), b 5.1836(1), c 9.4057(2) A˚, b
93.0546(19)8, V 298.68(1) A˚3, Z 2,Dc 1.602 g cm
3, 939 unique
data (2ymax 144.68), R 0.022 (for 935 reflections with I.
2.0s(I)), wR 0.061 (all data), S 1.02.
Compound 14, C6H8O3, M 128.13, T 150K, orthorhombic,
space group P212121, a 6.3711(1), b 9.5878(1), c 9.7015(1) A˚,
V 592.62(1) A˚3, Z 4, Dc 1.436 g cm
3, 1168 unique data (2ymax
144.68), R 0.025 (for 1154 reflections with I. 2.0s(I)), wR
0.064 (all data), S 1.03.
Structure Determinations
Images were measured on a Nonius Kappa CCD diffractometer
(MoKa, graphite monochromator, l 0.71073 A˚) and data
extracted using the DENZO package[24] for compound 5, or an
Agilent SuperNova CCD diffractometer (CuKa, mirror mono-
chromator, l 1.54184 A˚) and data extracted using the CrysAlis
PRO package[25] for compounds 9, 10, and 14. Structure
solution was by direct methods (SIR92).[26] The structures of
compounds 5, 9, 10, and 14 were refined using the CRYSTALS
program package.[27] Atomic coordinates, bond lengths and
angles, and displacement parameters have been deposited at the
Cambridge Crystallographic Data Centre (CCDC nos 1023960–
1023963 for compounds 5, 9, 10, and 14, respectively). These
data can be obtained free of charge via www.ccdc.cam.ac.uk/
data_request/cif, by emailing data_request@ccdc.cam.ac.uk, or
598 X. Ma et al.
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by contacting The Cambridge Crystallographic Data Centre, 12
Union Road, Cambridge CB2 1EZ, UK; fax:þ44 1223 336 033.
Supplementary Material
The anisotropic displacement ellipsoid plots derived from the
single-crystal X-ray structures of compounds 5, 9, 10, and 14
together with the 1H and 13C NMR spectra of compounds 2–16
are available on the Journal’s website.
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Figure S1: Structure of compound 5 (CCDC 1023960) with labelling of selected atoms, showing 
one location of the disordered atoms (O10: occupancy 0.5). Anisotropic displacement ellipsoids 
show 30% probability levels. Hydrogen atoms are drawn as circles with small radii. 
 
 
 
 
Figure S2: Structure of compound 5 (CCDC 1023960) with labelling of selected atoms, showing 
the alternative location of the disordered atoms (O101: occupancy 0.5). Anisotropic displacement 
ellipsoids show 30% probability levels. Hydrogen atoms are drawn as circles with small radii. 
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Figure S3: Structure of compound 9 (CCDC 1023961) with labelling of selected atoms. 
Anisotropic displacement ellipsoids show 30% probability levels. Hydrogen atoms are drawn as 
circles with small radii. 
 
 
 
 
Figure S4: Structure of compound 10 (CCDC 1023962) with labelling of selected atoms. 
Anisotropic displacement ellipsoids show 30% probability levels. Hydrogen atoms are drawn as 
circles with small radii. 
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Figure S5: Structure of compound 14 (CCDC 1023963) with labelling of selected atoms. 
Anisotropic displacement ellipsoids show 30% probability levels. Hydrogen atoms are drawn as 
circles with small radii. 
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Radical Solution to the Alkylation of the Highly Base-Sensitive 1,1-
Dichloroacetone. Application to the Synthesis of Z‑Alkenoates and
E,E‑Dienoates
Lucile Anthore,† Shiguang Li,‡ Lorenzo V. White,† and Samir Z. Zard*
Laboratoire de Synthes̀e Organique, CNRS UMR 7652 Ecole Polytechnique, Palaiseau 91128 Cedex, France
*S Supporting Information
ABSTRACT: A simple radical-based route to gem-α-dichloroketones, relying on the degenerative addition transfer of (S)-[3,3-
dichloro-2-oxopropyl]-O-ethyl dithiocarbonate (xanthate), is described. The adducts can then be converted into Z-enoates by
exposure to Et3N in methanol. In the case of certain substrates, it was possible to form skipped dienoic acid and methyl E,E-
dienoates.
Oleﬁns are a ubiquitous feature of biologically signiﬁcantmolecules1 and serve as fundamental substrates for many
widely exploited synthetic transformations.2 The stereochemical
conﬁguration of the oleﬁn, deﬁned as E or Z, inﬂuences its
biological properties and chemical reactivity.3 While numerous
methods detailing the preparation of E-oleﬁns exist,4 the
synthesis of Z-oleﬁns remains comparatively less well described
and is often problematic.
One underutilized approach to the synthesis of Z-oleﬁns is the
base-catalyzed Favorskii rearrangement of gem-α-dihaloketones.5
The application of this approach to the synthesis of Z-oleﬁns has
been restricted by diﬃculties associated with the requisite gem-α-
dichloroketo unit, which is practically diﬃcult to handle and
whose preparation often involves the use of reagents that are not
tolerant of a broad spectrum of functional groups.6 The use of
strongly acidic reagents7 or highly reactive organometallic
species generated at very low temperatures is often required,8
thereby conﬁning these chemistries to simpler molecular
systems. Furthermore, the extensive sensitivity to base of 1,1-
dichloroacetone has precluded approaches involving alkylation
of its enolate (see discussion below).
As part of our studies on the radical additions of xanthates,9 we
have examined the addition of α-chloroacetonyl xanthate to
various oleﬁns,10 and the success of this methodology led us to
suppose that similar xanthate-transfer-based processes would
allow the α,α-dichloroketo unit to be appended to a variety of
alkenes via a carbon−carbon bond-forming step. The advantage
of this strategy, described in Scheme 1, is that the xanthate-
transfer process allows us to combine xanthate 1with oleﬁns such
as 2 to generate adducts of the form 3 under neutral and mild
conditions. This feature would potentially overcome diﬃculties
previously restricting the application of the Favorskii rearrange-
ment of α,α-dihaloketones to the synthesis of Z-oleﬁns, as the
former allows the α,α-dichloroketo handle to be easily
incorporated into complex molecules according to a process
that limits typical ionic side reactions and does not require the
use of harsh reagents.
To assess the merits of our strategy, a simple and scalable
synthesis of xanthate 1 was required. This, however, proved to be
a nontrivial task, as direct substitution of commercially available
1,1,3-trichloroacetone with potassium O-ethyl xanthate under a
variety of conditions resulted in inseparable mixtures of the
mono-, di-, and trisubstituted products. After extensive
experimentation, we determined that the slow addition of the
xanthate salt to a large excess of 1,1,3-trichloroacetone (>10
equiv) at low temperature (−5 °C) allowed the requisite
xanthate to be prepared on multigram scale and in a synthetically
practical yield of 76% (Scheme 1). The xanthate salt is suﬃciently
basic to induce enolate formation from dichloroketone 1a,
resulting ultimately in unwanted multiple substitutions (via an
oxy allyl cation analogous to 6a; see Scheme 4 and discussion
below). Hence, there is a need for the slow addition to keep the
basicity as low as possible.
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Scheme 1. Xanthate-Transfer Reaction and Favorskii
Rearrangement
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With a good stockpile of xanthate 1a available, we set out to
determine the substrate scope of the radical addition of 1 to
various oleﬁns according to the reaction manifold outlined in
Scheme 1. The xanthate adducts synthesized in this way are
detailed in Scheme 2; they demonstrate the broad functional
group tolerance of the xanthate addition-transfer process,
allowing us to generate α,α-dichloroacetonyl xanthate adducts
with oleﬁns containing esters (4a, 4c), ketones (4j, 4s), epoxides
(4b), alcohols (4e), amides (4d), sulfonamides (4g, 4h), imides
(4n), halogens (4f, 4m), silicon (4l), aromatic groups (4k), and
highly functionalized sugars (4t) in good yields. Consistent with
our previously established protocol,11 compounds 4f and 4h
could be further subjected to stoichiometric amounts of dilauroyl
peroxide (DLP) in reﬂuxing ethyl acetate at a higher dilution (0.1
M) to generate the corresponding indoline derivatives 4o and 4p
with no observable degradation of the α,α-dichloroketo unit.
Compound 4i results from the addition−fragmentation to β-
pinene and allows us to incorporate an oleﬁn into the resulting
adduct.12
The facile generation of α,α-dichloroacetonyl xanthate
adducts allowed us to turn our attention to the Favorskii
chemistry of these species. We hoped to aﬀect the transformation
via a mild and simple protocol and found that the rearrangement
could indeed be carried out by treating the α,α-dichloroacetonyl
products with an excess of triethylamine in methanol at ambient
temperature. The results of these initial rearrangements are
detailed in Scheme 3 and proved to be, in every case, completely
selective for the formation of the Z-alkene.
The formation of the Z-alkenoate is presumed to be the result
of the disrotatory electrocyclization of oxy allyl cation 6a
(Scheme 4) to give cis-disubstituted cyclopropanone 6b.13
Reaction of the latter ﬁnally gives rise to the observed product
via backside attack of the C−Cl bond. Oxy allyl cations such as 6a
are highly electrophilic and have been used in [3 + 4]
cycloadditions with electron-rich dienes and heteroaromatics,
especially furans.8 It is the very easy formation of oxy allyl cation
6a, even under extremely mild basic conditions, which
complicated the synthesis of our reagent 1. This factor has,
furthermore, precluded any attempt to alkylate 1,1-dichloroace-
tone 6c, a transformation that is not known, as far as we can tell.
These observations make the present radical addition even more
remarkable and useful, as it ﬁlls a serious gap in synthetic
methodology.
The yields of the rearranged compounds obtained via our
initial attempts at the Favorskii chemistry, while synthetically
useful, were consistently only moderate, with the notable
exception of 5h. This compound lacks the residual xanthate
moiety, and we suspected that reaction of the potentially
nucleophilic thiocarbonyl group with the oxy allyl cation
intermediate was responsible for the observed ineﬃciency of
conversion. Attempts to reductively remove14 the xanthate group
prior to the Favorskii step proved to be unsuccessful, so we began
to search for simple modiﬁcations to this group that would alter
its ionic reactivity. Inspired by our previous work,9 we ﬁrst
examined the O-neopentyl analogue 1b (Scheme 1) to assess
whether the increased bulk would slow the unwanted interaction
with the oxy allyl cation intermediate and thus lead to a better
yield of the desired Favorskii transformation.
Scheme 2. Addition of 1a to Various Oleﬁnsa
aReactions performed in reﬂuxing EtOAc in the presence of small
amounts of DLP (DLP = dilauroyl peroxide).
Scheme 3. Initial Results of the Favorskii Rearrangement
Scheme 4. Z-Oleﬁn Formation
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The results of the radical addition of theO-neopentyl xanthate
1b to various oleﬁns and the Favorskii rearrangements of the
resulting adducts 7 are shown in Scheme 5. The poor purity ofO-
neopentyl xanthate 1b, resulting from diﬃculties associated with
its synthesis and puriﬁcation, led to generally lower yields for its
addition to oleﬁns than was the case for the O-ethyl analogue 1a,
as can be seen by comparing the yields of compounds 7a and 7b
with 4a and 4c.
Moreover, the yields observed for Favorskii rearrangements of
adducts 7 containing theO-neopentyl xanthate did not represent
a signiﬁcant improvement over analogous reactions carried out
on the O-ethyl-containing substrates, as can be seen by
comparing the yields of compounds 8a, 8b, and 8c with those
of compounds 5a, 5b and 5g. This suggested that the neopentyl
group, despite its greater bulk, was unable to attenuate the
reactivity of the xanthate group and limit the undesired side
reactions.
In view of these unfavorable results, we decided to replace the
thiocarbonyl group with the less nucleophilic carbonyl group.We
had shown that this transformation could be readily accom-
plished by ozonolysis.15 The results of the ozonolysis of various
xanthate adducts and the subsequent subjection of the
thiocarbonates thus obtained to the Favorskii rearrangement
are shown in Scheme 6.
Ozonolysis of the xanthate adducts proceeded in good yield,
and crucially, the yields for the Favorskii rearrangement of the
resulting thiocarbonate derivatives were consistently much
higher than those seen for their xanthate analogues (as can be
seen by comparing the yields of compounds 10a, 10b, 10c, and
10d with compounds 5a, 5b, 5g, and 5f). This supports our
hypothesis regarding the cause of the ineﬃciency of the Favorskii
rearrangement of the latter. Lower yields for the rearranged
product were invariably observed when acidic groups were
situated in such a way as to react in an intramolecular sense with
the oxy allyl cation intermediate (compound 9g). The low yield
of sugar derivative 10h is in part due to methanolysis of the
acetate groups. Finally, in the case of 9f, exposure to
triethylamine resulted in ring closure to furnish bicyclic
compound 10f, isolated as an equimolar mixture of epimers
with the stereochemistry shown. Clearly, the internal aldol
reaction is faster than the Favorskii rearrangement.
Further support for our conjecture is found in Scheme 7,
whereby a second radical addition16 of the phthalimido xanthate
adduct 4n toN-allyl-4-chlorobenzamide allowed us to situate the
residual xanthate moiety in the product 11a further away from
the oxy allyl cation intermediate, thereby resulting in a 79% yield
of rearranged product 11b. A similar situation prevailed in the
rearrangement of xanthate adduct 4i and allowed for the
synthesis of the skipped diene 11c, in which the Z conﬁguration
of the enone double bond was preserved in a synthetically useful
yield. It is worth noting that in this case the use of methanol
resulted in partial isomerization of the alkene. This is due to the
higher acidity of the enolizable protons of the skipped diene in
ester 11d. In contrast, the acidity of enolizable protons in the free
carboxylic acid is considerably lower and the stereochemistry of
the Z-alkene is therefore preserved.
Scheme 5. Addition of Xanthate 1b to Various Oleﬁns and
Subsequent Favorskii Rearrangement
Scheme 6. Ozonolysis and Subsequent Favorskii
Rearrangement on the Xanthate Adducts
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The thiolcarbonate-containing enones 10a, 10b, and 10dwere
further elaborated into dienes 12a, 12b, and 12c, respectively
(Scheme 8), via reaction with DBU in toluene at ambient
temperature. In the case of compounds 10a and 10b, the enone
double bond in the product was isomerized cleanly to the E
isomer. In the case of 10d only diene 12c could be isolated from
the reaction mixture, albeit in poor yield.
Xanthate 1a solves indirectly, but powerfully, the problem of
alkylating 1,1-dichloroacetone and provides a direct, convergent
access to a large variety of functionalized α,α-dichloroketones.
These, in turn, lead to the corresponding Z-enoates and, in some
cases, to E,E-dienoates, thus complementing existing methods,
especially the Still−Gennari and Ando variations of the Horner−
Wadsworth−Emmons oleﬁnation17 and expanding considerably
the utility of the hitherto little used variation of the Favorskii
rearrangement. The fact that the sensitive α,α-dichloro ketone
survives the carbon−carbon bond forming process is a testimony
to the extremely mild experimental conditions.
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General techniques 
 
All reactions were carried out under dry, oxygen free nitrogen. Thin Layer Chromatography (TLC) was 
performed on alumina plates precoated with silica gel (Merck silica gel, 60 F254), which were 
visualized by the quenching of UV fluorescence when applicable (max = 254 nm and/or 366 nm) 
and/or by staining with anisadehyde in acidic ethanol solution and/or KMnO4 in basic water followed 
by heating. Flash chromatography was carried out on silica gel 60 (40-63 μm) as stationary phase. 
Petroleum ether refers to the fraction of petroleum boiling between 40 °C and 60 °C. DLP is dilauroyl 
peroxide which is sometimes sold under lauroyl peroxide. Infrared spectra were recorded as 
solutions in CH2Cl2 using NaCl cells on a Perkin-Elmer Spectrum Two. Absorption maxima (nmax) are 
reported in wavenumbers 𝜈 ̃ (cm−1). Melting points were recorded on a Stuart SMP40 and are 
uncorrected. Nuclear magnetic resonance spectra were recorded at ambient temperature on a 
Bruker Avance DPX 400 instrument. Proton magnetic resonance spectra (1H NMR) were recorded at 
400 MHz and coupling constants (J) are reported to ± 0.5 Hz. The following abbreviations were 
utilized to describe peak patterns when appropriate: br = broad, s = singlet, d = doublet, t = triplet, q 
= quartet and m = multiplet. Carbon magnetic resonance spectra (13C NMR) were recorded at 101 
MHz. Chemical shifts δ are quoted in parts per million (ppm) and are referenced to the residual 
solvent peak (CDCl3: H= 7.26 and C= 77.16). Fluorine magnetic resonance spectra (
19F NMR) were 
recorded on a Bruker Avance DPX 300 instrument at 282 MHz. Chemical shifts are quoted in part per 
million (ppm) and referenced to an internal reference (CFCl3 : 0.00 ppm). High-resolution mass 
spectra were recorded by electron impact ionization (EI) on a JMS-GCmateII mass spectrometer. The 
quoted masses are accurate to ± 5 ppm. The names of the molecules that appear in the following 
pages were generated using either Beilstein AutoNom 2000 (CAS) or ChemBioDraw.  
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Xanthate Addition-Transfer General Procedure 
 
 
 
A stirred solution of xanthate 1a (2 equivalents) and the olefin (1 equivalent) in EtOAc (1 M) was 
refluxed for ten minutes under an atmosphere of nitrogen to remove traces of oxygen. The ensuing 
deoxygenated solution was treated with DLP (5 mol %) every hour until TLC analysis indicated that 
most of the olefin had been consumed. The cooled solution was diluted with petroleum spirit and 
subjected to flash chromatography (silica, ethyl acetate/petroleum spirit elution). Concentration of 
the relevant fractions afforded the xanthate addition product. 
 
Ozonolysis General Procedure 
 
 
 
A solution of the xanthate adduct in a 97:3 mixture of acetone/H2O (0.1 M) was cooled to -78 °C. A 
stream of ozone diluted with oxygen was bubbled through the solution via a pasture pipette 
connected by a tube to an ozone generator. Once an obvious blue colour was persistent in solution, 
the ozone generator was switched off and pure oxygen was allowed to bubble through the reaction 
mixture for a further ten minutes to remove traces of ozone. The resulting clear solution was then 
warmed to room temperature before being diluted with EtOAc and washed with brine. The 
separated organic layer was dried over MgSO4 and concentrated under reduced pressure to yield the 
pure thiocarbonate derivative. Where necessary further purification was carried out via subjection of 
the product thus obtained to flash chromatography (silica, ethyl acetate/petroleum spirit elution). 
 
Favorskii Rearrangement General Procedure  
 
 
 
A stirred solution of the gem-α-dichloroketo compound (1 equivalent) in MeOH (0.1 – 0.3 M) was 
treated with NEt3 (3 equivalents) at room temperature. After 24 to 48 hours, the reaction mixture 
was diluted with EtOAc and washed with H2O. The separated aqueous phase was extracted twice 
with EtOAc and the combined organic extracts were dried over MgSO4 before being concentrated 
under reduced pressure. The brown oil thus obtained was subjected to flash chromatography (silica, 
ethyl acetate/petroleum spirit elution). Concentration of the relevant fractions afforded the Z-enone.  
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Compound 1a 
 
 
A vigorously stirred 10:1 mixture of 1,1,3-trichloroacetone (67 mL, 624 mmol, 10 eq.)/Et2O (7 mL) 
was cooled to ca. -10° C (ice/salt bath) under an atmosphere of nitrogen [occasionally, additional 
small amounts of Et2O were added to prevent crystalisation of the 1,1,3-trichloroacetone]. Potassium 
O-ethyl xanthate (10 g, 62.4 mmol, 1 eq.) was added in small portions over 1 h. Upon completion of 
the addition, the heterogeneous reaction mixture was stirred for a further 0.25 h. The reaction 
mixture was then diluted with Et2O (250 mL) and washed with H2O (150 mL). The separated organic 
phase was dried over MgSO4 and concentrated under reduced pressure. The yellow liquid thus 
obtained was then redissolved in petroleum spirit (300 mL) and washed with H2O (100 mL) to remove 
remaining traces of 1,1,3-trichloroacetone. The separated organic phase was dried over MgSO4 and 
concentrated under reduced pressure and the resulting yellow oil was subjected to flash 
chromatography (silica, 1:24 v/v Et2O/petroleum spirit elution). Concentration of the relevant 
fractions afforded the dichloroacetoxyl xanthate 1a (11.7 g, 76%) as a pale yellow oil.  
 
1H NMR  
(400 MHz, CDCl3) 
δ = 6.19 (s, 1H), 4.62 (q, J = 7.1 Hz, 2H), 4.36 (s, 2H), 1.40 ppm (t, J = 7.2 Hz, 3H) 
  
13C NMR 
(101 MHz, CDCl3) 
δ = 212.2, 189.7, 71.3, 69.4, 39.9, 13.6 ppm 
  
IR  
(thin film) 
𝜈 = 2988, 2941, 2251, 1746, 1444, 1367, 1238, 1113, 1049 cm-1  
  
HRMS  
(EI+) 
Calculated for [MC3H5OS2]
+: 245.9343                                              Found: 245.9336 
 
 
Compound 1b 
 
 
According to the procedure described for Compound 1a, 1,1,3-trichloroacetone (16 mL, 98.8 mmol) 
was allowed to react with potassium O-neopentyl xanthate (2 g, 9.8 mmol). Purification via flash 
chromatography (silica, 0:1 → 1:24 v/v Et2O/petroleum spirit elution) afforded dichloroacetoxyl 
xanthate 1b (1.76 g, 62%) as a pale yellow oil.  
 
1H NMR  
(400 MHz, CDCl3) 
δ = 6.20 (s, 1H), 4.41 (s, 2H), 4.26 (s, 2H), 1.01 ppm (s, 9H) 
 
  
13C NMR 
(101 MHz, CDCl3) 
δ = 213.1, 190.1, 84.8, 77.2, 69.7, 40.2, 32.1, 26.6 ppm 
  
IR  
(thin film) 
𝜈 = 2961, 2871, 1645, 1478, 1368, 1235, 1067, 1028, 949, 820, 744 cm-1  
 
  
HRMS  
(EI+) 
Calculated for [MC3H5OS2]
+: 287.9812                                             Found: 287.9818 
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Products of Xanthate Addition-Transfer Reactions.  
 
Compound 4a 
 
 
According to the general procedure, vinyl acetate (43 mg, 0.5 mmol) was allowed to react with 
xanthate 1a (247 mg, 1 mmol) of for 3 h. The total amount of DLP added was 30 mg (0.075 mmol, 15 
mol%). Purification via flash chromatography (silica, 1:10 → 1:5 v/v ethyl acetate/petroleum spirit 
elution) afforded adduct 4a (170 mg, 98%) as a pale yellow oil.  
 
1H NMR  
(400 MHz, CDCl3) 
δ = 5.83 (s, 1H), 4.74 – 4.51 (q, J = 7.1 Hz, 2H), 4.41 – 4.29 (dd, J = 11.5, 4.8 Hz, 
1H), 4.29 – 4.16 (dd, J = 11.4, 6.3 Hz, 1H), 4.08 – 3.85 (ddd, J = 9.8, 4.9, 1.5Hz, 
1H), 3.24 – 2.89 (ddd, J = 8.3, 6.8, 1.9 Hz, 2H), 2.27 – 2.14 (m, 1H), 2.08 (s, 3H), 
2.01 – 1.86 (m, 1H), 1.42 ppm (t, J = 7.1 Hz, 3H) 
  
13C NMR 
(101 MHz, CDCl3) 
δ = 212.5, 196.1, 170.5, 70.4, 69.7, 65.5, 48.6, 32.3, 24.9, 20.7, 13.7 ppm 
  
IR  
(thin film) 
𝜈 = 3463, 2983, 2937, 2439, 2271, 2080, 1765, 1444, 1381, 1236, 1112, 1053, 
790 cm-1  
  
HRMS  
(EI+) 
Calculated for [MC3H5OS2]
+: 225.0085                                             Found: 225.0082 
 
 
Compound 4b 
 
According to the general procedure, allyl glycidyl ether(57 mg, 0.5 mmol) was allowed to react with 
xanthate 1a (247 mg, 1 mmol) for 3 h. The total amount of DLP added was 30 mg (0.075 mmol, 15 
mol%). Purification via flash chromatography (silica, 1:5 v/v ethyl acetate/petroleum spirit elution) 
afforded 4b (164 mg, 91%) as a pale yellow oil.  
 
1H NMR  
(400 MHz, CDCl3) 
(mixture of diastereomers) δ = 5.88 (s, 1H), 4.67 (q, J = 7.1 Hz, 2H), 4.05 – 3.92 
(m, 1H), 3.88 – 3.75 (m, 2H), 3.73 – 3.60 (ddd, J = 22.0, 10.0, 6.8 Hz, 1H), 3.51 – 
3.38 (m, 1H), 3.22 – 3.12 (m, 1H), 3.09 – 3.00 (m, 1H), 2.84 – 2.79 (ddd, J = 5.2, 
4.2, 1.4 Hz, 1H), 2.67 – 2.61 (m, 1H), 2.39 – 2.23 (m, 1H), 2.09 – 1.93 (m, 1H), 
1.44 ppm (t, J = 7.1 Hz, 3H) 
  
13C NMR 
(101 MHz, CDCl3) 
(mixture of diastereomers) δ = 213.5, 196.4, 73.1, 71.8, 71.6, 70.3, 69.8, 50.7, 
49.6, 44.1, 44.1, 32.6, 32.6, 25.3, 13.8 ppm 
  
IR  
(thin film) 
𝜈 = 3055, 2989, 2923, 2869, 1738, 1445, 1366, 1222, 1112, 1048, 851, 789 cm-1 
  
HRMS  
(EI+) 
Calculated for [MC3H5OS2]
+: 239.0242                                          Found: 238.0142 
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Compound 4c 
 
 
According to the general procedure, allyl 4-chlorobenzoate (1000 mg, 5.08 mmol) was allowed to 
react with xanthate 1a (2510 mg, 10.17 mmol) for 6 h. The total amount of DLP added was 300 mg 
(0.15 mmol, 30 mol%). Purification via flash chromatography (silica, 1:10 v/v ethyl acetate/petroleum 
spirit elution) afforded adduct 4c (1713 mg, 76%) as a pale yellow oil that solidified below 4 °C.  
 
1H NMR  
(400 MHz, CDCl3) 
δ = 7.98 (d, J = 8.6 Hz, 2H), 7.43 (d, J = 8.6 Hz, 2H), 5.84 (s, 1H), 4.70 – 4.60 (qd, J = 
7.2, 2.4 Hz, 2H), 4.60 – 4.55 (dd, J = 11.4, 5.0 Hz, 1H), 4.54 – 4.47 (dd, J = 11.4, 6.0 
Hz, 1H), 4.19 – 4.12 (m, 1H), 3.09 (t, J = 7.2 Hz, 2H), 2.38 – 2.24 (m, 1H), 2.09 – 1.96 
(m, 1H), 1.42 ppm (t, J = 7.1 Hz, 3H) 
  
13C NMR 
(101 MHz, CDCl3) 
δ = 212.4, 196.2, 165.3, 139.8, 131.1, 128.9, 128.1, 70.6, 69.7, 66.2, 48.9, 32.2, 
25.0, 13.7 ppm 
  
IR  
(thin film) 
𝜈 = 2983, 2918, 1725, 1595, 1403, 1375, 1270, 1224, 1106, 1047, 1015 cm-1  
  
HRMS  
(EI+) 
Calculated for [MC3H5OS2]
+: 320.9852                                              Found: 320.9845 
 
 
Compound 4d 
 
 
According to the general procedure, N-allyl-N-phenylacetamide (88 mg, 0.5 mmol) was allowed to 
react with xanthate 1a (247 mg, 1 mmol) for 6 h. The total amount of DLP added was 60 mg (0.15 
mmol, 30 mol%). Purification via flash chromatography (silica, 1:5 v/v ethyl acetate/petroleum spirit 
elution) afforded adduct 4d (129 mg, 61%) as a pale yellow oil.  
 
1H NMR  
(400 MHz, CDCl3) 
δ = 7.50 – 7.42 (m, 2H), 7.42 – 7.34 (m, 1H), 7.32 – 7.19 (m, 2H), 5.85 (s, 1H), 4.52 
(q, J = 7.1 Hz, 2H), 4.25 (dd, J = 13.4, 8.1 Hz, 1H), 3.89 – 3.80 (m, 1H), 3.76 (dd, J = 
13.4, 6.6 Hz, 1H), 3.06 – 3.00 (m, 2H), 2.35 – 2.23 (m, 1H), 1.99 – 1.82 (m, 4H), 
1.28 ppm (t, J = 7.1 Hz, 3H) 
  
13C NMR 
(101 MHz, CDCl3) 
δ = 212.7, 196.4, 171.0, 142.4, 129.8, 128.2, 70.1, 69.8, 51.2, 48.2, 32.3, 25.3, 22.7, 
13.5 ppm 
  
IR  
(thin film) 
𝜈 = 3062, 2982, 2934, 1738, 1660, 1652, 1596, 1496, 1436, 1394, 1291, 1221, 
1112, 1047, 913 cm-1  
  
HRMS  
(EI+) 
Calculated for [MC3H5OS2]
+: 299.0480                                       Found 299.0479 
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Compound 4e 
 
 
According to the general procedure, oct-1-en-3-ol (64 mg, 0.5 mmol) was allowed to react with 
xanthate 1a (247 mg, 1 mmol) for 4 h. The total amount of DLP added was 40 mg (0.1 mmol, 20 mol 
%). Purification via flash chromatography (silica, 1:10 v/v ethyl acetate/petroleum spirit elution) 
afforded adduct 4e (118 mg, 63%) as a pale yellow oil.  
 
1H NMR  
(400 MHz, CDCl3) 
(mixture of diastereomers) δ = 5.61 (s, 1H), 5.56 (s, 1H), 4.71 – 4.60 (m, 4H), 4.25 
(ddd, J = 7.9, 5.5, 2.1 Hz, 1H), 4.02 (q, J = 2.8 Hz, 1H), 3.88 (ddd, J = 11.3, 9.2, 
2.5Hz, 1H), 3.56 (ddd, J = 12.4, 10.9, 4.2 Hz, 1H), 2.85 (dd, J = 3.8, 2.6 Hz, 2H), 
2.39 – 2.29 (m, 1H), 2.26 – 2.18 (m, 1H), 2.18 – 2.08 (m, 2H), 2.08 – 2.01 (m, 1H), 
2.01 – 1.88 (m, 2H), 1.88 – 1.71 (m, 2H), 1.71 – 1.58 (m, 1H), 1.58 – 1.46 (m, 1H), 
1.47 – 1.39 (m, 6H), 1.36 – 1.22 (m, 11H), 0.92 – 0.82 ppm (m, 6H) 
  
13C NMR 
(101 MHz, CDCl3) 
(mixture of diastereomers) δ = 214.3, 212.6, 96.2, 95.7, 78.4, 73.3, 73.2, 71.9, 
70.17, 70.1, 50.4, 35.8, 33.0, 32.5, 31.8, 31.5, 31.5, 31.3, 30.4, 30.1, 26.6, 26.5, 
26.1, 25.0, 24.8, 22.6, 22.6, 22.5, 19.2, 14.0, 14.0, 13.8, 13.8 ppm 
  
IR  
(thin film) 
𝜈 = 3550, 3458, 2955, 2936, 2859, 1644, 1454, 1380, 1214, 1111, 1047, 1002, 
771 cm-1  
  
HRMS  
(EI+) 
Calculated for [MC3H5OS2]
+: 253.0762                                             Found: 253.0775 
 
Compound 4f 
 
 
According to the general procedure, 250 mg of N-allyl-N-(4-bromophenyl)methanesulfonamide 
(1.00 mmol) was allowed to react with 494 mg (2.00 mmol) of xanthate 1a for 4 h. The total amount 
of DLP added was 160 mg (0.4 mmol, 40 mol%). Purification via flash chromatography (silica, 0:10 → 
2:8 v/v diethyl ether/petroleum spirit elution) afforded adduct 4f (357 mg, 66%) as a yellow oil. 
1H NMR  
(400 MHz, CDCl3) 
δ = 7.60 – 7.55 (m, 2H), 7.33 – 7.28 (m, 2H), 5.80 (s, 1H), 4.57 (q, J = 7.1 Hz, 
2H), 4.00 – 3.83 (m, 2H), 3.65 (tdd, J = 9.4, 5.6, 3.8 Hz, 1H), 3.09 – 2.91 (m, 
2H), 2.89 (s, 3H), 2.49 – 2.33 (m, 1H), 1.98 – 1.78 (m, 1H), 1.35 ppm (t, J = 7.2 
Hz, 3H)  
  
13C NMR 
(101 MHz, CDCl3) 
δ = 212.3, 196.2, 137.7, 133.0, 130.6, 122.8, 70.6, 69.9, 53.6, 48.4, 37.5, 32.0, 
24.42, 13.80 ppm 
  
IR (thin film) 𝜈 = 2988, 1735, 1484, 1442, 1404, 1342, 1261, 1275, 1223, 1155, 1111, 1046, 
210
S8 
 
1011, 962, 765, 750 cm-1 
  
HRMS (EI+) Calcd for [MC3H6OS2]
+: 412.9255 Found 412.9258 
 
Compound 4g 
 
 
 
According to the general procedure, 211 mg of N-allyl-4-methylbenzenesulfonamide (1.00 mmol) 
was allowed to react with 494 mg (2.00 mmol) of xanthate 1a for 3 h. The total amount of DLP added 
was 120 mg (0.3 mmol, 30 mol%). Purification via flash chromatography (silica, 2:8 v/v ethyl 
acetate/petroleum spirit elution) afforded adduct 4g (339 mg, 74%) as an orange oil. 
 
1H NMR  
(400 MHz, CDCl3) 
δ = 7.74 (d, J = 8.1 Hz, 2H), 7.31 (d, J = 8.1 Hz, 2H), 5.82 (s, 1H), 5.04 (t, J = 6.6 
Hz, 1H; NH), 4.60 (q, J = 7.1 Hz, 2H), 3.79 (dq, J = 11.0, 5.9 Hz, 1H), 3.23 (t, J = 
6.4 Hz, 2H), 3.03 – 2.91 (m, 2H), 2.42 (s, 3H), 2.17 (dtd, J = 14.8, 7.4, 4.8 Hz, 
1H), 1.89 (ddt, J = 14.4, 9.6, 6.8 Hz, 1H), 1.39 ppm (t, J = 7.1 Hz, 3H) 
  
13C NMR 
(101 MHz, CDCl3) 
δ = 212.4, 196.3, 143.8, 137.0, 130.0, 127.2, 70.7, 69.8, 50.0, 46.5, 32.4, 25.2, 
21.7, 13.82 ppm 
  
IR 
(thin film) 
𝜈 =  3282 (br), 2982, 2926, 1735, 1598, 1495, 1443, 1330, 1222, 1160, 1111, 
1093, 10448, 913, 814, 734, 706, 664 cm-1 
  
HRMS (EI+) Calcd for [M]+: 457.0010 Found 457.0024 
 
Compound 4h 
 
 
 
According to the general procedure, 451 mg of N-allyl-N-(p-tolyl)methanesulfonamide (2.00 mmol) 
was allowed to react with 989 mg (4.00 mmol) of xanthate 1a for 3 h. The total amount of DLP added 
was 240 mg (0.6 mmol, 30 mol%). Purification via flash chromatography (silica, 0:10 → 2:8 v/v diethyl 
ether/petroleum spirit elution) afforded adduct 4h (868 mg, 91%) as a yellow oil. 
 
1H NMR  δ = 7.28 (d, J = 8.5 Hz, 2H), 7.24 (d, J = 8.5 Hz, 2H), 5.80 (s, 1H), 4.56 (q, J = 
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(400 MHz, CDCl3) 7.1 Hz, 1H), 3.99 – 3.84 (m, 2H), 3.69 (tdd, J = 9.7, 6.1, 3.8 Hz, 1H), 3.07 – 2.90 
(m, 2H), 2.89 (s, 3H), 2.47 – 2.39 (m, 1H), 2.38 (s, 3H), 1.98 – 1.83 (m, 1H), 
1.33 ppm (t, J = 7.1 Hz, 2H) 
  
13C NMR 
(101 MHz, CDCl3) 
δ = 212.3, 196.2, 138.9, 136.0, 130.4, 128.8,  70.4, 69.9, 53.7, 48.4, 37.4, 32.1, 
24.6, 21.3, 13.8 ppm 
  
IR 
(thin film) 
𝜈 = 2984, 2929, 1738, 1510, 1444, 1340, 1223, 1154, 1112, 1046, 963, 881, 
821, 798, 759, 721 cm-1  
  
HRMS (EI+) Calcd for [M]+: 4721.0166 Found 471.0150 
 
Compound 4i 
 
 
According to the general procedure, β-pinene (68 mg, 0.5 mmol) was allowed to react with xanthate 
1a (247 mg, 1 mmol) for 2 h. The total amount of DLP added was 10 mg (0.05 mmol, 10 mol %). 
Purification via flash chromatography (silica, 1:20 v/v ethyl acetate/petroleum spirit elution) afforded 
adduct 4i (171 mg, 89%) as a pale yellow oil.  
 
1H NMR  
(400 MHz, CDCl3) 
δ = 5.81 (s, 1H), 5.47 – 5.40 (m, 1H), 4.68 (q, J = 7.1 Hz, 2H), 2.92 (dd, J = 8.0, 6.9 
Hz, 2H), 2.30 (t, J = 7.5 Hz, 2H), 2.15 (d, J = 16.3 Hz, 1H), 2.08 – 1.95 (m, 4H), 1.90 
(m, 1H), 1.47 (s, 6H), 1.45 (t, J = 7.2 Hz, 3H), 1.38 – 1.23 ppm (m, 2H) 
  
13C NMR 
(101 MHz, CDCl3) 
δ = 214.2, 196.6, 135.5, 121.5, 121.5, 69.9, 69.9, 69.3, 59.0, 42.7, 33.4, 31.1, 29.6, 
29.6, 27.1, 25.2, 24.8, 24.6, 13.8 ppm 
  
IR  
(thin film) 
𝜈 = 2967, 2925, 2838, 1738, 1442, 1356, 1233, 1112, 1040, 1003, 793 cm-1  
  
HRMS  
(EI+) 
Calculated for [M]+: 382.0595                                                        Found: 382.0589 
 
Compound 4j 
 
 
 
According to the general procedure, 190 mg of 1-(4-methoxyphenyl)pent-4-en-1-one (1.00 mmol) 
was allowed to react with 400 mg (1.62 mmol) of xanthate 1a for 3 h. The total amount of DLP added 
was 120 mg (0.3 mmol, 30 mol%). Purification via flash chromatography (silica, 1:9 v/v ethyl 
acetate/petroleum spirit elution) afforded adduct 4j (395 mg, 90%) as a yellow oil. 
 
1H NMR  δ = 7.93 (d, J = 8.9 Hz, 2H), 6.93 (d, J = 8.9 Hz, 2H), 5.85 (s, 1H), 4.71 – 4.47 (m, 
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(400 MHz, CDCl3) 2H), 3.94 – 3.80 (m, 1H), 3.87 (s, 3H), 3.11 (ddd, J = 8.2, 6.4, 5.1 Hz, 2H), 3.04 
(t, J = 7.7 Hz, 2H), 2.31 – 2.12 (m, 2H), 2.12 – 1.93 (m, 2H), 1.40 ppm (t, J = 7.1 
Hz, 3H) 
  
13C NMR 
(101 MHz, CDCl3) 
δ = 213.8, 197.6, 196.6, 163.7, 130.5, 130.0, 113.9, 70.4, 70.0, 55.6, 50.6, 
35.5, 32.7, 29.7, 29.12, 29.06, 13.9 ppm 
  
IR 
(thin film) 
𝜈 = 2932, 1735, 1674, 1599, 1575, 1510, 1443, 1418, 1366, 1308, 1217, 1170, 
1111, 1047, 913, 839, 743 cm-1 
  
HRMS (EI+) Calcd for [M]+: 436.0337 Found 436.0341 
 
Compound 4k  
 
 
 
According to the general procedure, 266 µL of allylbenzene (2.00 mmol) was allowed to react with 
247 mg (1.00 mmol) of xanthate 1a for 1 h. The total amount of DLP added was 80 mg (0.2 mmol, 20 
mol%). Purification via flash chromatography (silica, 3:97 v/v diethyl ether/petroleum spirit elution) 
afforded adduct 4k (265 mg, 73%) as a yellow oil. 
 
1H NMR  
(400 MHz, CDCl3) 
δ = 7.38 – 7.22 (m, 5H), 5.78 (s, 1H), 4.63 (q, J = 7.1 Hz, 2H), 4.00 (dddd, J = 
10.0, 8.5, 6.0, 4.2 Hz, 1H), 3.18 (dd, J = 13.9, 5.9 Hz, 1H), 3.02 (ddd, J = 18.3, 
9.0, 5.4 Hz, 1H), 2.92 (ddd, J = 18.2, 9.7, 6.4 Hz, 1H), 2.87 (dd, J = 13.9, 8.5 Hz, 
1H), 2.13 (dddd, J = 15.2, 9.0, 6.4, 4.3 Hz, 1H), 1.86 (dtd, J = 14.8, 9.2, 5.4 Hz, 
1H), 1.42 ppm (t, J = 7.1 Hz, 3H) 
  
13C NMR 
(101 MHz, CDCl3) 
δ = 213.7, 196.4, 138.2, 129.4, 128.7, 127.0, 70.2, 69.9, 51.6, 41.6, 32.8, 27.0, 
13.9 ppm 
  
IR 
(thin film) 
𝜈 = 2984, 2924, 1734, 1603, 1495, 1454, 1403, 1366, 1291, 1218, 1146, 1111, 
1050, 1002, 788, 750, 701 cm-1 
  
HRMS (EI+) Calcd for [M]+: 364.0125 Found 364.0131 
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Compound 4l 
 
 
 
According to the general procedure, 238 mg of allyltrimethylsilane (1.50 mmol) was allowed to react 
with 124 mg (0.50 mmol) of xanthate 1a for 3 h. The total amount of DLP added was 60 mg 
(0.15 mmol, 30 mol%). Purification via flash chromatography (silica, 0:100 → 2:98 v/v diethyl 
ether/petroleum spirit elution) afforded adduct 4l (133 mg, 74%) as a yellow oil. 
 
1H NMR  
(400 MHz, CDCl3) 
δ = 5.83 (s, 1H), 4.63 (q, J = 7.1, 1.5Hz, 2H), 3.90 (tdd, J = 8.3, 7.0, 4.4 Hz, 1H), 
3.03 – 2.87 (m, 2H), 2.18 (dddd, J = 15.1, 8.4, 6.9, 4.4 Hz, 1H), 1.91 (dtd, J = 
14.4, 8.3, 5.8 Hz, 1H), 1.41 (t, J = 7.1 Hz, 3H), 1.14 (dd, J = 14.8, 7.1 Hz, 1H), 
1.00 (dd, J = 14.9, 8.2 Hz, 1H), 0.08 ppm (s, 9H) 
  
13C NMR 
(101 MHz, CDCl3) 
δ = 214.1, 196.7, 70.0, 69.9, 48.0, 32.5, 31.1, 23.5, 13.9, 0.64 ppm 
  
IR 
(thin film) 
𝜈 = 2957, 2557, 1734, 1711, 1444, 1407, 1387, 1364, 1251, 1221, 1147, 1112, 
1051, 1004 cm-1 
  
HRMS (EI+) Calcd for [MC3H5OS2]
+: 239.0426 Found 239.0432  
 
Compound 4m 
 
 
 
According to the general procedure, 230 µL of allylpentafluorobenzene (1.50 mmol) was allowed to 
react with 124 mg (0.50 mmol) of xanthate 1a for 1.5 h. The total amount of DLP added was 40 mg 
(0.10 mmol, 20 mol%). Purification via flash chromatography (silica, 1:19 v/v diethyl ether/petroleum 
spirit elution) afforded adduct 4m (197 mg, 86%) as a pale yellow oil. 
 
1H NMR  
(400 MHz, CDCl3) 
δ = 5.82 (s, 1H), 4.60 (q, J = 7.1 Hz, 2H), 4.03 (dtd, J = 9.9, 7.6, 4.4 Hz, 1H), 3.19 
– 3.07 (m, 2H), 3.04 (dd, J = 7.7, 6.6 Hz, 2H), 2.14 (dtd, J = 14.9, 7.5, 4.3 Hz, 
1H), 1.94 (ddt, J = 14.3, 10.0, 6.8 Hz, 1H), 1.41 ppm (t, J = 7.1 Hz, 3H) 
  
13C NMR 
(101 MHz, CDCl3) 
δ = 212.3, 196.2, 148.00 – 143.61 (m), 142.43 – 139.06 (m), 139.06 – 135.69 
(m), 114.14 – 108.07 (m), 70.6, 69.8, 49.3, 32.4, 28.1, 27.5, 13.7 ppm 
  
IR 𝜈 = 2986, 2960, 2929, 2858, 1736, 1657, 1521, 1505, 1446, 1367, 1300, 1226, 
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(thin film) 1125, 1113, 1051, 1004, 974 cm-1 
  
HRMS (EI+) Calcd for [M]+: 453.9654 Found 453.9659 
 
Compound 4n 
 
 
 
According to the general procedure, 346 mg of N-vinylphthalimide (2.00 mmol) was allowed to react 
with 989 mg (4.00 mmol) of xanthate 1a for 5 h. The total amount of DLP added was 240 mg 
(0.6 mmol, 30 mol%). Purification via flash chromatography (silica, 1:9 v/v ethyl acetate/petroleum 
spirit elution) afforded adduct 4n (573 mg, 68%) as a yellow oil. 
 
1H NMR  
(400 MHz, CDCl3) 
δ = 7.87 (dd, J = 5.5, 3.1 Hz, 2H), 7.76 (dd, J = 5.5, 3.0 Hz, 2H), 6.33 (t, J = 
7.9 Hz, 1H), 5.81 (s, 1H), 4.64 (q, J = 7.1 Hz, 2H), 3.12 – 2.91 (m, 2H), 2.58 (qd, 
J = 7.5, 1.5Hz, 2H), 1.41 ppm (t, J = 7.1 Hz, 2H) 
  
13C NMR 
(101 MHz, CDCl3) 
δ = 210.7, 195.5, 166.9, 134.6, 131.7, 123.9, 70.8, 69.7, 57.1, 32.1, 27.9, 
13.9 ppm 
  
IR 
(thin film) 
𝜈 = 2983, 1780, 1717, 1612, 1469, 1380, 1335, 1232, 1111, 1045, 882, 793, 
719 cm-1 
  
HRMS (EI+) Calcd for [M]+: 418.9820 Found 418.9836 
 
Compound 4o 
 
 
 
Xanthate 4h (600 mg, 1.27 mmol) was heated to reflux in EtOAc (13 mL) for 15 min under a nitrogen 
atmosphere. DLP (25 mol%) was added every hour until total consumption of starting material. The 
total amount of DLP added was 632 mg (1.56 mmol, 125 mol%). Purification via flash 
chromatography (silica, 3:7 v/v diethyl ether/petroleum spirit) afforded indoline 4o (301 mg, 68%) as 
a yellow oil. 
 
1H NMR  
(400 MHz, CDCl3) 
δ = 7.28 (d, J = 8.6 Hz, 1H), 7.04 (d, J = 8.6 Hz, 1H), 7.03 (s, 1H), 5.83 (s, 1H), 
4.03 (dd, J = 10.4, 9.0 Hz, 1H), 3.64 (dd, J = 10.4, 5.8 Hz, 1H), 3.39 (tt, J = 9.1, 
5.4 Hz, 1H), 3.01 – 2.84 (m, 2H), 2.85 (s, 3H), 2.32 (s, 3H), 2.18 (dddd, J = 13.9, 
8.3, 6.9, 4.9 Hz, 1H), 1.91 ppm (dtd, J = 13.9, 8.4, 5.9 Hz, 1H) 
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13C NMR 
(101 MHz, CDCl3) 
δ = 196.6, 139.5, 134.0, 133.8, 129.3, 125.5, 113.6, 69.9, 56.1, 39.2, 34.3, 
32.1, 28.8, 21.04 ppm 
  
IR 
(thin film) 
𝜈 = 2930, 1738, 1615, 1488, 1408, 1345, 1223, 1159, 1115, 1064, 988, 958, 
819, 771, 7336 cm-1 
  
HRMS (EI+) Calcd for [M]+: 349.0306 Found 349.0300 
 
Compound 4p 
 
 
 
Xanthate 4f (317 mg, 0.59 mmol) was heated to reflux in EtOAc (6 mL) for 15 min under a nitrogen 
atmosphere. DLP (25 mol%) was added every hour until total consumption of starting material. The 
total amount of DLP added was 294 mg (0.74 mmol, 125 mol%). Purification via flash 
chromatography (silica, 0:10 → 2:8 v/v ethyl acetate/petroleum spirit) afforded indoline 4p (163 mg, 
67%) as a yellow oil. 
 
1H NMR  
(400 MHz, CDCl3) 
δ = 7.39 – 7.32 (m, 2H), 7.32 – 7.25 (m, 1H), 5.84 (s, 1H), 4.06 (dd, J = 10.4, 9.1 
Hz, 1H), 3.67 (dd, J = 10.4, 5.9 Hz, 1H), 3.42 (tt, J = 9.3, 5.4 Hz, 1H), 3.05 – 2.91 
(m, 2H), 2.89 (s, 3H), 2.18 (dtd, J = 14.5, 7.5, 5.0 Hz, 1H), 1.92 ppm (dtd, J = 
14.5, 8.1, 5.9 Hz, 1H) 
  
13C NMR 
(101 MHz, CDCl3) 
δ = 196.4, 141.1, 136.2, 131.8, 128.1, 116.6, 115.2, 69.9, 56.1, 39.1, 34.9, 
31.8, 28.6 ppm 
  
IR 
(thin film) 
𝜈 = 2930, 1733, 1477, 1411, 1347, 1241, 1160, 1122, 1067, 961, 880, 820, 
772 cm-1 
  
HRMS (EI+) Calcd for [M]+: 412.9255 Found 412.9259 
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Compound 4q 
 
 
 
According to the general procedure, 1.47 mL of vinyl pivalate (10.0 mmol) was allowed to react with 
1.24 g (5.00 mmol) of xanthate 1a for 1 h. The total amount of DLP added was 200 mg (0.5 mmol, 5 
mol%). Purification via flash chromatography (silica, 4:96 v/v diethyl ether/petroleum spirit elution) 
afforded adduct 4q (1.55 g, 82%) as a yellow liquid. 
 
1H NMR  
(400 MHz, CDCl3) 
δ = 6.64 (t, J = 6.5 Hz, 1H), 5.84 (s, 1H), 4.84 – 4.53 (m, 2H), 3.07 – 2.92 (m, 
2H), 2.42 – 2.20 (m, 2H), 1.42 (t, J = 7.1 Hz, 3H), 1.20 ppm (s, 9H) 
  
13C NMR 
(101 MHz, CDCl3) 
δ = 209.8, 195.6, 176.9, 79.8, 70.5, 69.8, 39.1, 30.9, 28.6, 27.1, 13.81 ppm 
  
IR 
(thin film) 
𝜈 = 2978, 2936, 2873, 1739 (very s), 1480, 1461, 1443, 1397, 1368, 1274, 
1230 (very s), 1134 (very s), 1112, 1050, 1033, 913, 797, 732 cm-1 
  
HRMS (EI+) Calcd for [MC3H5O]
+: 253.0398 Found 253.0393 
 
Compound 4r 
 
 
 
According to the general procedure, 416 mg of 1,1,1-trifluoro-2-(trifluoromethyl)pent-4-en-2-ol 
(2.00 mmol) was allowed to react with 257 mg (1.00 mmol) of xanthate 1a for 3 h. The total amount 
of DLP added was 120 mg (0.3 mmol, 30 mol%). Purification via flash chromatography (silica, 5:95 v/v 
ethyl acetate/petroleum spirit elution) afforded adduct 4r (868 mg, 91%) as a yellow oil. 
 
1H NMR  
(400 MHz, CDCl3) 
δ = 5.84 (s, 1H), 4.67 (qd, J = 7.1, 1.0 Hz, 2H), 4.26 (br. s, 1H; HO), 4.12 – 3.89 
(m, 1H), 3.03 (t, J = 7.5 Hz, 2H), 2.49 (dd, J = 16.6, 4.8 Hz, 1H), 2.41 – 2.28 (m, 
2H), 2.09 – 1.87 (m, 1H), 1.44 ppm (t, J = 7.1 Hz, 3H) 
  
13C NMR 
(101 MHz, CDCl3) 
δ = 211.9, 196.7, 123.0 (q, JC-F = 286.4 Hz; CF3),  76.8 – 75.5 (m), 71.0, 69.8, 
44.6, 35.0, 32.5, 29.2, 13.8 ppm  
  
19F NMR 
(282 MHz, CDCl3) 
δ = 72.09 (q, J = 9.8 Hz), 72.64 ppm (q, J = 9.9 Hz) 
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IR 
(thin film) 
𝜈 = 3456, 2988, 1738, 1446, 1371, 1217, 1147, 1114, 1048, 1004, 938, 853, 
793, 767, 722 cm-1  
  
HRMS (EI+) Calcd for [M]+: 453.9666 Found 453.9670 
 
Compound 4s 
 
 
 
According to the general procedure, 276 mg of 2-allylcyclohexanone (2.00 mmol) was allowed to 
react with 247 mg (1.00 mmol) of xanthate 1a for 4 h. The total amount of DLP added was 120 mg 
(0.3 mmol, 30 mol%). Purification via flash chromatography (silica, 5:95 v/v ethyl acetate/petroleum 
spirit elution) afforded adduct 4s (274 mg, 71%) as a yellow oil. 
 
1H NMR  
(400 MHz, CDCl3) 
δ = 5.87 (s, 0.5H), 5.83 (s, 0.5H), 4.72 – 4.49 (m, 2H), 3.91 – 3.63 (m, 1H), 3.10 
– 2.95 (m, 2H), 2.64 – 2.46 (m, 1H), 2.46 – 2.38 (m, 1H), 2.38 – 2.15 (m, 4H), 
2.11 (m, 3.5H), 2.06 – 1.91 (m, 0.5H), 1.86 (m, 0.5H), 1.79 – 1.58 (m, 1.5H), 
1.44 (t, J = 7.2 Hz, 1.5H) 1.41 (t, J = 7.1 Hz, 1.5H), 1.37 – 1.24 ppm (m, 1H) 
  
13C NMR 
(101 MHz, CDCl3) 
δ = 214.2, 214.1, 212.4, 212.2, 196.7, 196.6, 70.4, 70.3, 70.02, 69.97, 49.6, 
48.5, 48.4, 48.2, 42.5, 42.2, 35.4, 34.8, 34.0, 33.5, 32.9, 32.5, 29.9, 29.5, 28.4, 
28.0, 25.5, 25.2, 13.9, 13.90 ppm 
  
IR 
(thin film) 
𝜈 =  2932, 2859, 1736, 1708, 1447, 1404, 1368, 1291, 1218, 1146, 1130, 1111, 
1048, 1004, 791, 730 cm-1 
  
HRMS (EI+) Calcd for [M]+: 384.0387 Found 384.0393 
 
Compound 4t 
 
 
 
According to the general procedure, 230 mg of (2R,3S,4R,5R,6S)-5-acetamido-2-(acetoxymethyl)-6-
(allyloxy)tetrahydro-2H-pyran-3,4-diyl diacetate (0.59 mmol) was allowed to react with 293 g 
(1.19 mmol) of xanthate 1a for 6 h. The total amount of DLP added was 35 mg (0.09 mmol, 15 mol%). 
Purification via flash chromatography (silica, 2:8 v/v ethyl acetate/diethyl ether elution) afforded 
adduct 4t (310 mg, 83%) as a yellow oil. 
 
1H NMR  δ = 5.86 (s, 0.5H), 5.85 (s, 0.5H), 5.84 (d, J = 8.7 Hz, 0.5H; NH), 5.78 (d, J = 9.4 
218
S16 
 
(400 MHz, CDCl3) Hz, 0.5H; NH),
 5.23 – 5.09 (m, 2H), 4.90 (d, J = 3.8 Hz, 0.5H), 4.87 (d, J = 3.7 Hz, 
0.5H), 4.68 (q, J = 7.1 Hz, 1H), 4.67 (q, J = 7.1 Hz, 1H), 4.36 (tdd, J = 9.6, 5.6, 
3.7 Hz, 1H), 4.24 (ddd, J = 12.3, 6.3, 4.4 Hz, 1H), 4.10 (ddd, J = 12.4, 6.5, 
4.0 Hz, 1H), 4.03 – 3.96 (m, 2H), 3.96 – 3.83 (m, 1H), 3.66 (dd, J = 10.3, 5.0 Hz, 
0.5H), 3.60 (dd, J = 9.8, 5.8 Hz, 0.5H), 3.13 – 2.82 (m, 2H), 2.39 – 2.21 (m, 1H), 
2.09 (s, 1.5H), 2.09 (s, 1.5H), 2.03 (s, 3H), 2.02 (s, 3H), 1.99 (s, 1.5H), 1.97 (s, 
1.5H), 1.96 – 1.84 (m, 1H), 1.44 (t, J = 7.1 Hz, 1.5H),1.43 ppm (t, J = 7.1 Hz, 
1.5H) 
  
13C NMR 
(101 MHz, CDCl3) 
δ = 213.0, 212.8, 196.6, 196.5, 171.4, 171.41, 170.7, 170.3, 170.2, 169.4, 98.1, 
97.8, 71.4, 70.84, 70.80, 70.6, 70.3, 69.89, 69.87, 68.4, 68.3, 62.1, 62.07, 52.1, 
52.08, 50.1, 49.7, 32.4, 25.2, 24.9, 23.29, 23.26, 20.9, 20.7, 13.92, 13.9 ppm 
  
IR 
(thin film) 
𝜈 = 3301, 2956, 1747, 1667, 1529, 1443, 1367, 1229, 1114, 1045, 914, 
735  cm-1 
  
HRMS (EI+) Calcd for [MC3H5OS2]
+: 512.1090  Found 512.1086 
 
Compound 4u 
 
 
 
According to the general procedure, 94 mg of norbornene (1.00 mmol) was allowed to react with 
494 mg (2.00 mmol) of xanthate 1a for 3 h. The total amount of DLP added was 80 mg (0.2 mmol, 
20 mol%). Purification via flash chromatography (silica, 1:99 v/v diethyl ether/petroleum spirit 
elution) afforded adduct 4u (193 mg, 57%) as a yellow oil. 
 
1H NMR  
(400 MHz, CDCl3) 
Major product (cis) 
δ = 5.78 (s, 1H), 4.56 (q, J = 7.1 Hz, 2H), 3.80 (dd, J = 8.3, 2.0 Hz, 1H), 2.81 – 
2.73 (m, 2H), 2.56 – 2.49 (m, 1H), 2.30 (dd, J = 4.7, 1.5Hz, 1H), 1.98 (dd, J = 
4.3, 1.8 Hz, 1H), 1.68 – 1.49 (m, 3H), 1.46 – 1.27 (m, 2H), 1.34 (t, J = 7.1 Hz, 
3H), 1.15 ppm (dt, J = 10.4, 1.8 Hz, 1H) 
 
characteristic peaks for minor product (trans) 
δ = 5.72 (s, 1H), 4.57 (d, J = 7.1 Hz, 2H), 3.52 (ddd, J = 6.1, 3.8, 2.3 Hz, 1H), 
2.97 – 2.81 (m, 2H), 2.61 – 2.55 (m, 1H), 1.86 – 1.74 ppm (m, 1H) 
  
13C NMR 
(101 MHz, CDCl3) 
Major product (cis) 
δ = 214.4, 196.1, 70.14, 70.12, 56.5, 44.3, 42.2, 42.1, 38.4, 34.9, 29.3, 29.0,  
13.92 ppm 
 
characteristic peaks for minor product (trans) 
δ = 215.2, 195.84, 70.1, 70.0, 56.9, 44.1, 41.7, 41.1, 40.4, 36.3, 29.7, 23.5, 
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14.0 ppm 
  
IR 
(thin film) 
𝜈 = 2955, 2873, 1734, 1456, 1370, 1213, 1145, 1111, 1050, 946, 799, 726 cm-1  
  
HRMS (EI+) Calcd for [M]+: 340.0125 Found 340.0124 
 
Compound 4v 
 
 
According to the general procedure, N-allylphthalidimide (94 mg, 0.5 mmol) was allowed to react 
with xanthate 1a (247 mg, 1 mmol) for 4 h. The total amount of DLP added was 40 mg (0.1 mmol, 
20 mol %). Purification via flash chromatography (silica, 1:10 v/v ethyl acetate/petroleum spirit 
elution) afforded adduct 4v (118 mg, 63%), contaminated with a small amount of inseperable DLP 
residues. The impure compound was submitted to subsequent reactions in the absence of further 
purification. 
 
Compound 7a 
 
 
According to the general procedure, vinyl acetate (43 mg, 0.5 mmol) was allowed to react with 
xanthate 6 (289 mg, 1 mmol) for 6 h. The total amount of DLP added was 60 mg (0.15 mmol, 30 mol 
%). Purification via flash chromatography (silica, 1:20 → 1:10 v/v ethyl acetate/petroleum spirit 
elution) afforded adduct 7a (177 mg, 91%) as a pale yellow oil.  
 
1H NMR  
(400 MHz, CDCl3) 
δ = 5.83 (s, 1H), 4.34 (dd, J = 11.5, 4.8 Hz, 1H), 4.29 – 4.23 (m, 3H), 4.08 – 4.00 (m, 
1H), 4.08 – 4.00 (m, 1H), 3.05 (app. t, J = 8.2 Hz, 2H), 2.21 (dd, J = 7.4, 4.9 Hz, 1H), 
2.09 (s, 3H), 1.97 (dd, J = 7.4, 4.9 Hz, 1H), 1.01 ppm (s, 9H) 
  
13C NMR 
(101 MHz, CDCl3) 
δ = 212.8, 196.2, 170.5, 83.8, 69.7, 65.6, 48.5, 32.3, 31.9, 26.6, 25.0, 20.7 ppm 
  
IR  
(thin film) 
𝜈 = 2961, 2873, 1745, 1466, 1367, 1230, 1066, 1029, 951 cm-1  
 
  
HRMS  
(EI+) 
Calculated for [MC2H3O2]
+: 328.0125                                                 Found: 328.0133 
 
 
Compound 7b  
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According to the general procedure, allyl 4-chlorobenzoate (98 mg, 0.5 mmol) was allowed to react 
with xanthate 6 (289 mg, 1 mmol) for 8 h. The total amount of DLP added was 80 mg (0.2 mmol, 40 
mol %). Purification via flash chromatography (silica, 1:20 v/v ethyl acetate/petroleum spirit elution) 
afforded adduct 7b (185 mg, 76%) as a pale yellow oil. 
 
1H NMR  
(400 MHz, CDCl3) 
δ = 7.97 (d, J = 8.6 Hz, 2H), 7.43 (d, J = 8.6 Hz, 2H), 5.84 (s, 1H), 4.57 (d, J = 4.7 Hz, 
1H), 4.53 (d, J = 6.0 Hz, 1H), 4.27 (d, J = 2.0 Hz, 2H), 4.24 – 4.13 (m, 1H), 3.10 (app. 
t, J = 7.2 Hz, 2H), 2.40 – 2.22 (m, 1H), 2.13 – 1.96 (m, 1H), 1.01 ppm (s, 9H) 
  
13C NMR 
(101 MHz, CDCl3) 
δ = 212.8, 196.1, 165.3, 139.8, 131.1, 128.9, 128.1, 83.9, 69.7, 66.3, 48.8, 32.2, 
31.9, 26.5, 25.0 ppm 
  
IR  
(thin film) 
𝜈 = 2960, 1727, 1595, 1368, 1270, 1229, 1065, 1015, 849, 759 cm-1  
  
HRMS  
(EI+) 
Calculated for [MC3H5OS2]
+: 320.9853                                               Found: 320.9860 
  
 
Compound 7c 
 
 
 
According to the general procedure, 266 µL of allylbenzene (2.00 mmol) was allowed to react with 
289 mg (1.00 mmol) of xanthate 1a for 4 h. The total amount of DLP added was 160 mg (0.4 mmol, 
40 mol%). Purification via flash chromatography (silica, 0:100 → 15:985 v/v ethyl acetate/petroleum 
spirit elution) afforded adduct 7c (324 mg, 80%) as a yellow oil. 
 
1H NMR  
(400 MHz, CDCl3) 
δ = 7.39 – 7.20 (m, 5H), 5.78 (s, 1H), 4.26 (s, 2H), 4.11 – 3.97 (m, 1H), 3.21 (dd, 
J = 13.9, 5.9 Hz, 1H), 3.08 – 2.87 (m, 2H), 2.88 (dd, J = 13.9, 8.7 Hz, 1H), 2.17 – 
2.09 (m, 1H), 1.95 – 1.77 (m, 1H), 1.01 ppm (s, 9H) 
  
13C NMR 
(101 MHz, CDCl3) 
δ = 214.2, 196.5, 138.1, 129.5, 128.7, 127.0, 83.6, 69.9, 51.4, 41.5, 32.8, 32.0, 
26.8 ppm 
  
IR 
(thin film) 
𝜈 =  2959, 2928, 2869, 1735, 1496, 1466, 1454, 1401, 1367, 1273, 1224, 1066, 
1029, 951, 913, 747, 700 cm-1 
  
HRMS (EI+) Calcd for [MC6H12OS2]
+: 242.0265 Found 242.0270 
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Products of Ozonolysis reactions.  
 
Compound 9a 
 
 
According to the general procedure, xanthate adduct 4a (169 mg, 0.48 mmol) was treated with 
ozone for 0.25 h. Thiocarbonate 9a (153 mg, 95%) was obtained as a clear oil. 
 
1H NMR  
(400 MHz, CDCl3) 
δ = 5.84 (s, 1H), 4.33 – 4.22 (m, 4H), 3.59 (dd, J = 10.4, 5.1 Hz, 1H), 3.03 (m, 2H), 
2.16 (m, 1H), 2.08 (s, 3H), 1.92 (m, 1H), 1.31 ppm (t, J = 7.1 Hz, 3H). 
  
13C NMR 
(101 MHz, CDCl3) 
δ = 196.2, 170.5, 169.5, 100.0, 69.8, 69.7, 66.2, 64.1, 44.3, 32.3, 25.4, 20.7, 
14.3 ppm 
  
IR  
(thin film) 
𝜈 = 2984, 2939, 1745, 1704, 1447, 1384, 1366, 1238, 1147, 1034, 850, 788 cm-1  
 
  
HRMS  
(EI+) 
Calculated for [MC2H3O2]
+: 269.884                                                Found: 269.9873 
 
 
Compound 9b 
 
 
According to the general procedure, xanthate adduct 4c (299 mg, 0.67 mmol) was treated with ozone 
for 0.25 h. The product was purified via flash chromatography (silica, 1:10 v/v ethyl 
acetate/petroleum spirit elution). Concentration of the relevant fractions afforded thiocarbonate 9b 
(264 mg, 92 %) as a clear oil. 
 
1H NMR  
(400 MHz, CDCl3) 
δ = 7.98 (d, J = 8.5 Hz, 2H), 7.42 (d, J = 8.6 Hz, 2H), 5.85 (s, 1H), 4.52 (dd, J = 11.4, 
5.4 Hz, 1H), 4.46 (dd, J = 11.4, 6.1 Hz, 1H), 4.28 (q, J = 7.2 Hz, 2H), 3.73 (ddd, J = 
15.87, 10.4, 5.3, Hz, 1H), 3.13 – 3.04 (app. t, J = 7.3 Hz, 1H), 2.31 – 2.26 (ddd, J = 
15.0, 7.5, 4.4 Hz, 1H), 2.04 – 1.92 (m, 1H), 1.30 ppm (t, J = 7.1 Hz, 3H) 
  
13C NMR 
(101 MHz, CDCl3) 
δ = 196.2, 169.4, 165.2, 139.8, 131.1, 128.8, 128.2, 69.7, 66.8, 64.2, 44.5, 32.2, 
25.4, 14.3 ppm 
  
IR  
(thin film) 
𝜈 = 2925, 2855, 1723, 1595, 1490, 1452, 1270, 1144, 1092, 1051, 1015, 850, 
759 cm-1 
  
HRMS  
(EI+) 
Calculated for [MC3H5O2S]
+: 320.5847                                             Found 320.5036 
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Compound 9c 
 
 
According to the general procedure, xanthate adduct 4k (80 mg, 0.22 mmol) was treated with ozone 
for 0.25 h. The product was further purified via flash chromatography (silica, 1:20 v/v ethyl 
acetate/petroleum spirit elution). Concentration of the relevant fractions afforded thiocarbonate 9c 
(55 mg, 82%) as a clear oil. 
 
1H NMR  
(400 MHz, CDCl3) 
δ = 7.32 (m, 2H), 7.25 (m, 3H), 5.82 (s, 1H), 4.27 (q, J = 7.1 Hz, 2H), 3.70 – 3.54 
(m, 1H), 3.09 (dd, J = 13.8, 6.3 Hz, 1H), 3.04 – 2.97 (m, 1H), 2.97 – 2.87 (m, 2H), 
2.18 – 2.07 (m, 1H), 1.90 – 1.79 (m, 1H), 1.30 ppm (t, J = 7.1 Hz, 3H) 
  
13C NMR 
(101 MHz, CDCl3) 
δ = 196.3, 170.1, 138.1, 129.3, 128.4, 126.7, 69.8, 63.6, 47.1, 42.1, 32.7, 27.8, 
14.2 ppm 
IR  
(thin film) 
𝜈 = 3063, 3029, 2982, 2918, 2851, 1699, 1496, 1454, 1143, 1016, 849, 789, 701 
cm-1  
  
HRMS  
(EI+) 
Calculated for [MC3H5O2S]
+: 242.0265                                            Found 242.0262 
 
Compound 9d 
 
 
 
According to the general procedure, xanthate adduct 4m (200 mg, 0.449 mmol) was treated with 
ozone for 0.33 h. Thiocarbonate 9d (189 mg, 98%) was obtained as a clear oil. 
 
1H NMR  
(400 MHz, CDCl3) 
δ = 5.83 (s, 1H), 4.23 (q, J = 7.3 Hz, 2H), 3.62 – 3.52 (m, 1H), 3.17 – 2.95 (m, 
4H), 2.14 (ddt, J = 15.0, 7.7, 3.9 Hz, 1H), 2.02 – 1.87 (m, 1H), 1.27 ppm (t, J = 
7.2 Hz, 3H) 
  
13C NMR 
(101 MHz, CDCl3) 
δ = 196.3, 169.5, 147.38 – 143.27 (m), 141.97 – 138.99 (m), 139.06 – 135.74 
(m), 112.59 – 110.80 (m), 69.8, 64.2, 45.4, 32.5, 28.6, 28.1, 14.3 ppm 
  
19F NMR 
(282, CDCl3) 
δ = 136.94 (dd, J = 22.8, 8.2 Hz), 150.92 (t, J = 21.0 Hz), 157.36 ppm (td, J 
= 22.6, 8.5 Hz) 
  
IR 
(thin film) 
𝜈 = 2985, 1705, 657, 1522, 1504, 1448, 1367, 1300, 1148, 1049, 1013, 974, 
906, 849, 736, 675 cm-1 
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HRMS (EI+) Calcd for [M]+: 437.9883 Found 437.9890 
 
Compound 9e 
 
 
 
According to the general procedure, xanthate adduct 4u (140 mg, 0.410 mmol) was treated with 
ozone for 0.25 h. Purification via flash chromatography (silica, 2:98 v/v diethyl ether/petroleum spirit 
elution) afforded thiocarbonate 9e (83 mg, 75%) as a yellow oil. 
 
1H NMR  
(400 MHz, CDCl3) 
Major product (cis) 
δ = 5.87 (s, 1H), 4.25 (q, J = 7.1 Hz, 2H), 3.60 (dd, J = 8.4, 2.1 Hz, 1H), 2.92 – 
2.73 (m, 2H), 2.53 (tdd, J = 8.2, 6.3, 1.5Hz, 1H), 2.32 (dd, J = 4.7, 1.6 Hz, 1H), 
2.01 (dd, J = 3.8, 1.6 Hz, 1H), 1.74 – 1.51 (m, 2H), 1.47 – 1.31 (m, 3H), 1.29 (t, J 
= 7.1 Hz, 3H), 1.20 ppm (dt, J = 10.5, 1.8 Hz, 1H) 
 
characteristic peaks for minor product (trans) 
δ = 5.81 (s, 1H), 3.23 (ddd, J = 5.8, 3.8, 2.2 Hz, 1H), 3.08 – 2.88 (m, 2H), 2.49 – 
2.45 (m, 1H), 1.88 – 1.80 ppm (m, 1H) 
  
13C NMR 
(101 MHz, CDCl3) 
Major product (cis) 
δ = 196.0, 170.6, 70.1, 63.82, 52.2, 45.4, 42.1, 42.0, 38.7, 34.5, 29.5, 28.6,  
14.4 ppm  
 
characteristic peaks for minor product (trans) 
δ = 196.0, 171.3, 70.1, 63.6, 52.5, 45.3, 41.9 (2 CH), 40.6, 36.4, 29.7, 23.4, 14.4 
ppm  
  
IR 
(thin film) 
𝜈 = 2957, 2874, 1701, 1456, 1372, 1297, 1143, 1014, 850, 798, 725, 675 cm-1  
  
HRMS (EI+) Calcd for [M]+: 324.354 Found 324.0336 
 
Compound 9f 
 
 
 
According to the general procedure, xanthate adduct 4s (250 mg, 0.65 mmol) was treated with ozone 
for 1 h. Purification via flash chromatography (silica, 5:95 → 1:9 v/v ethyl acetate/petroleum spirit) 
afforded thiocarbonate 9f (156 mg, 65%) as a yellow oil.  
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1H NMR  
(400 MHz, CDCl3) 
δ = 5.87 (s, 0.5H), 5.85 (s, 0.5H), 4.28 (qd, J = 7.1, 1.4 Hz, 1H), 4.25 (q, J = 7.2 
Hz, 1H), 3.45 – 3.34 (m, 1H), 3.08 – 2.91 (m, 2H), 2.63 – 2.48 (m, 1H), 2.45 – 
2.30 (m, 2H), 2.26 – 2.14 (m, 2H), 2.13 – 2.04 (m, 2H), 2.00 – 1.82 (m, 2H), 
1.76 – 1.61 (m, 2H), 1.53 – 1.36 (m, 2H), 1.32 (t, J = 7.1 Hz, 1.5H), 1.30 ppm (t, 
J = 7.2 Hz, 1.5H) 
  
13C NMR 
(101 MHz, CDCl3) 
δ = 212.2, 212.1, 196.7, 196.6, 170.6, 170.5, 70.07, 70.05, 64.0, 63.8, 48.5, 
48.3, 45.2, 43.9, 42.5, 42.2, 35.4, 35.3, 34.2, 33.7, 32.9, 32.6, 30.5, 29.9, 28.4, 
28.0, 25.6, 25.3, 14.4 ppm  
  
IR 
(thin film) 
𝜈 =  2934, 2861, 1704, 1447, 1367, 1311, 1143, 1015, 849, 788, 736, 675 cm-1  
  
HRMS (EI+) Calcd for [M]+: 368.0616 Found 368.0610 
 
Compound 9g 
 
 
According to the general procedure, xanthate adduct 4r (238 mg, 0.54 mmol) was treated with ozone 
for 0.25 h. The product was further purified via flash chromatography (silica, 1:5 v/v ethyl 
acetate/petroleum spirit elution). Concentration of the relevant fractions afforded thiocarbonate 9g 
(219 mg, 92%) as a clear oil. 
 
1H NMR  
(400 MHz, CDCl3) 
δ = 5.83 (s, 1H), 5.48 (s, 1H), 4.34 (dd, J = 7.15, 2.7 Hz, 1H), 4.32 (dd, J = 7.15, 2.6 
Hz, 1H), 3.64 (m, 1H), 3.03 (m, 1H), 2.99 (m, 1H), 2.49 (m, 1H), 2.44 (m, 1H), 2.20 
(m, 1H), 1.96 (m, 1H), 1.33 ppm (t, J = 7.1 Hz, 3H) 
  
13C NMR 
(101 MHz, CDCl3) 
δ = 196.0, 195.0, 171.6, (127.3, 124.4, 121.6, 118.7) [CF coupling], (127.2, 124.3, 
121.5, 118.6) [CF coupling], (76.1, 75.8, 75.5, 75.2) [CF coupling], 69.6, 65.0, 39.4, 
38.0, 32.7, 29.1, 14.1 ppm 
  
19F NMR 
(282 MHz, CDCl3) 
δ = -71.4 (m), -73.7 ppm (m)  
  
IR  
(thin film) 
𝜈 = 3356, 2988, 2943, 2910, 1732, 1674, 1448, 1371, 1212, 1065, 1010, 958 cm-1  
  
HRMS  
(EI+) 
Calculated for [M]+: 437.9894                                                           Found: 437.9890 
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Compound 9h 
 
 
 
According to the general procedure, xanthate adduct 4t (106 mg, 0.167 mmol) was treated with 
ozone for 0.17 h. Thiocarbonate 9h (96 mg, 93%) was obtained as a yellow oil. 
 
1H NMR  
(400 MHz, CDCl3) 
δ = 5.95 (d, J = 9.6 Hz, 0.5H; NH), 5.87 (d, J = 9.1 Hz, 0.5H; NH), 5.86 (s, 0.5H), 
5.86 (s, 0.5H), 5.27 – 5.05 (m, 2H), 4.87 (d, J = 3.8 Hz, 0.5H), 4.86 (d, J = 3.7 Hz, 
0.5H), 4.40 – 4.28 (m, 3H), 4.27 – 4.21 (m, 1H), 4.09 (dq, J = 12.2, 2.2 Hz, 1H), 
4.04 – 3.92 (m, 1H), 3.87 – 3.81 (m, 1H), 3.69 – 3.57 (m, 1H), 3.57 – 3.45 (m, 
1H), 3.11 – 3.01 (m, 2H), 2.27 (dtd, J = 14.8, 7.5, 4.6 Hz, 0.5H), 2.20 – 2.12 (m, 
0.5H), 2.08 (s, 3H), 2.03 (s, 1.5H), 2.02 (s, 1.5H), 2.01 (s, 1.5H), 2.01 (s, 1.5H), 
1.97 (s, 1.5H), 1.97 (s, 1.5H), 1.94 – 1.84 (m, 1H), 1.32 (t, J = 7.2 Hz, 1.5H), 
1.31 ppm (t, J = 7.1 Hz, 1.5H) 
  
13C NMR 
(101 MHz, CDCl3) 
δ = 196.6, 196.5, 171.4, 171.3, 170.8, 170.3, 170.0, 169.7, 169.40, 169.38, 
98.2, 97.8, 71.6, 71.4, 71.4, 70.8, 69.88, 69.86, 68.4, 68.3, 68.2, 64.5, 64.4, 
62.0, 52.1, 52.0, 45.5, 45.3, 32.4, 32.3, 25.5, 25.3, 23.22, 23.19, 20.8, 20.7, 
14.38, 14.36 ppm 
  
IR 
(thin film) 
𝜈 = 3373, 2957, 1747, 1704, 1680, 1531, 1368, 1233, 1148, 1044, 960, 914, 
850, 785, 733, 676  cm-1  
  
HRMS (EI+) Calcd for [MC3H5O2S]
+: 512.1090 Found 512.1082 
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Products of Favorskii Rearrangements.  
 
Compound 5a 
 
 
According to the general procedure, of xanthate adduct 4a (160 mg, 0.46 mmol) was allowed to react 
with NEt3 (0.19 mL, 1.38 mmol) for 48 h. Purification via flash chromatography (silica, 1:5 v/v ethyl 
acetate/petroleum spirit elution) afforded enone 5a (83 mg, 59%) as a pale yellow oil. 
 
1H NMR  
(400 MHz, CDCl3) 
δ = 6.26 (ddd, J = 11.5, 7.2, 4.2 Hz, 1H), 5.90 (dd, J = 11.6, 1.8 Hz, 1H), 4.64 (q, 
J = 7.1 Hz, 2H), 4.31 (dd, J = 11.4, 5.2 Hz, 1H), 4.24 (dd, J = 11.5, 6.2 Hz, 1H), 
4.09 (m, 1H), 3.71 (s, 3H), 3.20 (m, 1H), 3.06 (m, 1H), 2.07 (s, 3H), 1.42 ppm (t, 
J = 7.1 Hz, 3H) 
  
13C NMR 
(101 MHz, CDCl3) 
δ = 212.8, 170.6, 166.3, 145.0, 121.9, 70.3, 65.1, 51.2, 48.8, 29.9, 20.7, 
13.7 ppm 
  
IR  
(thin film) 
𝜈 = 2986, 2952, 1746, 1722, 1650, 1439, 1382, 1226, 1112, 1050, 819 cm-1  
 
  
HRMS  
(EI+) 
Calculated for [M]+: 306.0596                                                       Found: 306.0588 
 
Compound 5b 
 
 
According to the general procedure, xanthate adduct 4c (200 mg, 0.49 mmol) was allowed to react 
with NEt3 (0.21 mL, 1.50 mmol) for 36 h. Purification via flash chromatography (silica, 1:10 v/v ethyl 
acetate/petroleum spirit elution) afforded enone 5b (109 mg, 55%) as a pale yellow oil. 
 
1H NMR  
(400 MHz, CDCl3) 
δ = 7.98 (d, J = 8.6 Hz, 1H), 7.42 (d, J = 8.6 Hz, 1H), 6.31 (dd, J = 11.5, 7.3 Hz, 
1H), 5.93 (d, J = 11.4 Hz, 1H), 4.65 (dd, J = 7.2, 4.1 Hz, 1H), 4.62 (dd, J = 7.2, 
4.1 Hz, 1H), 4.56 (dd, J = 11.4, 5.3 Hz, 1H), 4.50 (dd, J = 11.4, 6.0 Hz, 1H), 4.24 
(m, 1H), 3.68 (s, 3H), 3.32 (m, 1H), 3.14 (m, 1H), 1.41 (t, J = 7.1 Hz, 3H) ppm 
  
13C NMR 
(101 MHz, CDCl3) 
δ = 212.7, 166.3, 165.2, 144.6, 139.7, 131.1, 128.8, 128.2, 122.2, 70.4, 65.8, 
51.2, 49.0, 30.0, 13.7 ppm 
  
IR  
(thin film) 
𝜈 = 2986, 2951, 1724, 1650, 1595, 1439, 1403, 1270, 1217, 1115, 1092, 1049, 
850, 759, 684 cm-1 
  
HRMS  
(EI+) 
Calculated for [M]+: 402.0362                                                      Found: 402.0351 
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Compound 5c 
 
 
According to the general procedure, xanthate adduct 4b (150 mg, 0.42 mmol) was allowed to react 
with NEt3 (0.18 mL, 1.26 mmol) for 48 h. Purification via flash chromatography (silica, 1:5 v/v ethyl 
acetate/petroleum spirit elution) afforded enone 5c (36 mg, 27%) as a pale yellow oil. 
 
1H NMR  
(400 MHz, CDCl3) 
(mixture of diastereomers) δ = 6.29 (ddd, J = 11.4, 7.1, 4.4 Hz, 1H), 5.87 (d, J = 
11.4 Hz, 1H), 4.63 (q, J = 7.0 Hz, 2H), 4.04 (m, 1H), 3.83 – 3.70 (m, 2H), 3.71 (s, 
3H), 3.66 – 3.56 (m, 1H), 3.43 (ddd, J = 11.6, 5.8, 2.0 Hz, 1H), 3.24 (m, 1H), 3.13 
(m, 2H), 2.78 (app. t, J = 4.3 Hz, 1H), 2.61 (m, 1H), 1.41 ppm (t, J = 7.1 Hz, 3H) 
  
13C NMR 
(101 MHz, CDCl3) 
(mixture of diastereomers) δ = 213.7, 166.4, 145.8, 145.8, 121.5, 72.7, 72.6, 71.7, 
71.6, 70.1, 51.1, 50.7, 49.9, 49.8, 44.1, 30.2, 13.7 ppm 
  
IR  
(thin film) 
𝜈 = 2900, 2951, 1722, 1648, 1439, 1207, 1112, 1050, 909, 818, 761 cm-1 
 
  
HRMS  
(EI+) 
Calculated for [M]+: 320.0752                                                            Found: 320.0759 
 
Compound 5d 
 
 
 
According to the general procedure, xanthate adduct 4l (61 mg, 0.168 mmol) was allowed to react 
with NEt3 (70 µL, 0.50 mmol) for 31 h. Purification via flash chromatography (silica, 1:15 v/v diethyl 
ether/petroleum spirit elution) afforded enone 5d (34 mg, 63%) as a colorless oil. 
 
1H NMR  
(400 MHz, CDCl3) 
δ = 6.28 (dt, J = 11.5, 7.0 Hz, 1H), 5.88 (dt, J = 11.5, 1.9 Hz, 1H), 4.63 (q, J = 7.1 
Hz, 2H), 3.96 (qd, J = 7.5, 5.1 Hz, 1H), 3.70 (s, 3H), 3.19 (dddd, J = 16.5, 7.0, 
5.2, 2.0 Hz, 1H), 3.05 (dtd, J = 16.5, 7.3, 1.8 Hz, 1H), 1.41 (t, J = 7.1 Hz, 3H), 
1.12 (dd, J = 14.9, 7.3 Hz, 1H), 1.02 (dd, J = 14.9, 8.1 Hz, 1H), 0.07 ppm (s, 9H) 
  
13C NMR 
(101 MHz, CDCl3) 
δ = 214.3, 166.7, 146.5, 121.4, 69.8, 51.3, 48.0, 35.9, 22.9, 13.9, 0.7 ppm 
  
IR 
(thin film) 
𝜈 = 2986, 2955, 2900, 2857, 1717, 1440, 1409, 1364, 1328, 1292, 1251, 1214, 
1181, 1112, 1051, 1001 cm-1 
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HRMS (EI+) Calcd for [M]+ : 320.0936 Found 320.0935 
 
Compound 5e 
 
 
According to the general procedure, xanthate adduct 4v (100 mg, 0.35 mmol) was allowed to react 
with NEt3 (0.14 mL, 1.05 mmol) for 48 h. Purification via flash chromatography (silica, 1:5 v/v ethyl 
acetate/petroleum spirit elution) afforded enone 5e (50 mg, 58%) as a pale yellow oil. 
 
1H NMR  
(400 MHz, CDCl3) 
δ = 7.84 (dd, J = 5.4, 3.1 Hz, 2H), 7.72 (dd, J = 5.5, 3.0 Hz, 2H), 6.32 (dd, J = 11.4, 
7.2 Hz, 1H), 5.90 (dd, J = 11.6, 1.7 Hz, 1H), 4.63 – 4.47 (m, 2H), 4.34 – 4.18 (m, 
1H), 3.99 (dd, J = 14.0, 8.4 Hz, 1H), 3.95 (dd, J = 14.0, 8.0 Hz, 1H), 3.66 (s, 3H), 
3.26 – 3.15 (m, 1H), 3.14 – 3.01 (m, 1H), 1.39 ppm (t, J = 7.1 Hz, 3H) 
  
13C NMR 
(101 MHz, CDCl3) 
δ = 212.4, 168.1, 166.4, 144.9, 134.3, 134.2, 132.0, 123.62, 123.5, 122.2, 70.4, 
51.3, 48.8, 40.6, 31.1, 13.8 ppm 
  
IR  
(thin film) 
𝜈 = 2989, 2930, 2553, 2421, 2308, 2219, 1774, 1716, 1440, 1384, 1224, 1112, 
1049, 1020 cm-1 
  
HRMS  
(EI+) 
Calculated for [M]+: 393.0705                                                            Found: 393.0701 
 
Compound 5f 
 
 
 
According to the general procedure, xanthate adduct 4m (77 mg, 0.17 mmol) was allowed to react 
with NEt3 (71 µL, 0.51 mmol) for 43 h. Purification via flash chromatography (silica, 5:95 v/v diethyl 
ether/petroleum spirit elution) afforded enone 5f (40 mg, 56%) as a pale yellow oil 
 
1H NMR  
(400 MHz, CDCl3) 
δ = 6.28 (dt, J = 11.5, 7.3 Hz, 1H), 5.92 (dt, J = 11.5, 1.7 Hz, 1H), 4.60 (qd, J = 
7.1, 1.1 Hz, 2H), 4.11 (qd, J = 7.8, 6.0 Hz, 1H), 3.71 (s, 3H), 3.26 – 2.95 (m, 4H), 
1.40 ppm (t, J = 7.1 Hz, 3H) 
  
13C NMR 
(101 MHz, CDCl3) 
δ = 212.7, 166.5, 147.59 – 143.53 (m), 144.9, 142.88 – 139.08 (m), 139.08 – 
135.81 (m), 122.3, 112.31 – 110.92 (m), 70.4, 51.4, 49.5, 32.9, 27.4, 13.8 ppm 
  
19F NMR 
(282 MHz, CDCl3)
 
δ = -136.76 (dd, J = 22.6, 8.4 Hz),-150.92 (t, J = 20.8 Hz), -136.76 (dd, J = 22.6, 
8.4 Hz) 
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IR 
(thin film) 
𝜈 = 2926, 2855, 1723, 1652, 1521,1505, 1440, 1212, 1180, 1123, 1050, 970, 
818, 731 cm-1 
  
HRMS (EI+) Calcd for [M]+ : 414.0383 Found 414.0389  
 
Compound 5g 
 
 
 
According to the general procedure, xanthate adduct 4k (108 mg, 0.296 mmol) was allowed to react 
with NEt3 (123 µL, 0.887 mmol) for 48 h. Purification via flash chromatography (silica, 5:95 v/v diethyl 
ether/petroleum spirit elution) afforded enone 5g (50 mg, 52%) as a yellow oil. 
 
1H NMR  
(400 MHz, CDCl3) 
δ = 7.38 – 7.19 (m, 5H), 6.23 (dt, J = 11.5, 7.1 Hz, 1H), 5.86 (dt, J = 11.5, 1.9 Hz, 
1H), 4.62 (qd, J = 7.1, 3.0 Hz, 2H), 4.05 (tt, J = 8.2, 6.0 Hz, 1H), 3.68 (s, 3H), 
3.17 (dd, J = 13.9, 6.3 Hz, 1H), 3.10 – 3.00 (m, 2H), 2.88 (dd, J = 13.9, 8.4 Hz, 
1H), 1.41 ppm (t, J = 7.1 Hz, 3H) 
  
13C NMR 
(101 MHz, CDCl3) 
δ = 214.0, 166.6, 146.1, 138.4, 129.5, 128.6, 126.9, 121.7, 70.0, 51.9, 51.3, 
41.0, 32.1, 13.9 ppm 
  
IR 
(thin film) 
𝜈 = 3028, 2987, 2949, 1722, 1648, 1496, 1438, 1407, 1208, 1176, 1111, 1050, 
816, 753, 701  cm-1 
  
HRMS (EI+) Calcd for [M]+: 324.0854 Found 324.0856 
 
Compound 5h 
 
 
 
According to the general procedure, adduct 4o (108 mg, 0.296 mmol) was allowed to react with NEt3 
(123 µL, 0.887 mmol) for 48 h. The combined organic layers were washed with HCl 1M, brine and 
dried over MgSO4 to afford compound 5g (123 mg, 99%) as an orange oil. 
 
1H NMR  
(400 MHz, CDCl3) 
δ = 7.28 (d, J = 8.1 Hz, 1H), 7.03 (s, 1H) 7.02 (d, J = 8.1 Hz, 1H), 6.22 (dt, J = 
11.5, 7.7 Hz, 1H), 5.93 (dt, J = 11.5, 1.6 Hz, 1H), 4.03 (dd, J = 10.6, 9.1 Hz, 1H), 
3.70 (s, 3H), 3.68 – 3.64 (m, 1H), 3.51 (td, J = 8.9, 4.3 Hz, 1H), 3.17 – 2.97 (m, 
3H), 2.86 (s, 3H), 2.30 ppm (s, 3H) 
  
13C NMR 
(101 MHz, CDCl3) 
δ = 166.6, 145.7, 139.7, 134.1, 133.6, 129.2, 125.4, 122.2, 113.7, 55.7, 51.3, 
39.8, 34.4, 33.6, 21.0 ppm  
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IR 
(thin film) 
𝜈 = 3014, 2951, 2929, 1717, 1646, 1488, 1440, 1409, 1347, 1210, 1160, 1115, 
1063, 990, 818, 769, 769 cm-1  
  
HRMS (EI+) Calcd for [M]+: 309.1035 Found 309.1030 
 
Compound 5i 
 
 
 
According to the general procedure, adduct 4p (139 mg, 0.335 mmol) was allowed to react with NEt3 
(139 µL, 1.00 mmol) for 48 h. Purification via flash chromatography (silica, 2:8 v/v ethyl 
acetate/petroleum spirit elution) afforded enone 5i (74 mg, 64%) as a yellow oil. 
 
1H NMR  
(400 MHz, CDCl3) 
δ = 7.35 – 7.27 (m, 3H), 6.20 (dt, J = 11.5, 7.7 Hz, 1H), 5.95 (dt, J = 11.5, 1.5Hz, 
1H), 4.05 (dd, J = 10.6, 9.3 Hz, 1H), 3.76 – 3.67 (m, 1H), 3.71 (s, 3H), 3.57 – 
3.47 (m, 1H), 3.07 – 3.01 (m, 2H), 2.90 ppm (s, 3H) 
  
13C NMR 
(101 MHz, CDCl3) 
δ = 166.5, 144.9, 141.2, 136.3, 131.6, 128.1, 128.0, 122.7, 116.5, 115.2, 55.6, 
51.5, 39.6, 35.0, 33.4 ppm 
  
IR 
(thin film) 
𝜈 = 2930, 1717, 1647,  1477, 14440, 1411, 1349, 1212, 1161, 1119, 1065, 971, 
913, 819, 771, 743 cm-1 
  
HRMS (EI+) Calcd for [M]+: 372.9983 Found 372.9987 
 
Compound 5j 
 
 
 
According to the general procedure, xanthate adduct 4h (203 mg, 0.369 mmol) was allowed to react 
with NEt3 (160 µL, 1.11 mmol) for 24 h. Purification via flash chromatography (silica, 1:1 v/v diethyl 
ether/petroleum spirit elution) afforded compound 5j (81 mg, 51%) as a yellow oil. 
 
1H NMR  
(400 MHz, CDCl3) 
δ = 7.31 – 7.18 (m, 3H), 6.21 (dt, J = 11.5, 7.3 Hz, 1H), 5.88 (dt, J = 11.5, 1.7 Hz, 
1H), 4.57 (qd, J = 7.2, 1.6 Hz, 2H), 3.92 (d, J = 7.6 Hz, 2H), 3.83 – 3.75 (m, 1H), 
3.72 (s, 3H), 3.31 (ddd, J = 16.0, 6.9, 4.8 Hz, 1H), 3.07 (dddd, J = 16.1, 8.8, 7.7, 
1.7 Hz, 1H), 2.89 (s, 3H), 2.38 (s, 3H), 1.35 ppm (t, J = 7.1 Hz, 3H) 
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13C NMR 
(101 MHz, CDCl3) 
δ = 212.8, 166.5, 144.8, 138.8, 136.1, 130.4, 130.2, 128.8, 122.2, 70.3, 53.2, 
51.4, 48.7, 37.5, 29.8, 21.3, 13.8 ppm 
  
IR 
(thin film) 
𝜈 = 2986, 2951, 1721, 1650, 1510, 1439, 1409, 1343, 1211, 1155, 1112, 1047, 
1000, 962, 850, 819, 760, 722, 654 cm-1 
  
HRMS (EI+) Calcd for [MC3H5OS2]
+: 309.1035 Found 309.1032 
 
Compound 8a 
 
 
According to the general procedure, xanthate adduct 7a (96 mg, 0.25 mmol) was allowed to react 
with NEt3 (0.1 mL, 0.75 mmol) for 24 h. Purification via flash chromatography (silica, 1:10 v/v ethyl 
acetate/petroleum spirit elution) afforded enone 8a (87 mg, 67%) as a pale yellow oil. 
 
1H NMR  
(400 MHz, CDCl3) 
δ = 6.27 (dt, J = 11.7, 7.1 Hz, 1H), 5.92 (m, 1H), 4.27 (m, 4H), 4.12 (m, 1H), 3.71 (s, 
3H), 3.22 (m, 1H), 3.07 (m, 1H), 2.08 (s, 3H), 1.01 ppm (s, 9H) 
  
13C NMR 
(101 MHz, CDCl3) 
δ = 213.1, 170.5, 166.3, 144.8, 122.0, 83.6, 65.2, 51.2, 48.6, 31.8, 30.0, 26.6, 26.5, 
20.7 ppm 
  
IR  
(thin film) 
𝜈 = 2959, 2872, 1747, 1723, 1650, 1439, 1367, 1228, 1067, 1029, 952, 818 cm-1  
  
HRMS  
(EI+) 
Calculated for [M]+: 348.1065                                                     Found: 348.1056 
 
 
Compound 8b 
 
 
According to the general procedure, xanthate adduct 7a (100 mg, 0.21 mmol) was allowed to react 
with NEt3 (0.85 mL, 0.62 mmol) for 24 h. Purification via flash chromatography (silica, 1:20 v/v ethyl 
acetate/petroleum spirit elution) afforded enone 8a (93 mg, 61%) as a pale yellow oil. 
 
1H NMR  
(400 MHz, CDCl3) 
δ = 7.98 (d, J = 6.2 Hz, 1H), 7.42 (d, J = 6.2 Hz, 1H), 6.31 (m, 1H), 5.93 (d, J = 
11.3 Hz, 1H), 4.54 (m, 1H), 4.27 (m, 3H), 3.67 (m, 3H), 3.33 (m, 1H), 3.14 (m, 1H), 
1.00 ppm (s, 9H) 
  
13C NMR 
(101 MHz, CDCl3) 
δ = 213.0, 166.2, 165.2, 144.6, 139.7, 131.1, 128.8, 128.8, 128.2, 122.2, 83.7, 
65.9, 51.2, 48.8, 31.8, 30.1, 26.5 ppm 
  
IR  
(thin film) 
𝜈 = 2959, 1725, 1595, 1439, 1271, 1227, 1174, 1066, 1015, 849, 759, 684 cm-1 
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HRMS  
(EI+) 
Calculated for [M]+: 444.0832                                                       Found: 444.0832 
 
 
Compound 8c 
 
 
 
According to the general procedure, xanthate adduct 7c (128 mg, 0.314 mmol) was allowed to react 
with NEt3 (131 µL, 0.942 mmol) for 22 h. Purification via flash chromatography (silica, 0:100 →2:98 
v/v ethyl acetate/petroleum spirit elution) afforded compound 8c (62 mg, 54%) as a yellow oil. 
 
1H NMR  
(400 MHz, CDCl3) 
δ = 7.27 – 7.13 (m, 5H), 6.16 (dt, J = 11.5, 7.1 Hz, 1H), 5.78 (dt, J = 11.6, 1.8 Hz, 
1H), 4.26 – 4.11 (m, 2H), 4.06 – 3.91 (m, 1H), 3.59 (s, 3H), 3.10 (dd, J = 13.9, 
6.2 Hz, 1H), 2.99 (td, J = 7.1, 1.7 Hz, 2H), 2.81 (dd, J = 13.9, 8.5 Hz, 1H), 
0.93 ppm (s, 9H) 
  
13C NMR 
(101 MHz, CDCl3) 
δ = 214.4, 166.6, 146.1, 138.3, 129.5, 128.6, 126.9, 121.7, 83.34, 51.6, 51.2, 
40.8, 32.2, 32.0, 26.7 ppm  
  
IR 
(thin film) 
𝜈 = 3028, 2958, 2855, 1724, 1648, 1496, 1454, 1438, 1408, 1367, 1273, 1200, 
1177, 1067, 1029, 952, 932, 817, 751, 700 cm-1  
  
HRMS (EI+) Calcd for [M]+: 366.1323 Found 366.1315 
 
Compound 10a 
 
 
According to the general procedure, thiocarbonate 9a (103 mg, 0.31 mmol) was allowed to react 
with NEt3 (0.2 mL, 1.4 mmol) for 24 h. Purification via flash chromatography (silica, 1:10 → 1:5 v/v 
ethyl acetate/petroleum spirit elution) afforded enone 10a (67 mg, 74%) as a clear oil. 
 
1H NMR  
(400 MHz, CDCl3) 
δ = 6.26 (ddd, J = 11.3, 7.2, 4.4 Hz, 1H), 5.90 (dd, J = 11.5, 1.8 Hz, 1H), 4.28 (m, 
2H), 4.24 (m, 2H), 3.75 – 3.68 (m, 4H), 3.19 – 3.08 (m, 1H), 3.08 – 2.96 (m, 1H), 
2.07 (s, 3H), 1.30 ppm (t, J = 7.1 Hz, 3H) 
  
13C NMR 
(101 MHz, CDCl3) 
δ = 170.5, 169.7, 166.3, 144.9, 121.9, 65.8, 63.9, 51.2, 44.5, 30.5, 20.7, 14.2 ppm 
  
IR  
(thin film) 
𝜈 = 2953, 1747, 1722, 1650, 1440, 1383, 1234, 1147, 1035, 850, 820, 676 cm-1  
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HRMS (EI+) Calculated for [MC2H3O2]
+: 230.0613                                               Found: 230.0618 
 
Compound 10b  
 
 
According to the general procedure, thiocarbonate 9b (247 mg, 0.58 mmol) was allowed to react 
with NEt3 (0.24 mL, 1.73 mmol) for 24 h. Purification via flash chromatography (silica, 1:10 → 1:5 v/v 
ethyl acetate/petroleum spirit elution) afforded enone 10b (193 mg, 86%) as a pale yellow oil. 
 
1H NMR  
(400 MHz, CDCl3) 
δ = 7.98 (d, J = 8.5 Hz, 2H), 7.42 (d, J = 8.5 Hz, 2H), 6.30 (dt, J = 11.5, 7.3 Hz, 1H), 
5.92 (dd, J = 11.6, 1.7 Hz, 1H), 4.48 (dd, J = 5.8, 2.5Hz, 2H), 4.27 (q, J = 7.1 Hz, 2H), 
3.86 (dd, J = 8.7, 5.8 Hz, 1H), 3.68 (s, 3H), 3.24 (m, 1H), 3.11 (m, 1H), 1.29 ppm (t, 
J = 7.1 Hz, 3H) 
  
13C NMR 
(101 MHz, CDCl3) 
δ = 169.6, 166.3, 165.2, 144.7, 139.6, 131.1, 131.1, 128.8, 128.8, 128.3, 122.1, 
66.5, 64.0, 51.2, 44.6, 30.5, 14.2 ppm 
  
IR  
(thin film) 
𝜈 = 2983, 2952, 2850, 1724, 1650, 1595, 1439, 1403, 1272, 1173, 1148, 1092, 
1015, 850, 820, 760 cm-1 
  
HRMS  
(EI+) 
Calculated for [MOCH3]
+: 355.0407                                            Found: 355.0393 
  
Compound 10c 
 
 
According to the general procedure, thiocarbonate 9b (56 mg, 0.16 mmol) was allowed to react with 
NEt3 (0.07 mL, 0.48 mmol) for 24 h. Purification via flash chromatography (silica, 1:10 → 1:5 v/v ethyl 
acetate/petroleum spirit elution) afforded enone 10c (40 mg, 81%) as a pale yellow oil. 
 
1H NMR  
(400 MHz, CDCl3) 
δ = 7.30 (m, 2H), 7.24 (m, 3H), 6.26 (ddd, J = 11.5, 7.1, 4.2 Hz, 1H), 5.88 (dd, J = 
11.5, 1.8 Hz, 1H), 4.26 (q, J = 7.1 Hz, 2H), 3.77 – 3.65 (m, 4H), 3.10 – 2.99 (m, 3H), 
2.91 (dd, J = 13.9, 8.0 Hz, 1H), 1.30 ppm (t, J = 7.1 Hz, 3H) 
  
13C NMR 
(101 MHz, CDCl3) 
δ = 170.3, 166.5, 146.0, 138.3, 129.4, 128.4, 126.7, 121.4, 63.5, 51.1, 47.4, 41.7, 
32.8, 14.2 ppm 
  
IR  
(thin film) 
𝜈 = 3029, 2984, 2951, 1722, 1704, 1650, 1455, 1439, 1291, 1202, 1143, 1015 cm-1  
  
HRMS  
(EI+) 
Calculated for [M]+: 308.1082                                                        Found: 308.1090  
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Compound 10d 
 
 
 
According to the general procedure, thiocarbonate 9d (175 mg, 0.408 mmol) was allowed to react 
with NEt3 (170 µL, 1.22 mmol) for 23 h. Purification via flash chromatography (silica, 7:93 → 5:95 v/v 
diethyl ether/petroleum spirit) afforded enone 10d (113 mg, 72%) as a colorless oil. 
 
1H NMR  
(400 MHz, CDCl3) 
δ = 6.28 (dt, J = 11.4, 7.3 Hz, 1H), 5.92 (dt, J = 11.5, 1.7 Hz, 1H), 4.21 (q, J = 
7.1 Hz, 2H), 3.76  3.66 (m, 1H), 3.70 (s, 3H), 3.19 – 2.99 (m, 4H), 1.26 ppm (t, 
J = 7.1 Hz, 3H) 
  
13C NMR 
(101 MHz, CDCl3) 
δ = 169.6, 166.5, 147.10 – 143.92 (m, Car), 145.0, 142.15 – 138.90 (m, Car), 
138.88 – 135.77 (m, Car), 122.2, 112.44 – 111.46 (m, Car), 64.0, 51.3, 45.5, 
33.5, 28.1, 14.3 ppm 
  
19F NMR 
(282 MHz, CDCl3) 
δ = 137.02 (dd, J = 22.6, 8.6 Hz), 151.29 (t, J = 20.8 Hz), 157.67 ppm (td, J 
= 22.2, 8.4 Hz) 
  
IR 
(thin film) 
𝜈 =  2987, 2955, 1723, 1652, 1505, 1521, 1441, 1409, 1356, 1350, 1299, 1204, 
1148, 1006, 971, 850, 820, 733, 676, 613 cm-1 
  
HRMS (EI+) Calcd for [M]+: 398.0611 Found 398.0615 
 
Compound 10e 
 
 
 
1:1 after purification 
1:4 in crude NMR 
According to the general procedure, xanthate adduct 9e (68 mg, 0.21 mmol) was allowed to react 
with NEt3 (87 µL, 0.63 mmol) for 28 h. Purification via flash chromatography (silica, 2:98 → 5:95 v/v 
diethyl ether/petroleum spirit) afforded compound 10e (39 mg, 66%) as a colorless oil and as a 1:1 
mixture of two diastereomers.* 
*Ratio changed from 1:4 in crude NMR to 1:1 after purification. 
 
1H NMR  
(400 MHz, CDCl3) 
Major isomer (cis product):  
δ = 6.06 (dd, J = 11.5, 10.3 Hz, 1H), 5.78 (dd, J = 11.4, 1.1 Hz, 1H), 4.29 – 4.15 
(m, 2H), 3.85 (dd, J = 10.3, 8.7 Hz, 1H), 3.70 (s, 3H), 3.65 (dd, J = 8.5, 2.2 Hz, 
1H), 2.43 – 2.29 (m, 1H), 2.07 (dd, J = 4.2, 1.6 Hz, 1H) 1.71 – 1.53 (m, 2H), 1.50 
– 1.38 (m, 4H), 1.26 ppm (t, J = 7.1 Hz, 3H) 
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minor isomer (trans product): 
δ = 6.12 (dd, J = 11.4, 9.9 Hz, 1H), 5.73 (dd, J = 11.4, 1.2 Hz, 1H), 4.29 – 4.15 
(m, 2H), 3.70 (s, 3H), 3.37 (ddd, J = 5.8, 3.8, 2.2 Hz, 1H), 3.23 (dd, J = 9.7, 5.8 
Hz, 1H), 2.59 – 2.48 (m, 1H), 2.18 – 2.09 (m, 1H), 1.81 – 1.68 (m, 1H), 1.71 – 
1.53 (m, 1H), 1.50 – 1.38 (m, 4H), 1.27 ppm (t, J = 7.1 Hz, 3H) 
  
13C NMR 
(101 MHz, CDCl3) 
Major isomer (cis product):  
δ = 170.6, 166.5, 149.2, 120.0, 63.4, 52.6, 51.2, 45.0, 44.8, 43.8, 34.5, 28.94, 
28.89, 14.4 ppm  
 
minor isomer (trans product): 
δ = 171.2, 166.6, 152.15, 118.66, 63.4, 53.81, 51.2, 47.7, 44.6, 42.03, 37.0, 
29.9, 23.4, 14.4 ppm  
  
IR 
(thin film) 
𝜈 = 2953, 2874, 1722, 1704, 1643, 1438, 1409, 1365, 1298, 1206, 1175, 1140, 
1016, 947, 914, 850, 823, 744, 675 cm-1  
  
HRMS (EI+) Calcd for [M]+: 284.1082 Found 284.1077 
 
Compound 10f 
 
 
 
According to the general procedure, adduct 9f (127 mg, 0.344 mmol) was allowed to react with NEt3 
(143 µL, 1.03 mmol) for 25 h. Purification via flash chromatography (silica, 5:95 v/v ethyl 
acetate/petroleum spirit) afforded trans-decaline 10f (81 mg, 64%) as a yellow oil and as a 1:1 
mixture of two diastereomers. 
1H NMR  
(400 MHz, CDCl3) 
δ = 5.86 (s, 0.5H), 5.83 (s, 0.5H), 4.26 (dq, J = 8.5, 7.2 Hz, 2H), 3.93 (dt, J = 4.1, 
1.9 Hz, 0.5H), 3.39 (tt, J = 12.6, 4.4 Hz, 0.5H), 3.30 (dd, J = 12.7, 3.1 Hz, 0.5H), 
3.08 (dd, J = 12.5, 3.4 Hz, 0.5H), 2.81 (d, J = 1.5 Hz, 0.5H; OH), 2.80 (d, J = 1.4 
Hz, 0.5H; OH), 2.54  2.36 (m, 0.5H), 2.30 – 2.19 (m, 0.5H), 2.17 – 2.02 (m, 
1H), 1.80 – 1.62 (m, 3H), 1.60  1.40 (m, 4H), 1.42 – 1.19 ppm (m, 7H) 
  
13C NMR 
(101 MHz, CDCl3) 
Cis diastereomer : 
δ = 200.4, 170.4 , 70.6, 69.8, 63.6, 53.5, 44.8, 42.5, 37.7, 34.0, 33.9, 28.04, 
25.9, 21.5, 14.4 ppm  
 
Trans diastereomer : 
δ = 201.4, 170.2, 71.3, 69.9, 63.7, 49.4, 42.9, 40.4, 37.6, 33.0, 32.8, 27.9, 26.0, 
21.48, 14.5 ppm  
  
236
S34 
 
IR 
(thin film) 
𝜈 = 3545, 2934, 2858, 1704, 1447, 1391, 1352, 1319, 1282, 1198, 1141, 1055, 
1015, 972, 933, 912, 877, 850, 807, 740, 692, 676 cm-1  
  
HRMS (EI+) Calcd for [M]+: 465.0616 Found 468.0606 
 
Compound 10h 
 
 
 
According to the general procedure, adduct 9h (59 mg, 95 µmol) was allowed to react with NEt3 
(40 µL, 0.29 mmol) for 21 h. Purification via flash chromatography (silica, 1:9 → 2:8 v/v ethyl 
acetate/diethyl ether) afforded enone 10e (17 mg, 31%) as a yellow oil. 
 
1H NMR  
(400 MHz, CDCl3) 
δ = 6.38 – 6.24 (m, 1H), 6.18 (d, J = 9.7 Hz, 0.5H; NH), 6.10 (d, J = 9.5 Hz, 0.5H; 
NH), 5.99 – 5.90 (m, 1H), 5.18 (ddd, J = 15.8, 10.4, 5.6 Hz, 1H), 5.11 (dd, J = 
9.7, 7.7 Hz, 1H), 4.90 – 4.81 (m, 1H), 4.38 (ddt, J = 10.0, 6.8, 3.0 Hz, 1H), 4.30 
(qd, J = 7.2, 2.7 Hz, 2H), 4.23 (ddd, J = 12.2, 4.4, 2.1 Hz, 1H), 4.10 (dq, J = 12.3, 
2.7 Hz, 1H), 3.98 (dddd, J = 9.5, 7.0, 4.4, 2.3 Hz, 1H), 3.90 – 3.75 (m, 1.5H), 
3.73 (s, 1.5H), 3.72 (s, 1.5H), 3.71 – 3.67 (m, 0.5H), 3.67 – 3.60 (m, 0.5H), 3.55 
(dd, J = 9.9, 6.4 Hz, 0.5H), 3.45 – 3.32 (m, 0.5H), 3.33 – 3.19 (m, 0.5H), 3.12 – 
2.98 (m, 0.5H), 2.85 (dt, J = 15.6, 8.2 Hz, 0.5H), 2.09 (s, 3H), 2.02 (s, 1.5H), 
2.02 (s, 1.5H), 2.01 (s, 1.5H), 2.00 (s, 1.5H), 1.98 (s, 1.5H), 1.98 (s, 1.5H), 1.32 
ppm (t, J = 7.2 Hz, 3H) 
  
13C NMR 
(101 MHz, CDCl3) 
δ = 171.2, 171.1, 170.7, 170.3, 170.3, 170.1, 169.8, 169.40, 169.4, 166.6, 
166.6, 145.3, 145.3, 122.2, 122.0, 98.1, 97.7, 71.64, 71.60, 70.9, 69.9, 68.5, 
68.43, 68.40, 68.35, 64.3, 64.2, 62.14, 62.12, 51.98, 51.96, 51.5, 51.4, 45.6, 
45.2, 30.7, 30.2, 23.1, 23.1, 20.8, 20.8, 20.7, 14.4, 14.4 ppm  
  
IR 
(thin film) 
𝜈 = 3374, 2954, 1748, 1721, 1531, 1439, 1410, 1368, 1231, 1148, 1042, 960, 
913, 850, 820, 742, 676 cm-1 
  
HRMS (EI+) Calcd for [MC2H3O2]
+: 518.1696 Found 518.1689 
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Further transformations 
 
Compound 11a 
 
 
According to the general procedure, 352 mg of N-allyl-4-chlorobenzamide (1.80 mmol) was allowed 
to react with 380 mg (0.90 mmol) of xanthate adduct 4n for 3 h. The total amount of DLP added was 
81 mg (0.2 mmol, 22.5 mol%). Purification via flash chromatography (silica, 2:8 → 3:7 v/v ethyl 
acetate/petroleum spirit elution) afforded adduct 11a (289 mg, 52%) as an inseparable mixture of 
two diastereomers. 
 
1H NMR  
(400 MHz, CDCl3) 
δ = 7.85 (dd, J = 5.4, 3.1 Hz, 1H), 7.80 (dd, J = 5.5, 3.0 Hz, 1H), 7.78 – 7.69 (m, 
2H), 7.70 (d, J = 8.6 Hz, 1H), 7.65 (d, J = 8.6 Hz, 1H), 7.39 (d, J = 8.6 Hz, 1H), 
7.37 (d, J = 8.6 Hz, 1H), 6.51 (t, J = 5.9 Hz, 0.5H; NH), 6.45 (t, J = 5.8 Hz, 0.5H; 
NH), 5.79 (s, 0.5H), 5.77 (s, 0.5H), 4.65 – 4.39 (m, 3H), 3.99 – 3.88 (m, 0.5H), 
3.91 – 3.81 (m, 0.5H), 3.80 – 3.64 (m, 2H), 2.98 – 2.73 (m, 2H), 2.58 – 2.31 (m, 
2.5H), 2.24 – 2.06 (m, 1H) 1.98 (ddd, J = 15.4, 11.7, 4.2 Hz, 0.5H), 1.31 (t, J = 
7.1 Hz, 1.5H), 1.29 ppm (t, J = 7.1 Hz, 1H) 
  
13C NMR 
(101 MHz, CDCl3) 
δ = 214.4, 213.3, 196.1, 168.7, 168.6, 166.8, 166.5, 138.1, 138.0, 134.3, 132.7, 
132.6, 132.0, 131.9, 129.0, 128.9, 128.7, 128.6, 123.6, 123.5, 71.0, 70.6, 69.9, 
69.8, 49.4, 49.1, 48.9, 48.7, 44.6, 43.3, 35.1, 33.7, 32.2, 27.2, 26.5, 13.7 ppm 
  
IR 
(thin film) 
𝜈 =  3332, 2933, 1773, 1708, 1651, 1596, 1534, 1486, 1468, 1372, 1335, 1223, 
1112, 1093, 1047, 1014, 918, 847, 793, 758, 722 cm-1  
  
HRMS (EI+) Calcd for [MC3H5OS2]
+: 493.0488 Found 493.0483 
 
Compound 11b 
 
 
According to the general procedure, xanthate adduct 11a (190 mg, 0.308 mmol) was allowed to react 
with NEt3 (128 µL, 0.925 mmol) for 19 h. Purification via flash chromatography (silica, 2:8 → 3:7 v/v 
diethyl ether/petroleum spirit) afforded enone 11b (125 mg, 71%) as a colorless oil and as 1:1 
mixture of two diastereomers. 
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1H NMR  
(400 MHz, CDCl3) 
δ = 7.89 – 7.76 (m, 2H), 7.75 – 7.59 (m, 4H), 7.42 – 7.33 (m, 2H), 6.56 (t, J = 
6.0 Hz, 0.5H; NH), 6.49 (t, J = 5.8 Hz, 0.5H; NH), 6.13 (dtd, J = 11.5, 7.4, 1.7 Hz, 
1H), 5.80 (ddd, J = 13.2, 3.0, 1.7 Hz, 1H), 4.80 – 4.63 (m, 1H), 4.58 – 4.41 (m, 
2H), 4.02 – 3.91 (m, 1H), 3.83 (t, J = 5.7 Hz, 1H), 3.72 (td, J = 5.7, 3.8 Hz, 1H), 
3.66 (s, 1.5H), 3.64 (s, 1.5H), 3.48 – 3.31 (m, 1H), 3.21 – 3.03 (m, 1H), 2.99 
(ddd, J = 14.9, 11.5, 3.4 Hz, 0.5H), 2.55 (ddd, J = 14.8, 9.6, 6.7 Hz, 0.5H), 2.27 
(ddd, J = 14.8, 7.6, 4.9 Hz, 0.5H), 2.01 (ddd, J = 15.4, 11.4, 4.1 Hz, 0.5H), 1.35 – 
1.2 ppm (m, 3H) 
  
13C NMR 
(101 MHz, CDCl3) 
δ = 214.4, 213.5, 168.6, 168.5, 166.7, 166.5, 166.4, 166.35, 144.4, 144.2, 
138.0, 137.9, 134.2, 134.15, 132.8, 132.75, 132.02, 131.99, 129.0, 128.9, 
128.67, 128.66, 123.5, 123.4, 122.54, 122.50, 70.9, 70.6, 51.32, 51.31, 49.9, 
49.0, 48.97, 48.8, 44.6, 43.3, 34.9, 33.5, 32.8, 32.1, 13.7 ppm  
  
IR 
(thin film) 
𝜈 = 3336, 2950, 1773, 1710, 1648, 1596, 1536, 1486, 1468, 1439, 1392, 1363, 
1224, 1112, 1093, 1048, 911, 873, 847, 820, 722 cm-1 
  
HRMS (EI+) Calcd for [M]+: 574.0999 Found 574.1003 
 
Compound 11c  
 
 
A stirred solution of xanthate adduct 4i (100 mg, 0.26 mmol) in a 1:1 mixture of THF/H2O (2 mL) was 
treated with NEt3 (0.18 mL, 1.3 mmol) at ambient temperature. After 2 h the reaction mixture was 
diluted with H2O (3 mL) and washed with Et2O (10 mL). The separated aqueous phase was then 
acidified via the addition of a 5 % aqueous solution of HCl and extracted twice with EtOAc (2 x 10 
mL). The combined organic extracts were dried over MgSO4 before being concentrated under 
reduced pressure and the yellow oil thus obtained was subjected to flash chromatography (silica, 1:1 
→ 2:1 v/v ethyl acetate/petroleum spirit elution). Concentration of the relevant fractions afforded 
the Z-acid (62 mg, 73%) as a pale yellow oil.  
 
1H NMR  
(400 MHz, CDCl3) 
δ = 6.34 (ddd, J = 11.6, 7.7, 4.1 Hz, 1H), 5.85 (dd, J = 11.5, 1.7 Hz, 1H), 5.45 (dd, J 
= 4.3, 2.5Hz, 1H), 4.68 (q, J = 7.1 Hz, 2H), 3.32 (app. t, J = 9.3 Hz, 2H), 2.16 (d, J = 
16.1 Hz, 1H), 2.08 – 1.84 (m, 5H), 1.47 (s, 6H), 1.44 (t, J = 7.1 Hz, 3H), 1.37 – 1.24 
ppm (m, 2H) 
  
13C NMR 
(101 MHz, CDCl3) 
δ = 214.2, 171.4, 150.4, 135.1, 122.1, 122.1, 119.6, 69.3, 59.0, 42.7, 36.6, 29.8, 
27.2, 25.1, 24.8, 24.6, 13.8 ppm 
  
IR  
(thin film) 
𝜈 = 3393, 2925, 1694, 1639, 1440, 1366, 1293, 1233, 1111, 1023, 833 cm-1  
  
HRMS  
(EI+) 
Calculated for [M]+: 328.1167                                                       Found: 328.1167 
239
S37 
 
Compound 11d (E and Z isomers)  
 
 
According to the general procedure, xanthate adduct 4i (100 mg, 0.26 mmol) was allowed to react 
with NEt3 (0.18 mL, 1.3 mmol) for 24h. Purification via flash chromatography (silica, 1:10 → 1:5 v/v 
ethyl acetate/petroleum spirit elution) afforded compound 11d (52 mg, 58%) as a ca. 4:1 ratio of the 
E/Z isomers.  
 
E isomer: 
1H NMR  
(400 MHz, CDCl3) 
δ = 6.12 (d, J = 15.7 Hz, 1H), 5.68 (m, 1H), 5.60 (dd, J = 15.7, 7.2 Hz, 1H), 4.67 (q, J 
= 7.1 Hz, 2H), 3.68 (s, 3H), 3.12 (d, J = 7.1 Hz, 2H), 2.31 (m, 2H), 2.06 (m, 4H), 1.49 
(s, 3H), 1.47 (s, 3H), 1.44 (t, J = 7.1 Hz, 3H), 1.35 – 1.27 (m, 1H) ppm 
  
13C NMR 
(101 MHz, CDCl3) 
δ = 214.1, 172.3, 136.2, 135.1, 128.1, 118.1, 69.3, 58.9, 51.8, 42.8, 38.0, 27.7, 
25.6, 25.00, 24.9, 24.2, 13.8 ppm 
  
IR  
(thin film) 
𝜈 = 2923, 1739, 1435, 1366, 1233, 1155, 1111, 1040, 966, 856 cm-1  
  
HRMS  
(EI+) 
Calculated for [MC3H5O2S]
+: 220.1542                                             Found: 220.1506 
 
Z isomer: 
1H NMR  
(400 MHz, CDCl3) 
δ = 6.21 (dd, J = 11.4, 7.6 Hz, 1H), 5.83 (d, J = 11.5 Hz, 1H), 5.44 (d, J = 5.3 Hz, 1H), 
4.68 (q, J = 7.1 Hz, 2H), 3.71 (s, 3H), 3.32 (m, 2H), 2.16 (m, 1H), 2.09 – 1.83 (m, 
5H), 1.47 (s, 6H), 1.44 (t, J = 7.1 Hz, 3H), 1.37 – 1.24 ppm (m, 1H) 
  
13C NMR 
(101 MHz, CDCl3) 
δ = 214.5, 166.9, 148.0, 135.5, 121.9, 120.0, 77.2, 69.5, 59.2, 51.2, 42.9, 36.6, 
29.9, 27.4, 25.3, 25.0, 24.8, 13.9 ppm 
  
IR  
(thin film) 
𝜈 = 2923, 1739, 1435, 1366, 1233, 1155, 1111, 1040, 966, 856 cm-1  
  
HRMS  
(EI+) 
Calculated for [MC3H5O2S]
+: 220.1542                                             Found: 220.1531 
 
Compound 12a 
 
 
A stirred solution of enone 10a (65 mg, 0.22 mmol) in PhMe (2 mL), maintained under an 
atmosphere of nitrogen, was treated with DBU (0.1 mL, 0.67 mmol, 3 eq.) at ambient temperature. 
After 0.25 h the brown reaction mixture was loaded directly onto a chromatography column and 
subjected to flash chromatography (silica, 1:10 → 1:5 v/v ethyl acetate/petroleum spirit elution). 
Concentration of the relevant fractions afforded diene 12a (mg, 77 %) as a clear oil.  
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S38 
 
1H NMR  
(400 MHz, CDCl3) 
δ = 7.26 (dd, J = 15.1, 11.1 Hz, 1H), 6.83 (dd, J = 15.3, 11.0 Hz, 1H), 6.14 (ddd, J = 
15.5, 11.4, 5.8 Hz, 1H), 5.92 (d, J = 15.5 Hz, 1H), 4.67 (d, J = 5.8 Hz, 2H), 3.75 (s, 
3H), 2.09 ppm (s, 3H) 
  
13C NMR 
(101 MHz, CDCl3) 
δ = 170.5, 167.1, 143.2, 135.3, 130.5, 122.1, 63.7, 51.6, 20.8 ppm 
  
IR  
(thin film) 
𝜈 = 2956, 2851, 1732, 1715, 1651, 1436, 1372, 1241, 1145, 1045, 726, 606 cm-1 
  
HRMS  
(EI+) 
Calculated for [M]+: 184.0736                                                       Found: 184.0741 
 
Compound 12b 
 
 
A stirred solution of enone 10b (80 mg, 0.21 mmol) in PhMe (1 mL), maintained under an 
atmosphere of nitrogen, was treated with DBU (0.01 mL, 0.63 mmol, 3 eq.) at ambient temperature. 
After 1 h the brown reaction mixture was diluted with EtOAc (10 mL) and quenched with a saturated 
aqueous solution of NH4Cl (5 mL). The separated aqueous phase was extracted twice with EtOAc (2 x 
10 mL) and the combined organic extracts were dried over MgSO4 before being concentrated under 
reduced pressure. The brown oil thus obtained was subjected to flash chromatography (silica, 1:5 v/v 
ethyl acetate/petroleum spirit elution). Concentration of the relevant fractions afforded diene 12b 
(35 mg, 60 %) as a white powder (m.p. range 73 – 75 °C.)  
 
1H NMR  
(400 MHz, CDCl3) 
δ = 7.99 (d, J = 8.6 Hz, 2H), 7.43 (d, J = 8.6 Hz, 2H), 7.28 (dd, J = 15.3, 10.9 Hz, 1H), 
6.46 (dd, J = 15.4, 11.0 Hz, 1H), 6.24 (dd, J = 15.3, 5.8 Hz, 1H), 5.95 (d, J = 15.4 Hz, 
1H), 4.92 (d, J = 5.8 Hz, 2H), 3.76 ppm (s, 3H) 
  
13C NMR 
(101 MHz, CDCl3) 
δ = 167.0, 165.2, 143.1, 139.7, 135.0, 131.1, 130.9, 128.8, 128.8, 128.4, 122.4, 
64.4, 51.6 ppm 
  
IR  
(thin film) 
𝜈 = 3009, 2956, 2854, 1713, 1620, 1435, 1334, 1274, 1223, 1011, 848, 756, 729, 
680 cm-1  
  
HRMS  
(EI+) 
Calculated for [M]+: 280.0502                                                        Found: 280.0507 
 
Compound 12c 
 
 
 
A stirred solution of enone 10d (95 mg, 0.24 mmol) in PhMe (1 mL), maintained under an 
atmosphere of nitrogen, was treated with DBU (0.11 mL, 0.73 mmol) at ambient temperature. After 
1 h the brown reaction mixture was directly subjected to flash chromatography (silica, 0:100 → 3:97 
v/v diethyl ether/pentane) to afford diene 12c (13 mg, 19%) as a colorless oil. 
241
S39 
 
1H NMR  
(400 MHz, CDCl3) 
δ = 7.06 (dd, J = 16.1, 10.4 Hz, 1H), 6.40 (d, J = 16.1 Hz, 1H), 6.36 – 6.25 (m, 
1H), 6.03 (dt, J = 15.0, 7.2 Hz, 1H), 3.72 (s, 3H), 3.22 ppm (dd, J = 7.3, 1.3 Hz, 
2H) 
  
13C NMR 
(101 MHz, CDCl3) 
δ = 171.5, 146.6 – 143.1 (m, Car), 141.45 – 138.82 (m, Car), 138.84 – 136.29 (m, 
Car), 136.98 (td, J = 8.3, 2.8 Hz), 134.1, 129.6, 116.0, 113.09 – 111.38 (m, Car), 
52.2, 38.1 ppm  
  
19F NMR 
(282 MHz, CDCl3) 
δ = 137.99 – 138.28 (m), 151.83 (t, J = 20.8 Hz), 158.01 – 158.63 ppm 
(m) 
  
IR 
(thin film) 
𝜈 = 2956, 1742, 1653, 1521, 1497, 1437, 1330, 1256, 1201, 1169, 1147, 999, 
961, 914, 783, 743, 658 cm-1 
  
HRMS (EI+) Calcd for [M]+: 292.0523 Found 292.0515 
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Copies of the NMR Spectra 
Compound 1a 
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Compound 1b 
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Compound 11d (E isomer) 
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Publication 8 
 
Carbonodithioic Acid S-[3-(Diethoxyphosphinyl)-2-oxopropyl] O-Ethyl Ester 
 
Lorenzo V, White.   
 
Manuscript accepted for publication in Encyclopedia of Reagents for Organic Synthesis.  
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Appendix One 
Single-crystal X-ray report for compound 10 of publication 3.  
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Appendix Two 
Single-crystal X-ray report for compound 14 of publication 3.  
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Appendix Three 
Single-crystal X-ray report for compound 22 of publication 3. 
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Appendix Four 
Single-crystal X-ray report for compound 3a of publication 5 
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Appendix Five 
Single-crystal X-ray report for compound 7a of publication 5 
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Appendix Six 
Single-crystal X-ray report for compound 5 of publication 6. 
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